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ChlR1 is a DNA helicase implicated in diverse cellular processes including sister 
chromatid cohesion and DNA replication and repair. However, the mechanism by which 
ChlR1 participates in these processes is unknown. Data presented in this thesis show that 
siRNA-mediated depletion of ChlR1 causes increased sensitivity to chemically-induced 
replication stress. Treatment of ChlR1-depleted cells with hydroxyurea results in 
increased mono-ubiquitination of PCNA and increased chromatin-associated RPA, 
indicating stalled DNA replication. Furthermore, ChlR1 is recruited to chromatin 
following hydroxyurea treatment, supporting a role in the stabilisation of forks during 
replication stress. Fibroblasts derived from a Warsaw Breakage Syndrome (WABS) 
patient caused by mutation of ChlR1 (G57R) have both defective sister chromatid 
cohesion and G2 checkpoint following radiation-induced damage. Complementation with 
wild-type ChlR1 rescued this mutant phenotype while a known helicase dead mutant of 
ChlR1 (K50R) or the WABS-associated mutants G57R or ΔK897 did not. However, 
increased and prolonged Chk1 activation was observed in both K50R and ΔK897 
complemented cells after treatment with hydroxyurea while the G57R was comparable to 
wild-type. These data suggest that the novel WABS mutation (G57R) may retain some 
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1.1 Maintenance of genomic stability is essential for cell survival and proliferation 
The ability of a cell to survive, function and replicate depends upon the successful co-
ordination of essential cellular processes that enable the integrity of the genome to be 
maintained.  The consistently accurate transmission of genetic information to subsequent 
generations involves the careful control and regulation of important cellular processes such 
as DNA replication, DNA damage repair and sister chromatid cohesion.  
Cells must accurately synthesise exact copies of the DNA in each chromosome to pass on 
to their progeny following mitosis. This requires not only accurate, error-free replication of 
each DNA molecule but also the successful detection and repair of any damage prior to 
completion of cell division. Additionally, cells must also ensure that chromosomes are 
correctly segregated so that each daughter cell is genetically identical and has the 
appropriate chromosomal complement following cytokinesis. This is achieved via the 
encircling of two newly-replicated DNA molecules, now termed sister chromatids, by a 
protein complex called cohesin until separation occurs at the onset of anaphase. Disruption 
or deregulation of any of these processes can result in loss of genomic integrity. In humans 
this can have serious consequences for cell survival and can lead to severe inherited 
genetic disorders as well as contributing to both the development and progression of 
cancer [1, 2].  
Consequently, cells have evolved very elegant mechanisms which allow the tight 
regulation and coupling of these essential processes. This requires the coordination and 
participation of an army of cellular proteins, many of which function in more than one of 
these pathways. How diverse cellular processes such as DNA replication, DNA repair and 
cohesion establishment can function both individually and in collaboration to promote 
genome stability maintenance will be discussed in subsequent sections. 
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1.2 DNA replication, DNA damage repair and the maintenance of genetic stability 
Accurate transmission of genetic material from a parent cell to its daughter cells during 
mitosis is absolutely essential if cell viability and genetic stability is to be maintained. This 
requires that the cell has precisely replicated its DNA such that each of its offspring 
receives an identical copy of each chromosome following cell division. To ensure this is 
achieved, cells have evolved sophisticated machinery that allows them to sense mistakes in 
replication or damage to DNA and to take appropriate action [3].  
 
1.2.1 Overview of eukaryotic DNA replication 
In eukaryotic cells, replication initiation occurs at sites across the genome known as 
origins of replication [4, 5]. The specific factors influencing origin selection as well as 
origin spacing and distribution throughout the genome, while thought to be sequence 
independent, still present an area of ongoing study. What is clear however is that origin 
selection depends upon the binding of the origin recognition complex (ORC), a six subunit 
complex consisting of ORC1-ORC6, which associates with potential origins in the G1 
phase of the cell cycle. Also during G1, components of the pre-replication complex (pre-
RC) are recruited to origins by the ORC. These include the replicative helicase MCM2-7 
(mini-chromosome maintenance 2-7) as well as CDC6 (cell division cycle 6) and CDT1 
(chromatin licensing and DNA replication factor 1). This process is also referred to as 
origin licencing [6-9]. Replication is then initiated in early S-phase via the specific 
phosphorylation of various subunits of the pre-RC by cellular kinases CDK2 (cyclin-
dependent kinase 2) and DDK (Dbf4-dependent kinase or CDC7 kinase as it is also 
known) which serves as a signal for subsequent loading of CDC45 and the GINS (go-ichi-
ni-san) complex to form the active replicative helicase complex comprised of CDC45, 
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MCM2-7 and GINS (CMG) [10-12]. This in turn promotes origin firing and replication 
fork progression [13-16]. In eukaryotes, two individual replication complexes are 
assembled and activated at each origin and then proceed to move away from the origin in 




Figure 1.1. Schematic representation of the proteins required for origin licensing and 
replication initiation (A) and key components of the assembled replication machinery 
required for subsequent fork progression and replication termination (B). This figure 




Other components of the active replisome at this stage include the clamp loader RFC 
(replication factor c) as well as the sliding clamp protein PCNA (proliferating cell nuclear 
antigen) which is responsible for the tethering of the DNA polymerase enzymes to the 
template and promoting processivity [18]. The replisome actually comprises three 
polymerase enzymes, each with a specific role to play in the process. Polymerase α 
synthesises the DNA primer required to kick-start DNA synthesis, polymerase δ is 
responsible for lagging strand synthesis while polymerase ε replicates the leading strand. 
The switch between the polymerase α and the replicative polymerases is regulated by 
PCNA [19]. This polymerase switching mechanism is also important for activation of the 
translesion synthesis (TLS) pathway where additional specialised low-fidelity polymerases 
are recruited by PCNA to allow bypass of some DNA lesions (reviewed in [20]). This 
method of DNA damage tolerance will be discussed further in subsequent sections. RFC 
and PCNA also act as a scaffold for the loading of other critical replication proteins such 
as DNA ligase and the flap endocuclease Fen1 which are both essential in the processing 
of Okazaki fragments generated during lagging strand synthesis [21]. A schematic 
representation of the proteins involved in replication fork progression is shown in figure 
1.1B. 
While the processes of replication initiation and fork progression have been well-
characterised, much remains unknown with regards to how replication is terminated in 
eukaryotes. It is thought to involve the convergence of two moving replication forks 
although the precise mechanisms by which the cell co-ordinates this process are not clear. 
There has been some suggestion that it may ultimately require decatenation of sister 
chromatids by topoisomerase enzymes with the cooperation of DNA helicases [22]. 
Termination sites, much like origins of replication, appear to be randomly distributed 
across the genome in a non-sequence specific manner [23]. Work carried out by Gambus 
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and colleagues has recently shed new light on the elusive process of replication 
termination. They show that in Xenopus egg extracts, replisome disassembly at converging 
replication forks is mediated by the polyubiquitination of the MCM7 subunit of the 
replicative helicase which then leads to its removal by chromatin remodelling protein 
p97/VCP/Cdc48 [24]. 
 
1.2.2 Replication fork stalling and replication-coupled DNA damage 
When replication forks encounter obstacles on the DNA template which impede their 
progression, this can result in DNA damage and subsequent loss of genome integrity. 
Barriers to replication fork progression can be endogenous, for example unusual DNA 
secondary structure or topological entanglements as well as potential collisions with 
transcription machinery or other chromatin-bound protein complexes. Alternatively, 
replication stress can be induced by exogenous factors such as DNA damaging agents 
which cause physical DNA lesions such as DNA crosslinks, DNA-protein complexes or 
double strand breaks (DSBs) [25]. Sophisticated cellular mechanisms are therefore in place 
to allow cells to respond to these potential sources of DNA damage and preserve the 
fidelity of the replication process. The type of damage response initiated by the cell and 
choice of repair mechanism will depend upon both the type of lesion as well as the cell 
cycle phase. The successful completion of replication thus requires the coordinated action 
of proteins from diverse pathways including checkpoint signalling, homologous 
recombination, DNA repair/damage response as well as proteins directly involved in 
maintaining replication fork stability or progression. Defects in many of these pathways 
have been shown to lead to altered replication dynamics and an increase in replication-
associated DNA damage [17, 26].  
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1.2.3 DNA damage tolerance and the translesion synthesis (TLS) pathway 
In some instances, when a cell encounters damaged template DNA during replication, 
PCNA can recruit specialised DNA polymerases that have the flexibility to accommodate 
the damaged DNA template which allows them to synthesise across lesions [20, 27, 28]. 
This damage tolerance mechanism is tightly controlled via the monoubiquitination of 
PCNA by the E3 ubiquitin ligase Rad18 in conjunction with the E2 conjugating enzyme 
Rad6 [29, 30]. However, as this is an error-prone pathway it is thus carefully regulated at 
sites of DNA damage. All of the low-fidelity polymerase enzymes which have so far been 
characterised have been shown to contain a ubiquitin binding domain which allows them 
to interact specifically with monoubiquitinated PCNA [31, 32]. Interestingly, it has been 
widely observed that depletion of the cellular nucleotide pool with the replication inhibitor 
hydroxyurea (HU), also results in PCNA monoubiquitination. In the absence of any actual 
lesion to bypass, it may be that this monoubiquitin signal also recruits other factors 
involved in the maintenance of fork stability.  
In addition to this error-prone process, a second error-free damage tolerance pathway has 
been characterised in yeast. This pathway is Rad5-dependent and involves utilisation of the 
replicated sister chromatid as a template for synthesis of the damaged section of DNA in a 
process termed ‘template switching’. The initial monoubiquitination of PCNA by the 
Rad6-Rad18 complex is followed by Rad5 mediated construction of Lysine-63 linked 
polyubiquitin chains, which appear to act as a signal for the template switching mechanism 
[33]. Conservation of this pathway has only recently been established in higher eukaryotes 
[34, 35]. A human homologue of Rad5 has been identified as HLTF (helicase-like 
transcription factor) which has been shown to have the ability to facilitate PCNA 
polyubiquitination as well as displaying replication fork regression activity similarly to its 
yeast counterpart [36]. 
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1.2.4 The intra-S checkpoint 
When an active replication fork encounters an obstacle, the fork will initially stall to allow 
the removal, repair or resolution of the perceived impediment. Following successful 
removal of the block, the fork may then simply resume replicating. However, if the fork 
remains stalled for a prolonged period of time, it has been shown that at some point these 
forks are no longer able to restart and instead collapse [37]. In these instances the 
replication machinery becomes disassociated from the DNA and a double strand break 
may be formed which then requires processing and repair.  
Often, when a replication fork encounters a block or lesion on the DNA, the helicase 
activity becomes uncoupled from the polymerase which leads to a scenario whereby the 
replicative helicase continues to unwind the duplex ahead of the replicon[38]. This results 
in long tracts of single-stranded DNA (ssDNA) which becomes coated with the single 
strand binding protein RPA (replication protein A) and can be visualised by 
immunofluorescence. The generation of single stranded DNA is also a feature of nuclease-
mediated DNA resection which occurs during the processing of double strand breaks and 
other DNA lesions [39].   
The primary checkpoint pathway activated in response to replication-coupled damage is 
the ATR signalling pathway [40]. ATR (ataxia telangiectasia and Rad3-related) is an 
essential gene in mammalian cells although mutations in ATR which partially abrogate its 
activity have been linked to Seckel syndrome, a rare genetic disorder which is 
characterised by growth and developmental defects [41]. ATR and its binding partner 
ATRIP (ATR interacting protein) recognise and are recruited to RPA coated ssDNA [42]. 
Activated ATR then mediates phosphorylation of a number of key downstream effectors 
including other signalling proteins and repair factors including Chk1 [43], the key 
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downstream effector kinase in the ATR pathway, H2AX [44] and p53 [45, 46]. Chk1 in 
turn then phosphorylates cellular phosphatases to downregulate CDK activation and inhibit 
the progression of cells through S-phase which thus allows time for damage repair and/or 
fork restart to occur [47, 48]. In this capacity Chk1 has also been shown to inhibit new 
origin firing as well as being able to phosphorylate DNA repair proteins such as BRCA2 
and Rad51 [49-52]. Efficient activation of ATR and subsequent phosphorylation of Chk1 
also depends upon various other proteins involved in the replication checkpoint pathway 
including Rad17, Rad9, Topbp1 (DNA topoisomerase 2-binding protein 1) as well as 
Claspin and components of the replication fork protection complex Timeless and Tipin 
[53-58].  
Checkpoint control of DNA replication is also important in unperturbed replication and 
components of checkpoint pathways are crucial regulators of replication initiation, 
progression and fork stability even in the absence of damage [59]. Inhibition of the ATR 
signaling pathway has been shown to lead to upregulation of origin firing during S-phase 
as well as an overall reduction in replication fork speeds [60-63]. Even in normal 
replication, ssDNA is transiently generated upon unwinding of the DNA by the replicative 
helicase during replication initiation and progression. This is thought to lead to low-level 
checkpoint activation which in turn regulates cellular levels of CDC25 phosphatases and 
CDK activity which allows cells to maintain tight control over the replication process by 
downregulating further origin firing [60]. It has also been shown that CDK2 inhibition in 
Chk1 deficient cells suppresses the slow replication fork speed phenotype with CDC7 
depletion also able to restore normal replication fork speeds in the absence of Chk1. This 
suggests that control and regulation of replication initiation may be the key to explaining 
the effects of aberrant checkpoint control on replication fork progression [62]. Higher fork 
density, as a result of more active origins mediated by a loss of checkpoint control, could 
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potentially lead to more fork collisions, an increased need for the resolution of replication 
blocks and subsequent downstream DNA damage.  
Additional roles for the checkpoint in promoting efficient replication fork progression have 
been suggested and could include a role in the maintenance of replicon stability [64-66]. It 
can be conceived that unstable forks prone to collapse or stalling could also lead to the 
slower replication fork speed observed in checkpoint deficient cells. There is also some 
evidence to suggest that activation of the checkpoint in the presence of DNA damage not 
only leads to a global reduction in origin firing, but actually results in replication fork 
slowing. Although, precisely how this is achieved remains unclear.  
While it is clear that checkpoint proteins play an important role in the control of replication 
and replication fork stability, the replication fork protection complex (FPC) consisting of 
Timeless and Tipin is thought to act to promote replication fork stability via a direct 
interaction with the replication machinery in addition to promoting ATR-dependent 
checkpoint signalling [54, 55, 65, 67]. Downregulation of either Timeless or Tipin leads to 
a reduction in protein levels of the other suggesting that formation of the heterodimeric 
complex is important for protein stability [67, 68]. The FPC has been shown to localise to 
replication origins and to associate with the replication machinery during DNA replication. 
It has also been shown that depletion of either protein increases sensitivity to various 
genotoxic agents including hydroxyurea (HU) and ultraviolet (UV) radiation and that Chk1 
phosphorylation is reduced in response to these agents. Conversely, in unperturbed cells 
that have been depleted of Timeless an increase in basal levels of Chk1 activation has been 
observed compared to control cells [54, 55, 65]. This indicates that while the FPC is 
required for a robust checkpoint response to replication stress inducing agents, it also plays 
a role in the promotion of fork stability under normal conditions which leads to a slightly 
elevated basal level of checkpoint activation in its absence. This apparent checkpoint 
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function of the FPC is thought to be dependent on the Tipin subunit which directly binds to 
RPA coated ssDNA at the replication fork where it then recruits Claspin, a key mediator of 
checkpoint signalling, and thus promotes Chk1 activation [55]. Work on the yeast 
functional homologues of these proteins has suggested that the complex also inhibits 
excessive ssDNA formation by preventing uncoupling of the replicative helicase and 
polymerase activities perhaps via a direct interaction with MCM subunits [69-71]. In 
human cells, depletion of Timeless results in slower replication fork progression and 
spontaneous DNA breaks in undamaged cells as well as displaying downstream sister 
chromatid cohesion defects [54, 65]. Additionally, elevated Rad51 foci and increased 
levels of sister chromatid exchanges were observed in Timeless depleted cells which 
suggests that the FPC may act to prevent fork collapse and/or suppress inappropriate 
recombination repair at sites of stalled or damaged replication forks [72]. Collectively, this 
data supports the premise that the FPC has an important role in maintaining the stability of 
the replication fork during normal DNA replication as well as potentially monitoring, 
detecting and responding to fork stalling and damage. Cohesion defects that arise as a 
consequence of FPC depletion may be attributable to loss of coordination between the 
processes of DNA replication and cohesion establishment due to increased fork instability 
in the face of endogenous replication challenges.  
 
1.2.5 DNA double strand break repair 
Specific DNA repair mechanisms and pathways are employed in cells to deal with 
particular types of DNA lesion. DSBs are potentially the most deleterious and dangerous 
lesion a cell can encounter, leading to genome rearrangements and chromosomal 
instability. DSBs can occur as a result of direct exogenous damage from sources such as 
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ionising radiation (IR), as a result of damaged replication forks (as discussed above) and 
can also be generated via the processing of other types of DNA lesions. The two main 
cellular pathways for repairing DSBs are homologous recombination (HR) repair which 
occurs preferentially in S and G2 phases of the cell cycle, and non-homologous end joining 
(NHEJ) which takes place primarily in G1 [73, 74]. 
NHEJ is the preferred mechanism for DSB repair during G1 when no homologous 
template is available and the high degree of chromatin compaction inhibits homology 
searching and resection. DNA DSBs are detected by the Ku heterodimer, a component of 
the DNA-PK complex, which recognises and binds to the DNA ends [75]. The DNA-PK 
(DNA-dependent protein kinase) catalytic subunit is then recruited and activated at the 
break site, facilitating the recruitment and phosphorylation of other repair factors and 
signalling proteins. Eventually, the process is completed by binding of the XRCC4-DNA 
ligase IV complex to accomplish annealing of the DNA strands [76]. Often described as an 
error-prone mechanism of DSB repair, NHEJ is nevertheless a crucial repair pathway in 
cells with the activity of CDKs ensuring DNA end resection is limited during G1 to 
minimize the extensive end processing that may result in loss of genomic stability [39, 77]. 
Several recent studies have also implicated the ATM target protein 53bp1 as a crucial 
player in determining DSB repair pathway choice [78, 79]. It has been shown that 53bp1 
inhibits end resection in G1 and is removed from DNA ends during S-phase in a BRCA1 
(breast cancer 1, early onset) dependent process. This leads to inaccurate repair of 
replication associated DSBs by NHEJ rather than the favoured mechanism of HR repair in 
BRCA1 deficient cells, which can lead to genomic rearrangements and instability [78].  
HR repair makes use of homologous DNA sequences usually from a sister chromatid as a 
template for repair and re-synthesis of the sequence around a DNA break or lesion. The 
process is regulated in a cell-cycle dependent manner and is therefore usually restricted to 
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the S and G2 phases of the cycle when a homologous template is available in the form of a 
replicated sister chromatid [80]. Inappropriate HR can lead to genomic rearrangements and 
instability which can have a catastrophic effect on cell survival. HR repair is perhaps best 
known as one of the key pathways by which cells respond to and repair double strand 
breaks in DNA, however, components of the HR repair pathway also have roles in the 
repair of other DNA lesions as well as in the maintenance and repair of replication forks 
[81]. 
Just as ATR signalling is primarily responsible for the cellular response to stalled 
replication forks, a second master checkpoint kinase ATM (Ataxia telangiectasia-mutated) 
phosphorylates downstream targets in response to DNA double strand breaks. ATM 
signalling is dependent upon damage sensors such as the MRN complex (Mre11-Rad50-
NBS1) which detects a DSB before utilising the intrinsic nuclease activity of Mre11 
(Meiotic recombination 11 homolog 1) to resect the DNA at the break site [82]. The 
binding of Rad51, a crucial mediator of HR repair, requires a 3’ overhang to be generated 
by cellular nucleases such as Mre11 and EXO1 (exonuclease 1), to facilitate its binding to 
DNA [83-87]. This resection of DNA by nuclease enzymes is regulated by CDKs and also 
only occurs in S-phase and G2. CtIP, another endonuclease which is essential for efficient 
Mre11-mediated resection, is activated by CDK phosphorylation at the G1/S transition to 
promote HR-dependent repair processes [88, 89]. Rad51-coated DNA filaments initiate the 
process of homology searching for appropriate DNA sequences, subsequently followed by 
strand invasion and recombination. The resolution of intermediate displacement loop (D-
loop) and Holliday junction (HJ) structures is necessary to complete the repair process 
[84]. A catalogue of important HR repair factors are required for successful completion of 
each of these steps including BRCA2 which is involved in stabilising Rad51 filaments [90-
92] and cellular resolvase enzymes such as GEN1 (Flap endonuclease GEN homolog 1) 
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which acts to remove HJs [93].  Components of the Fanconi Anaemia (FA) pathway, 
topoisomerase enzymes and the RecQ-like helicases BLM (Bloom Syndrome helicase) and 
WRN (Werner Syndrome helicase) are also required for efficient HR repair [93-96].  
 
1.2.6 HR mediated replication fork restart 
Evidence using bacterial models initially suggested that the HR machinery is important for 
replication fork stability and promotion of replication restart after stalling [97]. However, 
it is clear that HR-dependent modes of replication fork restart are also employed in 
eukaryotic cells [98-100]. Mutations in proteins involved in HR often exhibit spontaneous 
DSBs and sensitivity to replication stress and, additionally, cells with defects in the HR 
pathway have shown slower replication fork progression consistent with an inability to 
efficiently resolve endogenous replication blocks or with reduced fork stability [101-103]. 
DNA structures similar to traditional HR intermediates can arise at a stalled fork either 
because a DSB is generated or via fork processing events and these require resolution by 
components of the HR machinery. 
Furthermore, studies on both Mre11 and Rad51, two key HR proteins, have shown them to 
be important for effective replication restart after treatment with replication inhibitors. 
Mre11 is recruited to stalled forks and may be involved in processing the fork via end 
resection to allow subsequent loading of Rad51 and efficient fork restart [102, 104]. 
Interestingly, although it has been shown that Rad51 is required for replication fork restart 
after stalling, this function seems to be distinct from its role in HR repair of DSBs [37]. 
The latter results in the formation of visible Rad51 foci by IF which are not detectable in 
cells which have undergone Rad51-dependent replication restart. It is possible that other 
HR proteins also have alternative functions in replication compared with DSB repair. The 
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process of HR-mediated replication fork restart is likely to involve the limiting of crossing-
over between homologous sequences as this could lead to potentially damaging genomic 
rearrangements. It is thought that the BLM helicase may function as part of a complex 
with TOP3A (topoisomerase 3 alpha) and hRMI1 (RecQ-mediated genome instability 
protein 1 or BLAP75) to dissolve double Holliday junction intermediate structures and 
suppress recombination events at damaged replication forks [94, 105].  
 
1.3 Sister chromatid cohesion is essential for the maintenance of genomic stability 
1.3.1 Cohesion and the cohesin complex 
During the process of DNA replication, each newly replicated sister chromatid pair must 
be physically associated with each other until their separation and subsequent distribution 
to each daughter cell at mitosis. This is facilitated by a protein complex comprised of both 
structural and regulatory subunits and collectively known as cohesion factors [106]. Work 
carried out in yeast identified four genes which, when mutated, resulted in high-frequency 
chromosome loss. These included two SMC (Structural Maintenance of Chromosomes) 
family members as well as two uncharacterised genes which were named SCC1 and SCC3 
(Sister Chromatid Cohesion) [107]. It was shown in later work that these four proteins are 
assembled as a large ring-like protein complex in cells, termed the cohesin complex, and 
that they facilitate the cohesion between newly synthesised sister chromatids by physically 
linking them together [108] (figure 1.2). Interestingly, it was also discovered that the Scc1 
subunit of the cohesin complex is specifically degraded at the onset of anaphase which 
coincides with the dissolution of cohesion and chromosome separation. This led to 
speculation that removal of Scc1 is the molecular trigger required for chromosome 






Figure 1.2. Schematic representation of structure of the core cohesin complex. Scc1 is 
shown in purple and is thought to be degraded at the onset of anaphase to trigger 
chromatid separation. This figure has been taken from a review by Feeney, Wasson 
[106]. 
 
In higher eukaryotes, however, the picture is somewhat more complicated. While much of 
the early work in the establishment and regulation of cohesion has been carried out using 
yeast as a model organism, it is clear that there may be some differences in the way 
cohesion is regulated in mammalian cells. For instance, while in yeast it has been 
demonstrated that cohesin remains associated with chromosomes until the metaphase-
anaphase transition when segregation occurs, in mammalian cells it seems that cohesin 
removal is more of a stepwise process that is highly regulated throughout the cell cycle 
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[111]. During the progression of cells from prophase to metaphase it has been observed 
that while sister chromatids remained joined at their centromeres, cohesion between 
chromosome arms is lost [112]. This removal of cohesin from chromosome arms earlier in 
the cell cycle is thought to be independent of the conventional mechanism of cohesin 
removal which is mediated by cleavage of the Scc1 subunit (Rad21 in vertebrates) by the 
cysteine protease separase [110]. Studies have suggested that Polo-Like kinase 1 (Plk1) 
has a role in the regulation of cohesin removal and it has been shown that Plk1 can 
phosphorylate cohesin subunits with phosphorylation leading to a reduced affinity of the 
complex for the chromosome arms during prophase [112, 113]. Nevertheless, a fraction of 
cohesin does remain associated with chromosomes at their centromeric regions and allows 
the maintenance of cohesion between sister chromatids until the mitotic spindle checkpoint 
has been approved. This is then subject to removal via the proteolytic cleavage of the 
Rad21 subunit by separase, thus supporting the idea that this is a conserved trigger for 
chromosome segregation [109, 113, 114]. 
 The discovery of two distinct mechanisms for cohesin regulation at different points in the 
cell cycle supports the idea that cohesin may have more dynamic roles in cell processes in 
addition to its canonical role in promoting accurate chromosome segregation. Indeed, 
cohesin has also been implicated in DNA damage repair, possibly via facilitation of 
homologous recombination, and also in control of gene expression by transcriptional 
regulation (reviewed in [106]).  
 
1.3.2 Cohesion factors and regulation of sister chromatid cohesion  
Although sister chromatid cohesion is established during DNA replication, studies have 
shown that cohesin actually becomes associated with DNA in G1 phase in the case of 
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lower eukaryotes while in mammalian cells it has been observed that cohesin re-localises 
to DNA towards the end of telophase [107, 115, 116]. Loading of cohesin onto DNA 
molecules is brought about by its interaction with the Scc2-Scc4 cohesin loading complex. 
The energy driving this process is generated by the ATPase activity of the SMC subunits 
which is thought to allow either opening of the complex at the hinge region or transient 
dissociation of Scc1 [117]. Since cohesin is associated with DNA prior to the 
establishment of sister chromatid cohesion it can be presumed that there must be other 
cellular factors at work to regulate the actual process of cohesion establishment. 
In yeast, several classes of proteins, generally termed cohesion factors, have been 
identified. These include the proteins discussed above which form the cohesin complex as 
well as proteins involved in the loading of cohesin onto chromosomes and also cohesion 
establishment factors [118-120]. Several of these cohesion establishment factors have been 
shown to interact with components of the DNA replication machinery and thus are 
essential in ensuring that the processes of DNA replication and sister chromatid cohesion 
are closely coupled to each other such that newly synthesized sister DNA molecules are 
tethered together [21, 68, 119, 121]. 
The cohesion establishment factor Eco1 (establishment of cohesion protein 1), also known 
in the literature as Ctf7 (Chromosome transmission fidelity protein 7) in yeast and as 
ESCO1/2 in humans, has been shown to be vital in the establishment of sister chromatid 
cohesion during S-phase [119, 120].  Skibbens et al. identified Ctf7 as an essential protein 
in S. cerevisiae that is highly conserved across species [118]. With the use of temperature 
sensitive Ctf7 mutants they showed that when placed at the restrictive temperature at S-
phase, cells rapidly lost viability and displayed severe chromosome cohesion defects. 
However, when the cells were placed at the restrictive temperature during mitosis the cells 
appeared normal, thus suggesting that Ctf7 is required during S-phase for establishment of 
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cohesion but not for its maintenance during early mitosis. These findings were 
recapitulated by Toth et al. using a different mutant allele of Ctf7, indicating the results are 
reliable and not allele-specific [118, 120]. Furthermore, genetic interactions between CTF7 
and both POL30 (DNA processivity factor PCNA) and CTF18 (a component of yeast 
Replication Factor C complex) provided tentative evidence that the processes of cohesion 
establishment and DNA replication are linked [122]. RFC complexes work by using ATP 
hydrolysis to direct the loading of PCNA onto DNA and drive forward processive 
replication.  It was shown that POL30 was a high-copy suppressor of the CTF7 
temperature sensitive mutant phenotype and that both POL30 and CTF18 were 
synthetically lethal in combination with CTF7. As well as the genetic interaction between 
CTF7 and genes encoding components of the replication machinery previously described, 
it was also subsequently confirmed that Ctf7p physically associates with several proteins 
involved in DNA replication, including PCNA and Ctf18p [119, 122]. Yeast CTF7 
mutants unable to bind PCNA were defective in sister chromatid cohesion indicating the 
interaction between these two proteins is crucial for successful cohesion establishment 
[122]. Evidence of a connection between replication and cohesion establishment allows for 
interesting speculation about the implications of this interaction. It is also tempting to 
speculate about the potential role for these cohesion factors in other aspects of DNA 
metabolism such as transcription and DNA damage repair, processes which may depend 
on local remodelling of chromatin structure and the dynamic association of cohesins in 
order to function successfully. 
The actual mechanism by which Ctf7 is involved in the establishment of cohesion still 
requires some resolution.  The ‘handcuff’ model, put forward by Skibbens et al., suggests 
that Ctf7 associates with the replication machinery and in effect brings together two 
cohesin complexes associated with individual sister chromatids [123]. This model fits in 
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with other observations, for example that cohesin is found associated with DNA prior to 
the development of sister chromatid cohesion and that loading of cohesin is independent of 
cohesion establishment [116, 124]. It also explains phenotypes that have been observed 
whereby cohesion is compromised despite the detectable presence of cohesin on the 
chromosomes [120]. However, work carried out by Lengronne et al. using chromatin 
immunoprecipitation experiments to look at replication-fork associated proteins found only 
a small amount of Ctf7p was localized to the replication fork compared with other 
replication factors also known to be important for cohesion such as Ctf18p and Ctf4p 
[121]. Whether this is due to the potentially transient nature of the association has yet to be 
determined.  
The more established model of sister chromatid cohesion, supported by data from EM 
studies of cohesin structure, suggests that the ring-like cohesin complex encircles the two 
sister DNA molecules [108, 125]. It is proposed that the complex forms a V-shaped 
heterodimer consisting of the Smc1 and Smc3 subunits with the gap bridged by Scc1 to 
complete the circle. It is suggested that this vast ring-shaped molecule then allows the 
replication fork to pass through it resulting in efficient pairing of only identical sister 
chromatids. This model is supported by several studies which showed that no interaction 
could be detected between differentially tagged subunits of the cohesin complex in FRET 
(Fluorescence Resonance Energy Transfer) experiments. Additionally, treatment with 
crosslinking agents generated cohesin-DNA complexes that were not sensitive to 
degradation by protease treatment which strongly supports the model of a single cohesin 
molecule that encircles both sister chromatids [108, 126]. 
The main caveats of the ‘ring’ model, it has been suggested, are firstly that it does not 
reveal a role for Ctf7p despite previous evidence showing this protein to be required for 
cohesion establishment and also, as mentioned above, there have been instances where 
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cohesion defects have been observed in cells without any notable defects in either cohesin 
deposition or DNA replication. This suggests that there is a missing link between the two 
processes that results in the defective phenotype. In other words, if the ring model is 
correct then there are likely to be other factors, perhaps including Ctf7, involved in 
regulating the passage of the replication machinery through the cohesin ring, a scenario 
which is extremely plausible in light of the numerous cellular factors which have so far 
been implicated in both cohesion establishment and replication.  
As yet neither of these proposed models has been definitively proven to be correct and 
there is still much investigation to be carried out in order to fully elucidate the regulation 
of cohesion. There is still significant controversy surrounding the actual mechanism of 
cohesion establishment and several groups have published data that seems to contradict the 
widely accepted ‘ring’ model of cohesion. For example, in conflict with the FRET study 
discussed above, Zhang and colleagues were in fact able to detect an association between 
the Scc1 subunits of individual cohesin complexes [127] while another study suggested 
that the greater diameter of compact heterochromatic DNA supported a ‘handcuff’ model 
of cohesion in these regions [128]. A schematic representation of the proposed models of 





Figure 1.3. Schematic representation of the proposed models of sister chromatid 
cohesion. The Ring model depicted in (A) suggests that a single cohesin molecule 
encircles both sister chromatids following replication while the handcuff models 
depicted in (B) propose that each daughter strand is encircled by single cohesin 
molecules that are then physically associated with each other via an as yet 




It has also been shown that Ctf7p interacts with the DNA helicase Chl1p (chromosome 
loss protein 1) in yeast [129]. Furthermore, as well as an interaction with Ctf7p, the human 
equivalent of Chl1p, hChlR1 (Chl1-related protein) has been shown to interact with other 
cohesion and replication factors, including components of the cohesin complex itself, 
PCNA and Ctf18-RFC [21, 130, 131]. The potential involvement of a DNA helicase in the 
establishment of cohesion is interesting as it could suggest a mechanism for alteration of 
DNA topology to allow replication progression in conjunction with establishment or 
maintenance of sister chromatid cohesion.  This, coupled with the discovery that Ctf7p 
(ESCO1/ESCO2 in humans) functions as an acetyltransferase which acetylates the SMC3 
subunit of the cohesin complex [132], suggests that local chromatin remodelling may be an 
important feature of the mechanisms underlying the establishment of cohesion following 
replication.  Mutation of the two highly conserved lysine residues in SMC3 which are 
acetylated by Ctf7p results in severe cohesion defects. Conversely, replacing these lysine 
residues with either glutamine or asparagine residues to mimic acetylation rescues the 
defect caused by loss of Ctf7p. The acetyltransferase activity of Ctf7p is suppressed during 
G1, G2 and mitosis, with SMC3 acetylation only occurring only during S-phase. This 
supports the hypothesis that acetylation of SMC3 is important for converting DNA 
associated cohesin rings to a cohesive state allowing for replication coupled cohesion 
establishment [133-135]. It is thought that Ctf7 mediated acetylation functions to promote 
either dissociation of cohesin rings from DNA or opening of the complex to allow passage 
of the replication fork. This is supported by evidence which suggests that in the absence of 
cohesin acetylation replication fork processivity is impaired [136]. It has also been shown 
that SMC3 acetylation inhibits the Wapl-Pds5 complex, which has a role in suppressing 
inappropriate cohesion establishment, prior to completion of replication, via a direct 
interaction with cohesin [137]. 
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1.3.3 Alternative functions of the cohesin complex 
Initially there was little evidence of the diversification of cohesin function in lower 
eukaryotes where early studies had focused on the canonical role of cohesin in sister 
chromatid cohesion and accurate chromosome segregation. However a publication by 
Schmidt et al provided evidence that, in S.pombe at least, not all cellular cohesin 
participates in chromosome segregation [138]. Using chromatin immunoprecipitation 
methods followed by analysis on high resolution oligonucleotide microarrays, they were 
able to show localization of cohesin along fission yeast chromosomes throughout the cell 
cycle. They show that a fraction of the cellular pool of cohesin does become dissociated 
from the chromosomes during prophase and that this dissociation is not separase 
dependent. Their data confirms that in the case of fission yeast there is also more than one 
pathway for the removal of cohesin and thus suggested that there was scope for further 
investigation into potentially conserved roles of cohesin using lower eukaryotes as model 
systems. 
Evidence from studies in vertebrate cells indicated that, intriguingly, cohesin re-localises 
to chromosomes immediately following mitosis and prior to S-phase when it would be 
assumed that it would again be required for sister chromatid cohesion [116]. This is 
supportive of the hypothesis that cohesin has more diverse cellular functions. Furthermore, 
perhaps some of the most compelling evidence supporting alternative roles for cohesin is 
provided by the phenotypes associated with human diseases that result from mutations of 
components of the complex [106, 139]. Diseases like Roberts Syndrome and Cornelia de 
Lange syndrome cause severe developmental defects that include mental retardation and 
craniofacial abnormalities but sufferers are not predisposed to the development of cancer 
which might be expected if genomic instability was primarily the cause of these 
phenotypes. This raises the possibility that it may be the disruption of other functions of 
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cohesin, such as transcriptional regulation, which lead to the symptoms exhibited in these 
diseases. Additionally, cohesin has been found to colocalise with the cohesin loading 
complex Scc2-Scc4 at sites of active transcription in eukaryotic cells suggesting a potential 
requirement for more dynamic cohesin association within these regions [140, 141].  
The observation in S. cerevisiae that cohesin molecules tended to accumulate at sites of 
convergent transcription first suggested that cohesin might have an important role to play 
in the regulation of this process [115]. It was hypothesised that the transcription machinery 
was too large to pass through the cohesin ring such that cohesin molecules were somehow 
translocated along the DNA in front of the transcription machinery until transcription 
termination [142]. A subsequent study posited that this accumulation of cohesin might act 
as a boundary between coding regions and have a direct function in successful termination 
of transcription [143].  However, in mammalian cells cohesin does not accumulate at sites 
of convergent transcription but instead is enriched at sites of CTCF binding [144]. CTCF 
(CCCTC binding factor) is a ubiquitously expressed zinc-finger containing protein 
involved in transcription regulation specifically by facilitating transcriptional insulation of 
the genes flanked by CTCF binding sites [145, 146]. Depletion of CTCF in mammalian 
cells alters the positioning of cohesin at these regions and downregulation of either CTCF 
or Rad21 leads to comparable transcriptional changes as measured by DNA chip 
technology. This further confirms that the insulator function of CTCF is at least partly 
mediated by cohesin [147]. 
In addition to its role in the control of gene expression, it has also been demonstrated in 
yeast that cohesin is important for effective DNA repair, specifically by homologous 
recombination. It can be envisaged that for efficient HR repair to occur homologous sister 
chromatids must be held in close proximity to each other via the establishment of sister 
chromatid cohesion during S-phase. It was shown that establishment of cohesion in S 
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phase is essential for DNA repair in G2 while de novo loading of cohesin onto DNA in the 
region of DSBs has also been demonstrated in both yeast and higher eukaryotes. 
Additionally, DNA damage has been shown to induce genome wide post-replicative 
cohesion which is dependent upon Ctf7 and Scc2, suggesting that newly loaded cohesin 
molecules participate in this damage-induced cohesion [148-151]. The function of cohesin 
in the response to DNA damage is less well characterised in mammalian cells. However, 
there is evidence that cohesin is recruited to sites of DSBs and that this recruitment is 
mediated by the Smc5-Smc6 complex which also promotes HR repair [152-154]. It has 
also been shown that cohesin is specifically recruited to DSBs only in S and G2 phases of 
the cell cycle and that repair of DSBs was slower in cells depleted of cohesin subunits in 
G2 but not G1 [155]. This supports a model whereby cohesin facilitates HR mediated 
repair by inducing localised cohesion bringing sister chromatids into proximity to use as 
templates for re-synthesis of damaged DNA.  
In addition to direct recruitment to sites of DSBs and promotion of HR repair, several 
studies also support an independent checkpoint function for the cohesin complex. SMC1 
and SMC3 are both phosphorylated by checkpoint kinases in response to UV and IR [156-
159]. This damage induced phosphorylation causes SMC1 to colocalise with γH2AX DNA 
damage foci. Mutation of the phosphorylation sites on either cohesin subunit leads to an 
attenuated damage response [160, 161]. Additionally, the breast cancer susceptibility 
protein and DNA repair factor BRCA2 has been shown to interact with the cohesin 
complex via the anti-establishment factor Pds5 and this association was shown to be 
important for HR repair and efficient DNA damage response [162]. Furthermore, a study 
by Watrin and colleagues suggests that the cohesin complex may function to recruit 




1.4 The DNA helicase Chl1 has a role in sister chromatid cohesion 
As discussed above, for cell viability and genome integrity to be maintained, accurate 
transmission of chromosomes to each daughter cell must occur during mitotic division. 
The process of chromosome segregation is regulated in eukaryotes by an array of proteins 
ranging from those involved in the control of vital cellular checkpoints to structural 
proteins responsible for the establishment and termination of sister chromatid cohesion and 
association with the mitotic spindle.  Studies of chromosomal missegregation using yeast 
as a model organism have resulted in the identification of many candidate genes with 
potential roles in the control of correct chromosome segregation as well as in other closely 
coupled cell cycle processes such as checkpoint regulation, and in DNA replication and 
repair [164, 165]. One such study, by Haber and colleagues, identified the gene Chl1 
(Chromosome loss mutation) as having a putative role in normal segregation of 
chromosomes at mitosis [166]. The screen was initially designed for the identification of 
mutants that exhibited abnormal mating phenotypes and thus Chl1 mutants were identified 
on the basis that they showed a high-frequency rate of missegregation of the yeast 
chromosome III which harbours the mating type alleles. Later it was determined by 
Gerring et al. that their CTF1 group (chromosome transmission fidelity) mutants, which 
they had isolated during a screen specifically for genes involved in chromosomal 
missegregation, were in fact mutants in Chl1 [167]. They then went on to demonstrate that 
in a Chl1 null mutant there was a significant increase in the rate of missegregation of 
genetic markers on chromosome III caused by both loss of the chromosome and non-
disjunction of sister chromatids [167, 168]. This strongly suggested a role for Chl1 gene 
product in the maintenance of normal chromosome segregation. Additionally, the study 
showed that although Chl1 null mutants are viable, indicating Chl1 is a non-essential gene 
in yeast, clear defects in chromosome segregation were observed and cells were shown to 
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exhibit a delay in cell cycle progression from G2 through to mitosis. This delay, it was 
noticed, was independent of the DNA damage checkpoint activation. 
Initial sequence analysis of the Chl1 gene showed that it had significant homology to 
Rad3, an ATP-dependent DNA helicase involved in the nucleotide excision repair pathway 
[167]. Although extensive biochemical analysis of yeast Chl1p has not thus far been 
carried out, sequence homology and characterisation of the human homologue ChlR1 
strongly suggests that Chl1p is a putative DNA helicase. Work performed by S. Holloway 
showed that by using site directed mutagenesis to mutate the ATP-binding site on budding 
yeast Chl1p, thereby abolishing its ATPase activity, that this resulted in loss of Chl1 
function [169]. This was demonstrated by transforming Chl1 deletion mutant cells with 
plasmids expressing either wild-type or ATP-binding site mutants of Chl1. Only wild-type 
Chl1 was able to rescue the aberrant chromosome segregation phenotype in these cells.  
Moreover, overexpression of mutant Chl1 in wild-type cells also resulted in abnormal 
chromosome segregation. This data strongly indicates that Chl1 functions in sister 
chromatid cohesion and that its role in chromosome segregation is likely to be dependent 
on its ATPase/helicase activities. One hypothesis from these observations could be that the 
helicase activity of Chl1p is important for topological modification of DNA to facilitate its 
interactions with cohesion factors or the cohesin complex itself. 
 
1.4.1 Chl1p interacts with Ctf7p and components of the replication machinery 
Further evidence of the role of Chl1p in sister chromatid cohesion was provided by 
Skibbens et al. In this publication it was shown that CHL1 genetically interacts with both 
CTF7 and CTF18 and that Chl1p co-immunoprecipitates with Ctf7p in vivo [129]. It 
should be noted however that this study uses an overexpression system that utilises tagged 
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proteins and that a physical interaction between endogenous proteins has not been 
confirmed. In addition, although this study goes on to suggest that the interaction has been 
confirmed in vitro thereby indicating that there is a direct physical association between the 
two proteins, the actual methods used cannot completely allow this assertion to be made. 
Although bacterially expressed GST-tagged Ctf7p is immobilised on glutathione 
Sepharose resin, the beads are then incubated with clarified yeast cell extract containing 
Chl1p-13Myc which does not allow us to discount the possibility that other protein 
cofactors are present and possibly required to mediate the interaction. However, evidence 
that indicates the involvement of Chl1p in sister chromatid cohesion was provided using a 
cohesion reporter strain where GFP is used to visualise the positions of the sister 
chromatids relative to each other. Chl1 mutant cells exhibited a significantly higher 
percentage of dissociated sister chromatids pre-anaphase compared to wild-type cells.  
The proposed human homologue of Chl1p (hChlR1) has been shown to interact with other 
cohesion and replication factors, including components of the cohesin complex itself, 
PCNA and Ctf18-RFC [21, 122, 131]. ChlR1, similarly to Ctf7, has been shown to interact 
with the flap endonuclease Fen1 and to stimulate its activity [21]. Fen1 is important in 
processing Okazaki fragments during lagging strand synthesis therefore it is tempting to 
speculate that this association with ChlR1 is somehow functionally important for resolving 
unusual DNA structures that arise during lagging strand processing events in DNA 
replication or for coupling lagging strand processing to cohesion establishment.  
Additionally, it has also been shown in S. cerevisiae that simultaneous deletion of Chl1 
and CTF8, another RFC subunit, resulted in cohesion defects and that Chl1 is a high-copy 
suppressor of the spore lethality caused by missegregation observed in CTF8 null cells, 
thus providing further evidence that Chl1 has a role in cohesion establishment and that this 
is coupled to DNA replication [130]. Interestingly, Petronczki et al. suggest that the role of 
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Chl1 in cohesion may be more prominent in meiosis compared with mitosis with a far 
increased incidence of missegregation observed in the second meiotic division in Chl1 
mutant cells [130]. In light of recent evidence suggesting that Chl1 may have a role in 
DNA damage repair, it is possible that this increased defect observed in meiosis could be 
due to problems in the HR pathway that results in further chromosomal instability. 
Alternatively, the increased meiotic missegregation may simply be a downstream 
consequence of defective HR due to an absence of cohesion rather than a direct result of 
Chl1 loss of function.  
 
1.4.2 A putative role for Chl1p in response to DNA damage has been proposed 
Despite initial observations to the contrary, further investigations into Chl1p function have 
suggested that Chl1p may have a role in the repair of DNA damage. Chl1 has 23% 
homology to the nucleotide excision repair (NER) gene RAD3, the human homologue of 
which is the helicase XPD. Moreover, one of the most closely related human genes to 
yeast Chl1 is the helicase FANCJ (BACH1) which has been implicated in Fanconi 
Anaemia (FA), breast cancer susceptibility and in the repair of interstrand crosslinks and 
double strand breaks in DNA via the homologous recombination pathway [167, 170]. Laha 
et al. show that Chl1p is necessary in S-phase for cell viability either upon exposure of 
cells to DNA damaging agents or for protection from DNA damage caused by pre-existing 
gene mutations [165]. The former is evidenced by increased sensitivity of Chl1 mutant 
strains to DNA damaging agents such as alkylating agents methyl methanesulfonate 
(MMS) or UV radiation. The mechanism underlying this hypersensitivity to DNA damage 
inducing agents was shown to be independent of the DNA damage checkpoint pathway as 
Chl1 mutant cells and wild type cells showed both comparable levels of Rad53p (Chk2 in 
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humans) phosphorylation and similar progression through S-phase compared to known 
checkpoint mutants, proving the checkpoint is functional. However, it was shown that 
Chl1 mutants are less proficient than wild type cells at repairing DNA damage induced by 
the alkylating agent MMS. DNA was extracted from both wild type and mutant cells, 
damaged by MMS, and then allowed time to repair prior to analysis of mobility on an 
agarose gel. DNA from Chl1 mutant cells contained more unrepaired breaks as visualized 
by its increased mobility on the gel supporting the hypothesis that Chl1p has a role DNA 
damage repair. Another study showed that the levels of Chl1p associated with chromatin 
substantially increased in response to induction of DNA damage by MMS and DNA repair 
was again shown to be deficient in Chl1 mutants [171]. Importantly, it was determined that 
these mutant cells also had defects in homologous recombination, an important pathway 
for DNA damage repair.  
These studies suggested an emerging role for Chl1p in the response to DNA damage but 
also raised the question of whether Chl1p is directly involved in the resolution of DNA 
damage or if defective repair is simply a consequence of impaired sister chromatid 
cohesion which would undoubtedly inhibit HR repair pathways. As a putative DNA 
helicase it is certainly conceivable that Chl1p could be involved directly in the repair of 
DNA lesions either independently or via homologous recombination. How this relates to 
the canonical function of Chl1p as a cohesion factor has still to be elucidated, although it 
can be imagined that cohesion between homologous chromosomes is likely to be crucial in 
the facilitation of DNA repair, particularly by HR. It is however important to note that this 
work was carried out in yeast and Chl1p shows significant homology to two human 
proteins, FANCJ and hChlR1. This suggests that Chl1 may be a common ancestor of both 
proteins which have subsequently diverged and evolved more specialised functions in 
higher eukaryotes.  
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1.4.3 The DNA helicase ChlR1 is the proposed human homologue of yeast Chl1 
In 1997, Annan et al reported the cloning of putative human homologues of yeast Chl1p, 
hCHLR1 (DDX11) and hCHLR2 (DDX12), and identified them as belonging to the 
DEAD/DEAH family of DNA helicases [172, 173]. These genes were found to be 
expressed only in actively proliferating cells. They also showed that hChlR1 protein binds 
to both single and double stranded DNA in the non-sequence specific manner that might 
be expected of a DNA helicase. A later biochemical study confirmed that human ChlR1 
has both ATPase and helicase activities and that these activities could be abrogated by a 
point mutation in the ATP binding pocket thus supporting the results of earlier 
experiments on yeast Chl1 by Holloway [174].  However, complementation of yeast Chl1 
mutants with the putative human homologue hCHLR1 could not be achieved. This may 
signify the evolution of functional specificity by the human homologue or the absence of 
necessary co-factors in yeast. A recent mouse knock-out of CHLR1 was embryonic lethal 
which is somewhat in conflict with the non-essential status of the yeast Chl1 gene [175]. 
The human helicase FANCJ (BACH1,) also exhibits significant homology to Chl1p, 
however while it has been definitively shown that FANCJ is required for DNA damage 
repair, early studies maintained that mutations in Chl1p do not result in any discernible 
DNA repair defects [167, 170]. This initial assertion has now been challenged as some 
more recent publications have attributed a role to Chl1p in DNA repair via homologous 
recombination as discussed in the previous section [171].  
Studies in yeast have demonstrated that Chl1p is localised to the nucleus as would be 
expected of a protein with a proposed role in sister chromatid cohesion establishment, a 
process which occurs during S-phase of the cell cycle [129, 169]. Work in mammalian 
cells also supports the nuclear localisation of ChlR1 [131]. Immunofluorescence data 
showed that ChlR1 is associated with condensed chromatin during early mitosis but 
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dissociates following progression to metaphase. The protein was also found to be localised 
around the spindle poles throughout mitosis. This dynamic localisation of ChlR1 to 
chromatin early on in mitosis followed by its subsequent dissociation as the cells enter 
metaphase corresponds to the observed localisation of the mammalian cohesin complex 
which is released from chromosome arms prior to metaphase despite remaining bound to 
centromeres until anaphase onset [111]. This supports the notion that the role of ChlR1 is 
to promote cohesion establishment rather than maintenance as no centromere associated 
ChlR1 was observed in metaphase.  Additionally, the mitotic delay in Chl1 mutant cells 
observed by Gerring et al. was recapitulated in mammalian cells where hChlR1 protein 
levels were depleted either by siRNA or in an inducible shRNA system. Morphological 
analysis showed that a high percentage of cells arrested in pro-metaphase and were unable 
to complete mitosis normally. It is thought that inability to satisfy the mitotic spindle 
checkpoint due to cohesion defects could be an explanation for this observation. This, 
combined with data showing that knock-down of hChlR1 levels results in abnormal 
loosely paired sister chromatids, is strongly indicative of a role for human ChlR1 in the S-
phase establishment of sister chromatid cohesion [131]. 
 
1.4.4 ChlR1 is mutated in Warsaw Breakage Syndrome (WABS) 
Although the mouse ChlR1 knockout was embryonic lethal, suggesting that this is an 
essential gene in mammalian development [175], an individual was recently identified 
with compound heterozygote mutations in ChlR1 which resulted in production of a protein 
which completely lacked catalytic activity. This led to the first diagnosis of a ChlR1-
assoociated genetic disorder that was termed Warsaw Breakage Syndrome (WABS) after 
the domicile of the affected individual [139]. Clinically, the patient displayed 
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microcephaly, abnormal skin pigmentation and developmental delay. At the cellular level 
patient-derived lymphoblasts showed an increased incidence of mitomycin-c (MMC) 
induced chromosomal breakage. Additionally, patient metaphase spreads also showed 
evidence of abnormal sister chromatid cohesion in untreated cells which was significantly 
exacerbated upon drug treatment with either MMC or camptothecin. These cytogenetic 
phenotypes appeared to combine features of both the DNA repair disorder Fanconi 
Anaemia and the cohesinopathy Roberts Syndrome [176]. Following the identification of 
this first patient, three affected individuals from the same Lebanese family were 
subsequently identified with a homozygotic point mutation which was also shown to result 
in a helicase-dead protein [177]. Whether this signifies an additional helicase-independent 
function for mammalian ChlR1 or whether the embryonic lethality exhibited in mice is due 
to the fact that in humans ChlR2 (or DDX12) has also been identified, which does not exist 
in mice and could compensate for some functions of ChlR1 [173]. At the sequence level 
ChlR2 is highly similar to ChlR1 and is thought to have arisen from a gene duplication 
event, so it is possible that some functional redundancy exists between these two proteins 
thus allowing the survival of individuals with potentially deleterious ChlR1 mutations. 
Follow up of these individuals will be important to define the clinical progression of this 
syndrome and to determine whether WABS patients are predisposed to the development of 
cancer or the progressive bone marrow failure characteristic of FA patients who have 
defects in the pathway for repair of DNA crosslinks. It might be expected that if ChlR1 
does have a direct role in DNA repair, then patients defective for ChlR1 function could 






1.4.5 ChlR1 and its role in DNA replication and repair 
Genetic and biochemical data have suggested that ChlR1 interacts with components of the 
replication machinery and that it somehow acts to promote the establishment of cohesion 
in concert with DNA synthesis [21, 131, 174]. More recent work from the Noguchi 
laboratory has proposed a role for ChlR1 in stabilisation of the replication fork via an 
interaction with the Timeless-Tipin FPC [65]. They showed that ChlR1 interacts with 
Timeless and that ChlR1 overexpression can partially rescue the cohesion defect observed 
in Timeless depleted cells. Whether ChlR1 overexpression rescues the DNA damage 
sensitivity observed in FPC depleted cells was not tested but could provide potential 
insight into ChlR1 function at the replication fork. A further study from the same group 
proposed a role for ChlR1 in recovery from replication-coupled DNA damage [178]. 
ChlR1 depleted cells were treated with cisplatin, a platinum based compound which causes 
interstrand crosslinking of DNA. These interstrand crosslinks present a dangerous obstacle 
to DNA metabolic processes as they link opposing DNA strands together preventing the 
strand separation that is essential for DNA transcription and replication. It was found that 
ChlR1 depleted cells were more sensitive to cisplatin treatment in cell survival assays and 
also accumulated more physical DNA damage as measured by single cell gel 
electrophoresis. This assay, also known as the comet assay, quantifies broken or 
fragmented DNA which is able to migrate from the nucleus of a single cell during 
electrophoresis on an agarose gel. In addition, this study also showed that after stalling 
replication using HU and releasing into fresh media containing cisplatin, ChlR1 depleted 
cells were less able to restart replication in comparison to control cells. This was measured 
by quantifying EdU foci, which will correspond to active replication forks. Fewer EdU 
foci were observed in ChlR1 depleted cells, indicating less efficient recovery from the 
replication stalling.   
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However, whether this is a true measure of replication recovery is somewhat contentious. 
The addition of cisplatin to the media following release from HU could prevent replication 
fork progression in ChlR1 depleted cells which is entirely independent of fork restart.  It is 
therefore possible that these results merely support the previous data that shows ChlR1 
deficient cells are sensitive to the replication blockages induced by cisplatin. It is possible 
that ChlR1 depleted cells lack the ability to remove the crosslinks, leading to fork stalling 
or collapse. Alternatively, in the absence of ChlR1, cells could be unable to stabilise the 
replication fork at the obstacle to allow time for the relevant repair pathways to resolve the 
block. Treatment with HU and release into fresh drug-free media would provide a better 
measure of replication fork recovery and in fact experiments in the Parish lab using the 
DNA fibre technique have shown that unperturbed replication fork progression is generally 
slower in ChlR1 depleted cells. This suggests a potential role for ChlR1 in the maintenance 
of fork stability during normal replication, perhaps via resolution of endogenous lesions or 
DNA secondary structures that occur during replication. The reported interaction between 
ChlR1 and the flap endonuclease Fen1 could indicate a role for ChlR1 in the resolution of 
specific DNA structures associated with lagging strand synthesis whereby absence of 
ChlR1 leads to problems with Okazaki fragment processing and reduced fork velocity. 
Biochemical data from Brosh and coworkers has indeed shown that purified recombinant 
ChlR1 has the potential, at least in vitro, to unwind a 5’ flap hairpin structure which could 
occur during lagging strand synthesis and otherwise inhibit Fen1 cleavage [179]. 
Interestingly, cells derived from the original WABS patient were shown to be sensitive to 
both MMC and CPT in cell survival assays but not to damage induced by either X-rays or 
UV radiation [139]. This specific sensitivity to agents which impede DNA replication 
certainly supports the hypothesis that ChlR1 has a role in replication fork stability or 
tolerance of replication stress.  
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1.5 Future directions for the study of ChlR1 function 
Recent biochemical studies have revealed a broad panel of in vitro DNA substrates for the 
helicase activity of ChlR1 [179]. While this provides valuable insight into the molecular 
structures upon which ChlR1 can act, this information must be placed in context with 
detailed functional and biological studies to provide a more comprehensive understanding 
of the cellular functions of ChlR1.  These studies will also be important for furthering our 
understanding of the complex mechanisms and pathways that regulate cellular processes 
like cohesion, replication and DNA repair.  
1.6 Aims of this project 
The work presented in this thesis aims to investigate the biological role of ChlR1 in DNA 
replication and repair and to provide insight into how ChlR1 functions in these processes. 
Using S. pombe as a model system, two different biochemical approaches were initially 
taken. A tandem affinity purification was used with the aim of identifying novel 
interacting proteins of Chl1. In parallel, Chl1 was cloned into an E. coli expression system 
in order to express and purify the protein for biochemical characterisation.  
Subsequent chapters aim to examine the effects of ChlR1 depletion or mutation on the 
cellular response to DNA damage and replication stress using siRNA mediated depletion 
of ChlR1 or complemented WABS patient fibroblast cell lines. The patient cells also 
provide the opportunity to functionally characterise the effects of a novel WABS mutation 
on the cellular phenotype. This work aims to further our understanding of the functional 
























2.1 Molecular biology 
2.1.1 Extraction of RNA from S. pombe  
Wild-type S. pombe cells were grown in complete medium (YE4S containing 0.5% yeast 
extract and 3% D-glucose supplemented with L-leucine, Uracil, Adenine hemisulphate and 
L-histidine at 0.05% each) and harvested while in the exponential growth phase as 
determined by an optical density measurement of 0.6 OD on a standard spectrophotometer 
at a wavelength of 600nM. Cells were harvested by centrifugation and RNA was extracted 
using Tri-Reagent (Sigma) according to the manufacturer’s instructions. Cell pellets were 
resuspended in 1 ml of Tri-Reagent inside a fume cupboard. Lysate was then transferred to 
1.5 ml microcentrifuge tube and allowed to stand for 7 mins at room temperature for 
complete dissociation of nucleoprotein complexes. Next, 0.2 ml of chloroform was added 
to the sample which was vortexed for 10 seconds before being allowed to stand for 10 
mins at room temperature. The resulting mixture was then centrifuged at 12,000 xg for 15 
mins at 4C. This separated the mixture into 3 phases: a red organic phase (protein) in the 
bottom, an interphase pellet (DNA) in the middle, and a colourless aqueous phase (RNA) 
at the top.  
The aqueous phase from the Tri Reagent extraction was carefully transferred to a new 
autoclaved microcentrifuge tube and 0.5 ml of isopropanol was added. The sample was 
mixed well and allowed to stand for 10 mins at room temperature before centrifuging at 
12,000 xg for 10mins at 4oC. The RNA precipitate forms a pellet on the bottom of the 
tube. The supernatant was then removed and the pellet washed with 75% ethanol (~1.5 
ml). The sample was then vortexed and centrifuged at 7,500 xg for 5 mins at 4oC. The 
ethanol was then carefully removed, taking care not to dislodge the pellet and the tubes 
placed upside down on a Kimwipe to remove traces of ethanol. The RNA pellet was 
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resuspended in 20 µl RNase free H2O before it completely dried out. RNA yield was then 
quantified using a Nanodrop spectrophotometer. 
 
2.1.2 Synthesis of cDNA 
Synthesis of cDNA was performed using an AffinityScript qPCR cDNA synthesis kit from 
Agilent Technologies and carried out according to the manufacturer’s protocol. Each 
reaction contained: 10.0 μl of first strand master mix (2X), 3.0 μl of oligo (dT) primers 
(0.1 μg/μl), 1.0 μl of AffinityScript RT/ RNase Block enzyme mixture and 0.5 μg of total 
RNA. Each reaction was made up to a volume of 20 μl with RNase-free H2O. Reactions 
were incubated in a thermal cycler programmed as follows: 25⁰C for 5 mins to allow 
primer annealing, 42⁰C for 15 mins to allow DNA synthesis and then 95⁰C for 5 mins to 
terminate the reaction. 
 
2.1.3 PCR amplification of cDNA 
Amplification of cDNA was carried out using the following reaction conditions: 10µl 5X 
High-Fidelity buffer (Thermo Scientific) cDNA template (50ng), 1mM dNTPs, 10 pmol of 
forward and reverse primers (Table 1) and 2 units of Phusion High-Fidelity polymerase 
(Thermo Scientific) in a final reaction volume of 50 µl. The thermal cycle conditions for 
the PCR reactions were: initial denaturing step of 95⁰C for 1minute 30 seconds followed 





2.1.4 Restriction digestion  
PCR amplified DNA was digested in parallel with vector DNA (pET24b) using the 
appropriate restriction enzymes to generate compatible DNA overhangs. The total amount 
of DNA digested per reaction ranged between 100 ng and 1 µg depending upon PCR and 
plasmid DNA yields. The reaction conditions were as follows: 2 µl of the appropriate 10X 
restriction enzyme buffer (Promega), 0.25 µg/µl BSA and 0.5 µl of each 10 U/µl 
restriction enzyme (Promega). Reactions were made up to 20 µl with sterile nuclease-free 
H2O and incubated for 2.5 hours at 37oC.  Linearisation of plasmid DNA was checked by 
agarose gel electrophoresis. 
 
2.1.5 DNA ligation 
Ligation of digested DNA inserts into the plasmid backbone was performed by incubating 
the digested DNA in the presence of T4 DNA ligase (Promega) using a 1:3 molar ratio of 
vector to insert. Reaction conditions were as follows: 2 µl of 10x DNA ligase buffer 
(Promega), 1 unit of T4 ligase enzyme, plus the appropriate volume of both vector and 
insert DNA made up to 15 µl with sterile nuclease-free H2O. The reaction was then 
incubated overnight at room temperature. 
 
2.1.6 Transformation of E.coli cells with plasmid DNA 
Depending upon the concentration of plasmid DNA, generally 1-2 µl of DNA was added 
to a 50 µl aliquot of chemically competent E.coli, maintaining aseptic conditions to avoid 
contamination. The mixture was incubated on ice for 20-30 minutes. Each sample was then 
subjected to a 42oC heat shock for 30 seconds and then incubated on ice for a further 2 
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minutes. 1 ml of Luria Broth (LB) was then added to the bacteria and the cells placed in a 
shaking incubator at 37oC and 220 rpm for 30 minutes. 100 µl of the bacterial suspension 
was plated on an agar plate containing the appropriate selective antibiotic(s) and incubated 
at 37oC overnight. 
 
2.1.7 Isolation of plasmid DNA from E.coli 
Following transformation, individual colonies were picked using a sterile pipette tip and 
used to inoculate 5 mls of LB supplemented with the appropriate antibiotic(s). The culture 
was then incubated in a shaking incubator at 37oC and 220rpm overnight. Cells were 
harvested the next day by centrifugation at 4000 xg  and cell pellets processed using the 
QIAprep Spin Miniprep Kit (Qiagen) according to the manufacturer’s instructions. DNA 
yield and purity was analysed using a NanoVue spectrophotometer (GE Healthcare). 
Plasmids expected to contain cloned DNA were subsequently digested with the restriction 
enzymes used for cloning and analysed by agarose gel electrophoresis to confirm the 
presence of the insert before being sequenced to confirm that cloning was successful.  
 
2.1.8 Generating glycerol stocks of plasmid DNA 
Glycerol stocks of transformed E.coli were generated by removing a 1ml aliquot from an 
overnight culture and mixing this with 1ml of autoclaved, sterile 40% glycerol solution. 





2.1.9 Site-directed mutagenesis 
Primers were designed to mutate lysine 50 of CHL1 to arginine in order to generate a 
helicase-dead mutant protein (K50R). The reaction was carried out using the QuickChange 
II Site-Directed Mutagenesis kit from Agilent Technologies and the sequenced wild type 
pET24b-CHL1 plasmid as a template. The reaction conditions were as follows: 5 µl 10X 
reaction buffer, DNA template (50 ng), 1 mM dNTPs, 125 ng each of forward and reverse 
mutagenesis primers (Table 1) and 1 µl of PfuUltra HF DNA polymerase in a final 
reaction volume of 50 µl. The following cycling conditions were used: initial denaturing 
step of 95⁰C for 1 minute, followed by 15 cycles of 95⁰C for 30 seconds, 55⁰C for 30 
seconds and 68⁰C for 5 mins. Extension step was determined by allowing 1 minute per 
kilobase (kb) of template. A DpnI digestion was performed by adding 1 µl of enzyme to 























































Table 1: Table of primer sequences used for all PCR, mutagenesis and sequencing 
reactions. Restriction sites are indicated in bold type where appropriate and the 
restriction enzyme is shown in brackets. 
 
2.2 Protein expression and biochemical methods 
2.2.1 Protein expression in E coli 
Sequenced and purified plasmid DNA was transformed into E.coli (BL21 or Rosetta 2 
strains) for protein expression using the method described in 2.4. An individual colony 
was once again picked and used to inoculate 5-10 ml of LB containing the appropriate 
antibiotic(s) before incubating in a shaking incubator at 37oC overnight at 220 rpm. 
Alternatively, an existing glycerol stock of bacteria containing the expression plasmid 
could also be used to inoculate a larger starter culture. The following morning, a fraction 
of the starter culture was used to inoculate a larger volume of LB, depending upon the 
scale of the experiment.  
For small scale analysis of protein expression, usually 0.5 ml of starter culture was used to 
inoculate 10 mls of LB. This was then grown until mid-log phase as determined by an 
optical density reading of 0.5 at a wavelength of 600 nm. At this point, a 0.5 ml aliquot of 
bacterial cell suspension was removed and harvested by centrifugation to represent an 
uninduced sample. The culture was then induced with 250 µM to 1 mM IPTG and allowed 
to grow for a further 3.5 hours before harvesting a second 0.5 ml aliquot. The remaining 
cell suspension was also harvested and the cell pellet stored at -20 oC for future analysis.  
The 0.5ml pellets were then resuspended in 100 µl of 1X SDS sample buffer (50 mM Tris-
HCl pH 6.8, 2% SDS, 10% glycerol, 100 mM DTT, 0.1% bromophenol blue) and boiled at 
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95 oC for 10 mins. 20 µl of each sample was then analysed by SDS PAGE to determine 
protein expression.  
These conditions were subsequently optimized for expression and solubility and it was 
determined that for the purposes of purifying Chl1, expression overnight at 18-20oC 
improved the soluble fraction of protein while still achieving a reasonable level of 
expression (see chapter 3).  
 
2.2.2 Polyacrylamide Gel Electrophoresis (SDS PAGE) 
The gel casting apparatus (Bio-Rad) was cleaned thoroughly with 20% ethanol (EtOH) and 
assembled as per manufacturer’s instructions. The resolving gel (375mM Tris-HCl pH 8.8, 
8-15% Acrylamide-bis, 1% SDS, 1% ammonium persulphate, 0.1% TEMED) was 
carefully poured between the casting plates, leaving approximately 1 cm between the 
resolving gel and the bottom of the gel comb. 20% EtOH was added on top of the 
resolving gel to remove air bubbles and to allow the gel to set smoothly. The gel was then 
allowed to set for approximately 30 minutes at room temperature prior to removing the 
EtOH and pouring the stacking gel. The stacking gel (125mM Tris-HCl pH 6.8, 5% 
Acrylamide-bis, 1% SDS, 1% ammonium persulphate and 0.1% TEMED) was then poured 
to within 1-2 mm of the top of the casting plates and the gel comb carefully inserted. The 
gel was then incubated for a further 10-15 minutes to allow the stacking gel to polymerise. 
Following polymerisation of the gel, the comb was removed and the wells washed 
thoroughly with H2O to remove any excess or unpolymerised acrylamide. The gel cassette 
was then assembled in the gel running tanks and the internal chamber filled with running 
buffer (25 mM Tris-HCl pH 8.5, 192 mM glycine, 0.1 % SDS). Additional running buffer 
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was added to the outer chamber of the tank up to the indicated fill line. 20-30 µl of pre-
prepared protein samples in SDS sample buffer were then loaded into the wells. A 
commercially available molecular weight marker was always added to the first well 
(Peqlab Protein Marker V). Electrophoresis was then carried out at 100V for 20-30 mins 
until the sample has progressed through the stacking gel before increasing to 150-180V 
until the proteins are sufficiently resolved. Gels can then be stained and proteins visualized 
with Coomassie Brilliant Blue stain (Bio-Rad) or the proteins can be transferred to a 
membrane for western blot and immunodetection. 
 
2.2.3 Small-scale nickel affinity purification 
For small-scale purifications, 1 ml of an overnight starter culture was used to inoculate 10 
mls of LB and the culture was then incubated until an OD of 0.5-0.6 was reached. 
Expression was induced by adding 0.2 mM IPTG and incubating for a further 3.5 hours at 
30oC or overnight at 18-20oC. The bacteria were then harvested by centrifugation, the cell 
pellets washed in PBS and then lysed in 0.5 ml bacterial lysis buffer (50 mM Tris-HCl 
pH7.6, 500 mM NaCl, 10 mM imidazole, 0.1% Triton-X 100, 0.5 mM DTT). Lysis buffer 
was supplemented with 1 protease inhibitor cocktail tablet (Roche) per 20 mls of buffer. 
Samples were sonicated on ice for 3 x 12 seconds at an amplitude of 50% and the lysate 
was then clarified by centrifuging at maximum speed on a bench top microcentrifuge 
(16,000 xg) for 10 minutes. The supernatant was removed to a clean microfuge tube and 
20 µl of HIS-Select® Nickel Magnetic Agarose Beads (Sigma) pre-equilibrated in lysis 
buffer, were added. Samples were incubated on a rotating wheel for 30 mins at room 
temperature. Beads were collected using a magnetic rack and supernatant removed. The 
beads were then washed twice with 0.5 ml of wash buffer (50 mM Tris-HCl pH7.6, 500 
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mM NaCl, 30 mM imidazole, 0.1 % Triton-X 100, 0.5 mM DTT) before eluting the bound 
protein with 50 µl elution buffer (50 mM Tris-HCl pH7.6, 500 mM NaCl, 250 mM 
imidazole, 0.1 % Triton-X 100, 0.5 mM DTT). 20 µl aliquots were removed at each of the 
above steps for quality control checks. For example to check that induction and protein 
expression was successful and that the protein was soluble in the lysis buffer. All samples 
were then analysed by SDS PAGE and Coomassie staining as well as immunodetection 
with anti-HIS antibody to detect the poly histidine tag on the purified proteins. 
 
2.2.4 Nickel affinity chromatography 
Bacterial cultures expressing Chl1 were grown and induced as described previously. For 
initial chromatography purifications 250 ml cultures were harvested by centrifugation and 
cell pellets were washed in PBS before resuspending in 20 mls of ice cold buffer A (50 
mM Tris-HCl pH 7.6, 500 mM NaCl, 20 mM imidazole, 0.5 mM DTT plus protease 
inhibitor). Lysates were sonicated at 60% amplitude for 30 seconds. This was repeated a 
total of 4 times with a 15 second break on ice in between. Lysates were then clarified by 
centrifugation at 20,000 rpm using the fixed-angle Beckman JA-25.50 rotor for 30 minutes 
at 4oC. The clarified supernatant was then passed through a 0.8 µm filter.  
The sample was loaded onto a 1ml Fast Flow HisTrap™ column (GE Healthcare) and then 
purified by FPLC (fast protein liquid chromatography) using the Akta™ chromatography 
system (GE Healthcare). The column was washed extensively with Buffer A before the 
imidazole gradient was increased by altering the ratio of Buffer A to Buffer B (50 mM 
Tris-HCl pH 7.6, 500 mM NaCl, 250 mM imidazole, 0.5 mM DTT). The column wash 
volumes, flow rate and the imidazole gradient were optimized over a number of 
experiments and depended upon the size of the original bacterial culture (see chapter 3). 
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All flow-through and eluted protein was collected by the automated fraction collector in 1 
ml fractions for subsequent analysis by SDS PAGE. All chromatography buffers were 
filtered and degassed using helium bubbling prior to use on the Akta™ system. 
 
2.2.5 Size exclusion (or Gel Filtration) chromatography 
Fractions containing protein for further purification were pooled and concentrated by 
centrifugation using a Vivaspin sample concentrator spin column (GE healthcare). The 
protein fractions were concentrated to a volume of 0.5-2 ml suitable for loading onto the 
gel filtration column. The column was pre-equilibrated in gel filtration buffer (50 mM 
Tris-HCl, 500 mM NaCl, 0.5 mM DTT). After loading of the sample, the column was 
washed with gel filtration buffer using a flow rate of 0.5 ml per minute on the Akta™ 
system. Fractions were once again collected by the automated fraction collector and 
samples corresponding to absorbance peaks on the chromatogram were analysed for 
protein by SDS PAGE. 
 
2.2.6 Heparin affinity chromatography 
Fractions for further purification on a 1 ml HiTrap Heparin HP column (GE healthcare) 
were buffer exchanged using Vivaspin sample concentrator spin column into MES buffer 
A (20 mM MES pH 6.0, 100 mM NaCl, 1 mM DTT) prior to loading onto the column and 
purifying using the Akta™ system. Bound protein was eluted from the column by 
increasing the ionic strength. This was achieved by increasing the ratio of MES buffer B 
(MES pH 6.0, 1 M NaCl, 1 mM DTT) to buffer A and collecting the fractions 
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corresponding to peaks in the chromatogram. Samples were analysed by SDS PAGE for 
the presence of purified protein. 
 
2.2.7 Tandem Affinity Purification from S.pombe cells 
The protocol for the tandem affinity purification (TAP) of a protein from S. pombe was 
adapted from Gould et al [180]. Briefly, S. pombe cells were cultured in YE4S medium 
and grown to an OD at 600 nm of 0.7-0.8 before harvesting by centrifugation. Twenty-four 
litres of cell culture were required per experiment: 12 litres of the TAP-CHL1 expressing 
cells and 12 litres of a wild-type (SP322) strain as a control. Cell pellets were then 
resuspended in 12 mls of 2X lysis buffer (12 mM Na2HPO4, 8 mM NaH2PO4, 0.3 NaCl, 4 
mM EDTA, 100 mM NaF, 0.2 mM Na3VO4, 0.2% NP-40 plus complete protease inhibitor 
tablet) and frozen as small pellets by pipetting droplets into liquid nitrogen. These pellets 
were then mechanically lysed using a Retsch grinding machine, all the while maintaining 
freezing conditions by immersion in liquid nitrogen to avoid the possibility of the sample 
thawing. 
The resulting powdered lysate was allowed to thaw before cell debris was collected by 
centrifuging at 14000 xg for 30 minutes. The clarified lysate containing soluble TAP-
tagged protein was then incubated for 1 hour with 200 µl of IgG Sepharose resin which 
had been pre-equilibrated in lysis buffer on a rotating wheel at 4oC. The sample was then 
spun down and the beads collected. The unbound supernatant was removed and an aliquot 
stored at -20oC for future analysis. The beads were washed 3 times with wash buffer (10 
mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1 % NP-40) and once with TEV cleavage buffer 
(10 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.5 mM EDTA, 1 mM DTT, 0.1 % NP-40) 
before incubation with 30 µl (10 U/µl) TEV protease (Life Technologies) diluted in 1 ml 
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of TEV cleavage buffer at 4oC overnight. This cleaves the tag at a specific TEV cleavage 
site, removing the protein A domain and eluting the protein of interest. Following 
incubation with TEV protease, the beads were again collected by centrifugation and the 
supernatant, containing the protein of interest, collected. The beads were washed again in 1 
ml of TEV cleavage buffer, spun down and the supernatants pooled to give a total volume 
of 2 ml.  
300 µl of calmodulin Sepharose was prepared by washing 3 times with calmodulin binding 
buffer (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM imidazole, 1 mM magnesium 
acetate, 2 mM CaCl2, 10 mM β-mercaptoethanol, 0.1 % NP-40).  6 mls of calmodulin 
binding buffer (CBB) was added to the 2 ml of TEV eluted protein. An additional 6 µl of 1 
M CaCl2 was also added to quench the EDTA in the TEV cleavage buffer.  The eluted 
protein solution was then incubated with the calmodulin Sepharose for 1 hour at 4oC on a 
rotating wheel. After incubation the beads were collected and washed twice with CBB. 
The tagged protein and its interacting partners were then eluted from the beads with 2 x 
500 µl of calmodulin elution buffer (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM 
imidazole, 1 mM magnesium acetate, 20 mM EGTA, 10 mM β-mercaptoethanol, 0.02 % 
NP-40). 
To the 1 ml elution 333 µl of 100% trichloroacetic acid (TCA) was added and incubated 
on ice for 30 minutes with periodic vortexing to precipitate the eluted protein. Samples 
were then spun at 20000 xg on a bench top microcentrifuge at 4oC for 30 minutes before 
carefully removing the supernatant. The pellet was then washed once in ice cold 
acetone/0.5 M HCl before centrifuging again at 20000 xg for 5 minutes. The supernatant 
was again removed and the invisible pellet subjected to a final wash in 1ml of 100 % 
acetone. The pellet was dried in a heat block at 30oC before resuspending in 20 µl of 1X 
SDS buffer prior to running on a 4-12 % NuPAGE® Bis-Tris Pre-Cast gel (Life 
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Technologies).  Gels were silver stained using the Bio-Rad Silver Stain Plus kit (Bio-Rad) 
according to the manufacturer’s instructions. Protein bands were then excised and analysed 
by mass spectrometry.  
 
2.3 Cell biology 
2.3.1 Mammalian cell culture 
All mammalian cell lines were cultured at 37oC in a humidified incubator with an 
atmosphere of 5% CO2.  HeLa cells were cultured in DMEM growth medium 
supplemented with 10% foetal bovine serum (FBS) without antibiotics while hTERT-
RPE1 cell lines were cultured in DMEM-F12 supplemented with 10% FBS, no antibiotics. 
Generally cells were passaged upon reaching ~90% confluence by removing medium, 
washing in warm PBS and incubating with trypsin-EDTA for 5 minutes until the cells 
became detached. Fresh medium was added to neutralize the trypsin-EDTA and the 
appropriate volume of cell suspension seeded into pre-warmed dishes of fresh medium. 
 
2.3.2 Nucleofection of mammalian cells with siRNA 
hTERT-RPE1 cells were grown to 60 % confluence prior to transfection with siRNA 
oligonucleotides. Cells were trypsinized, counted and 0.8 x 106 cells were then centrifuged 
at 250 xg for 10 minutes. Excess growth media was removed from the pellet which was 
then resuspended in 100 µl of electroporation solution with 20 µl of siRNA (20 µM stock). 
The suspension was then transferred to a cuvette for electroporation using an Amaxa 
Nucleofector. Immediately following electroporation, 1 ml of growth media was added to 
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the cuvette to resuspend the cells which were then plated in 2 x pre-warmed 10 cm dishes 
with appropriate growth medium.  
For all siRNA experiments, cells were cultured for either 48 or 72 hours post-transfection. 
A commercially available non-targeting control siRNA (Dharmacon) was used in all 
experiments along with a ChlR1 siRNA specific to the 3’ UTR of the gene. Sequences are 
shown below:  
ChlR1 3’ UTR siRNA AGUCACUCCUUCAGUAGAA 
non-targeting siRNA       UAAGGCUAUGAAGAGAUAC 
 
2.3.3 Cell synchronization 
Cells were synchronized in G1/S by double thymidine block. 2 mM thymidine was added 
to the growth medium of cells that had been cultured for 8 hours. Cells were then cultured 
for a further 16 hours and the thymidine was removed by gently washing cells twice in 
PBS. Fresh growth medium was then added and cells were incubated for a further 8 hours. 
Once again, 2 mM thymidine was added to the cells and they were cultured for 16 hours 
before harvesting or releasing into S-phase. 
 
2.3.4 Colony formation assay 
HeLa cells transfected with either control or ChlR1 siRNA were cultured for 24 hours 
post-transfection before trypsinising, counting and re-plating at low density into wells of a 
6-well plate. Typically, 150-1000 cells were plated per well depending upon the drug 
treatment and dose.  Untreated wells were seeded at 150 cells/well while the wells 
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receiving higher doses of DNA damaging drugs were seeded at higher densities. 
Approximately 4 hours post re-seeding, cells were treated with increasing doses of various 
DNA damaging agents. Depending upon the drug, treatments ranged in duration from 3 
hours to 24 hours before the drug was washed off and fresh medium added. The cells were 
then incubated at 37oC for 10 days to allow surviving cells to form colonies which could 
then be stained with methylene blue solution (0.2 % methylene blue, 50 % MeOH) and 
counted. Each condition was counted in triplicate and an average of the three wells taken.  
 
2.3.5 Cell Counting Kit-8 (CCK-8) proliferation assay 
hTERT-RPE1 cells were treated with either control or ChlR1 siRNA and grown for 24 
hours post-transfection. They were then harvested by trypsinisation, counted and re-seeded 
into 96-well plates. Seeding density was typically 500-1000 cells per well in 100 µl of cell 
suspension. 24 hours later cells were treated with increasing doses of various DNA 
damaging drugs in triplicate (3 wells per dose). Untreated samples as well as vehicle only 
samples (i.e. treated with PBS or DMSO) were included on each plate. Following drug 
treatment for the appropriate length of time, each well was washed gently in warm PBS 
and fresh medium added. 24-48 hours post-treatment 10 µl of CCK-8 solution was added 
to each well, taking care not to introduce air bubbles. The plate was incubated with the 
CCK-8 solution for 1-4 hours and the absorbance measured at 450 nM on a microplate 






2.3.6 Mammalian cell lysis and determination of protein concentration 
Each confluent 10 cm dish of cells was washed once with cold PBS before adding 1 ml of 
PBS to each dish and gently collecting the cells by scraping. Cells were then transferred to 
a clean microfuge tube and centrifuged at 1000 xg, for 10 minutes at 4oC. PBS was 
removed and pellet resuspended in 300 µl of lysis buffer (50 mM Tris-HCl pH 7.4, 100 
mM NaCl, 20 mM NaF, 10 mM KH2PO4, 10 % glycerol,, 1 mM DTT, 1 % TritonX-100 
plus 1 % protease inhibitor cocktail (Sigma)) and incubated on ice for 10 minutes. Lysate 
was sonicated at 40 % amplitude 3 x 10 seconds. The lysate was then clarified by 
centrifugation at 20,000 xg at 4oC for 10 minutes. Total protein concentration of each 
sample was determined by Bradford protein assay (Bio-Rad) according to the standard 
manufacturer’s protocol.  
 
2.3.7 Subcellular fractionation 
Method 1 
Cells were cultured and harvested by centrifugation as previously described in 2.24 and 
washed once in ice cold PBS. The cytoplasmic protein fraction was removed by incubation 
in hypotonic buffer (10 mM HEPES pH 7.0, 50 mM NaCl, 0.3 M sucrose, 0.5 % Triton X-
100, and protease inhibitor cocktail) for 10 min on ice and centrifugation at 1500 xg for 5 
min. The nuclear soluble fraction was removed by incubation with nuclear buffer (10 mM 
HEPES pH 7.0, 200 mM NaCl, 1 mM EDTA, 0.5 % NP-40 and protease inhibitor 
cocktail) for 10 min on ice before centrifugation at 20,000 xg for 2 min. Pellets were then 
resuspended in chromatin extraction buffer (10 mM HEPES pH 7.0, 500 mM NaCl, 1 mM 
EDTA, 1 % NP-40 and protease inhibitor cocktail), sonicated at 40 % amplitude for 3 x 15 
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seconds, and then centrifuged for 30 seconds at 20,000 xg. The supernatant represents the 




To provide more reliable and consistent fractionation data and to further confirm results 
obtained via the original method, a commercial sub-cellular fractionation kit (Pierce) was 
used in later experiments. Cells were harvested and collected by centrifugation as 
previously described in 2.24. Packed cell volume was determined after removal of PBS 
and from this the appropriate volume of CEB buffer was added. For example, a packed cell 
volume of 10 µl required the addition of 100 µl of CEB, a packed cell volume of 20 µl 
required 200 µl and so on. The volumes given in this method assumes a packed cell 
volume of 10 µl. The pellet was resuspended in CEB and incubated on ice for 10 minutes 
with gentle mixing. The sample was then centrifuged at 500 xg for 5 mins and the 
supernatant transferred to a clean pre-chilled microfuge tube (cytoplasmic fraction). 100 µl 
of chilled MEB supplemented with the protease inhibitor cocktail provided (1:100 
dilution) was then added to the pellet before incubation on ice for a further 10 mins with 
gentle mixing. The sample was then centrifuged at 3000 xg for 5 mins and the supernatant 
once again removed to a clean chilled tube (membrane fraction). The pellet was then 
resuspended in 50 µl ice cold NEB plus inhibitors and vortexed on the highest setting for 
15 seconds. The sample was then incubated for 30 mins on ice with gentle mixing. 
Following this incubation the sample was centrifuged at 5000 xg for 5 mins at 4oC. The 
supernatant was transferred to a clean pre-chilled tube and this represents the soluble 
nuclear fraction. The remaining pellet was then incubated with 50 µl of chromatin 
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extraction buffer (NEB plus 5 µl of 100 mM CaCl2 and 300 units of Micrococcal Nuclease 
per 100 µl of buffer). This incubation was carried out at room temperature for 15 mins. 
After incubation, the sample was vortexed on the highest setting for 15 seconds and then 
centrifuged at 16000 xg for 5 mins and the supernatant transferred to a clean chilled 
microfuge tube. This represents the chromatin associated fraction. At this stage, the final 
pellet was resuspended in 50 µl urea buffer (50 mM Tris-HCl pH 7.5, 9 M Urea, 5 mM 
DTT) and sonicated at 40% amplitude for 3 x 10s. This represented the cytoskeletal 
fraction. 
 
2.3.8 Flow cytometry 
Fixing 
Cells were harvested by trypsinisation and centrifuged for 4 minutes at 500 xg. The 
supernatant was aspirated to within 1-2 mm of the cell pellet. Cells were resuspended and 
washed with 5 ml of PBS. PBS was then aspirated off and the cell pellet resuspended in 
the residual liquid. 3 ml of 1% formaldehyde solution was then slowly added to the 
resuspended cell pellet while vortexing. This was incubated at room temperature for 20 
mins. The sample was then centrifuged at 500 xg and the formaldehyde removed. The cells 
were resuspended in the residual liquid before slowly adding 3 mls of 70 % EtOH while 
vortexing. The sample was then left at 4oC until ready to stain.  
Staining with anti-H3 antibody 
When ready to proceed with staining, samples were spun at 500 xg to pellet cells and the 
EtOH removed. Cell pellets were resuspended in the residual liquid and 3ml of PBS/BSA 
incubation buffer (PBS containing 0.5 % BSA) was added. The samples were spun again 
at 500 xg and the supernatant carefully poured off. Cell pellets were resuspended in 90 µl 
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of incubation buffer plus 2-3 µl Alexa 488 conjugated phosphorylated (serine 10) histone 3 
(P-H3) antibody (table 2) and incubated in the dark at room temperature for 1 hour. Cells 
were then washed in 3 mls of incubation buffer, spun at 500 xg and the supernatant 
removed. Cells were then typically also stained with propidium iodide, although the 
protocol can be stopped at this point and the cells simply resuspended in 500 µl incubation 
buffer before analyzing on the flow cytometer.  
Staining with propidium iodide (PI) 
To stain cells with propidium iodide, cells were washed in incubation buffer following 
fixation as for P-H3 staining. Cells were then resuspended in 500 µl of staining solution 
(PBS/BSA containing 50 μg/ml propidium iodide and 5 μg/ml RNAse A) and incubated in 
the dark at room temperature for 30 mins. Samples were then analysed using a FACSscan 
flow cytometer (Beckton-Dickinson). 
 
2.3.9 Alkaline comet assay 
Cells were transfected with either control or ChlR1-specific siRNA. 72 hours post-
transfection cells were harvested and 5 x 103 cells were re-suspended in 90 μl of 0.75 % 
low melting point agarose in PBS at 37oC. This suspension was then spread onto a fully 
frosted microscope slide pre-coated with 1 % normal melting point agarose that had been 
allowed to set. Slides were then placed on ice to allow the top agarose layer to solidify 
before treatment with 5-10 Gy gamma radiation to induce damage. Slides were either lysed 
immediately in alkaline lysis buffer (10 mM Tris-HCl pH 10, 2.5 M NaCl, 100 mM EDTA 
and 1 % Triton-X 100) or allowed to recover in appropriate growth medium. For 
experiments with hydroxyurea (HU), 2 mM HU was added to cell growth media after 
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suspension on the slides.  Lysis was performed overnight at 4oC and the following day 
slides were incubated in fresh alkaline electrophoresis buffer (0.3 M NaOH, 1 mM EDTA) 
for 40 minutes to enable unwinding of the DNA molecules. Electrophoresis was carried 
out for 20 minutes at 300 mA following which the slides were first drained and then 
washed three times (five minutes per wash) with neutralisation buffer (0.4 M Tris-HCl pH 
7.5). Slides were equilibrated in PBS for ten minutes before staining with 1 μg/ml 
propidium iodide in PBS for 2 hours at 4oC. Comets were visualized using a Zeiss 
epifluorescence microscope with TRITC filter set and individual cells were scored using 
the Comet Assay IV software tool. Fifty to one hundred cells were scored for each 
condition. 
 
2.3.10 Preparation of chromosome spreads 
Fibroblast cell lines growing in 10 cm plates were treated with 100 ng/ml of colcemid and 
incubated at 37oC for 1 hour to enrich for metaphase cells. After this incubation the 
medium was removed and collected in a 15 ml Falcon tube. The dish was rinsed with 2 ml 
of warm 1X trypsin-EDTA and this was also collected in the Falcon tube. A further 2 mls 
of trypsin-EDTA was added to the plate and incubated for 5 mins at 37oC. 2 mls of 
medium from the falcon tube was added to the plate to neutralize the enzyme and all 4 mls 
were then collected in the falcon tube to ensure all mitotic cells were collected. The cells 
were centrifuged at 500 xg for 10 minutes at 4oC. The majority of the medium was then 
removed leaving just 500 µl and the cells were resuspended in the remaining medium by 
gentle vortexing. 7 mls of hypotonic solution (0.8 % sodium citrate in deionized H2O) was 
then slowly added dropwise to the sample while vortexing before incubating at room 
temperature for 10 mins. Cells were then collected by centrifugation at 500 xg for 10 mins 
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at 4oC and the supernatant removed, leaving  500 µl to resuspend the pellet. 7 mls of 
Carnoy’s Fixative (75% MeOH, 25% acetic acid) was then slowly added dropwise to the 
sample and then incubated for 10 mins at room temperature. Cells were once again 
centrifuged at 500 xg for 10 mins at 4oC. The addition of the fixative was repeated twice 
more before removal of as much of the supernatant as possible and adding 300- 500 µl of 
Carnoy’s Fixative to resuspend the pellet. Cells were then dropped onto clean, microscope 
slides using a water bath set to 37oC to create a warm humid environment for optimal 
spreading. 3-4 slides were prepared per sample and allowed to dry inside a fume cupboard. 
Once slides were dry, they were stained with Giemsa stain (Sigma) for 30 mins before 














2.4 Immunological methods 
2.4.1 Western blotting and immunodetection 
Sections of polyvinylidine fluoride (PVDF) membrane (Roche) were cut to the required 
size before being placed in methanol (MeOH) for approximately 10 seconds to allow 
activation. They were then stored in transfer buffer (25 mM Tris-HCl pH 8.5, 192 mM 
glycine, 5% MeOH) until needed. Electrophoresed acrylamide gels were removed from the 
gel cassettes, carefully peeled from the glass plates and allowed to equilibrate in transfer 
buffer for 5 minutes. Sponges and filter paper sections were also pre-soaked in the buffer 
prior to assembly of the transfer module. The next steps were all carried out in a shallow 
plastic container containing a small volume of transfer buffer to keep all components moist 
throughout the assembly process. The bottom layer of sponge was placed on the black 
surface of the transfer cassette, followed by a layer of filter paper. Next, the gel was placed 
on top, taking care to avoid air bubbles. This was followed by the PVDF membrane, 
another layer of filter paper and finally a second sponge on top. Potential air bubbles were 
rolled out using a small glass rod and the cassette closed tightly. The cassette was then 
placed in the transfer tank and fully immersed in buffer. The gel was then transferred at 
constant 400 mA for 1 hour.  
Following transfer, the PVDF membrane was rinsed in dH2O and stained with Ponceau S 
solution (0.1% Ponceau S, 5% acetic acid) to ensure even transfer of protein from gel to 
membrane. The membrane was then rinsed again in dH2O to destain before blocking in 
TBS/T (10 mM Tris-HCl pH 7.6, 150 mM NaCl2, 1 % Tween 20) containing 5 % non-fat 
dry milk powder (blocking buffer). Membranes were typically blocked for 30 mins-1 hour 
at room temperature or overnight at 4oC. After blocking, the membranes were incubated 
with the appropriate primary antibody diluted in blocking buffer for 2-18 hours at room 
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temperature or 4oC. Membranes were then washed 3-5 times with TBS/T for 10 mins each 
before incubation with horseradish peroxidase conjugated secondary antibody diluted in 
blocking buffer for 1 hour at room temperature. TBS/T wash steps were repeated and 
proteins were detected using commercially available SuperSignal Dura Chemiluminescent 
Substrate (Pierce). Chemiluminescence signal was digitally detected using the Fusion™ 
imaging system (Peqlab). Table 2 shows a list of antibodies along with the appropriate 
dilution used for immunodetection. 
 
2.4.2 Immunoprecipitation 
Cell lysate was mixed 1:1 with binding buffer (50 mM Tris-HCl pH 7.4, 100 mM KCl, 0.1 
mM EDTA, 0.1 % BSA, 2.5 % glycerol,, 1 mM DTT, 0.2 % NP-40 plus 1 % protease 
inhibitor cocktail) along with the appropriate amount of antibody (usually 1 µg per 10 cm 
dish) plus 10 µl of protein G conjugated Sepharose bead slurry (Sigma) per reaction. 
Reactions were incubated on a rotating wheel at 4oC for 2-3 hours before collecting beads 
by centrifugation at 500 xg and washing 3 times with 1 ml of wash buffer (100 mM Tris-
HCl pH 7.4, 100 mM NaCl, 1 mM DTT, 0.5 % NP-40). Beads were then boiled in 1 X 
SDS sample buffer for 5 minutes before analysis by SDS PAGE. 
2.4.3 Immunocytochemistry 
Cells cultured on 22x22 mm coverslips were fixed in 4 % paraformaldehyde for 10 
minutes at room temperature. Cells were washed twice in PBS before permeabilisation in 
PBS containing 0.2 % Triton-X 100, again for 10 minutes at room temperature. Cells were 
then blocked in PBS supplemented with 20 % heat inactivated goat serum and 0.1 % BSA 
for 1 hour.  Incubation with primary antibodies at the appropriate dilution was performed 
overnight at 4oC.  Coverslips were then washed in PBS three times prior to incubation with 
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Alexa Fluor 488 conjugated secondary antibody (Life Technologies) at a 1:500 dilution for 
1.5 hours in the dark. Coverslips were washed three times with PBS again and then 
counterstained with Hoescht 33342. Coverslips were then mounted on microscope slides 
using Prolong Gold anti-fade reagent (Life Technologies) and stored at -20oC. Slides were 
imaged using a Zeiss epifluorescence microscope with FITC and UV filter sets. Antibodies 

















Antibody Manufacturer  Dilution 
(application) 
ChlR1 Dundee Cell Products* 1:500 (WB) 
HA (HA.11 clone, 
mouse) 
Covance (MMS-101P) 1:1000 (WB) 1:500 
(IF) 
HA (rabbit) Abcam (ab9110) 1:1000 (WB) 1:500 
(IF) 
Chk1 Cell signaling (#2360) 1:1000 (WB) 
Phospho-Chk1 (S345) Cell signaling (#2348) 1:1000 (WB) 
Chk2  Cell signaling (#2662) 1:1000 (WB) 
Phospho-Chk2 (T68) Cell signaling (#2661) 1:1000 (WB) 
Phospho-Histone H2A.X 
(S139) 
Millipore (05-636) 1:1000 (WB) 1:500 
(IF) 
PCNA Abcam (ab29) 1:5000 (WB) 
RPA34 Calbiochem (NA18) 1:500 (WB) 1:200 
(IF) 
Rad21 Abcam (ab992) 1:2000 (WB) 
SMC1 Abcam (ab9262) 1:2000 (WB) 
Timeless Abcam (ab109512) 1:2000 (WB) 
TopBP1 Bethyl Laboratories (A300-111A-1) 1:2000 (WB) 
Rad9 Bethyl Laboratories (A300-890A) 1:1000 (WB) 
6X his tag® (HIS.H8) Abcam (ab18184) 1:1000 (WB) 
β-actin Sigma (A5441) 1:5000 (WB) 
53BP1 Novus Biologicals (NB100-904) 1:1000 (IF) 
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Histone H3  Bethyl Laboratories (A300-823A) 1:5000 (WB) 
Phospho- Histone H3 
(Alexa Fluor® 488 
Conjugate) 
Cell Signaling (#9708) 1:50 (FC) 
GRB2 Cell Signaling (#3972) 1:1000 (WB) 
ORC2 Cell Signaling (#4736) 1:1000 (WB) 
Fen1 Bethyl Laboratories (A300-256A) 1:1000 (WB) 
Cytokeratin No 5/6 Boehringer Mannheim (1273-396) 1:2000 (WB) 
 
Table 2: Table of antibodies used for immunodetection, flow cytometry and 
immunofluorescence. Supplier and catalogue number are shown in column two. The 


















The biochemical purification and proteomic analysis 













3.1.  The role of the DNA helicase Chl1  
In yeast several classes of proteins, generally termed cohesion factors, have been 
identified. These include the proteins which form the cohesin complex as well as proteins 
involved in the loading of cohesin onto chromosomes and also cohesion establishment 
factors [118-120]. Several of these cohesion establishment factors have been shown to 
interact with components of the DNA replication machinery and thus are essential in 
ensuring that the processes of DNA replication and sister chromatid cohesion are closely 
coupled to each other such that newly synthesized sister DNA molecules are tethered 
together. One of these proteins is the DNA helicase Chl1p. Although it is known to be 
involved in the processes of cohesion establishment and potentially DNA replication, its 
exact role and mechanism of action is still not fully understood. 
It has also been suggested that Chl1p may have a role, either directly or indirectly, in the 
repair of DNA damage. Laha et al. showed that Chl1p is necessary in S-phase for cell 
viability either upon exposure of cells to DNA damaging agents [165]. As discussed in 
chapter 1, the mechanism underlying this hypersensitivity to DNA damage inducing agents 
was shown to be independent of the DNA damage checkpoint. Another study in yeast 
showed that the levels of Chl1p associated with chromatin increased in response to DNA 
damage induction by MMS and DNA repair was again shown to be deficient in Chl1 
mutants. Importantly, it was determined that these mutant cells also had defects in 
homologous recombination, an important pathway for DNA damage repair. However 
whether this HR defect is a consequence of the cohesion defect in these cells or whether 





3.2. Aims of Chapter 3 
A review of the literature surrounding the yeast Chl1p suggested that while the protein 
evidently has an important role in cohesion establishment, the exact biological function of 
Chl1p in chromatid cohesion, cellular DNA replication and DNA repair remained poorly 
understood. The mechanism by which it interacts with the replication machinery to couple 
DNA synthesis to sister chromatid cohesion was also unresolved and therefore there was 
much scope for further functional characterisation of this DNA helicase protein.   
Furthermore, work had been carried out in recent years using Schizosaccharomyces pombe 
as a model organism that demonstrated a role for Chl1p in the repair of DNA damage.  In 
addition, while other groups had, at this time, undertaken some limited biochemical 
analysis of the human homologue ChlR1, the yeast proteins had not been similarly 
characterised. 
To further understand the biological role of Chl1p using S. pombe as a model system, two 
different biochemical approaches were initially taken. Firstly, a tandem affinity 
purification was used with the aim of identifying novel interacting proteins of S. pombe 
Chl1p. In parallel, S. pombe Chl1 was cloned into an E. coli expression system in order to 
express and purify both the wild-type and a helicase-dead mutant protein for subsequent 







3.3. Tandem affinity purification of Chl1p to identify novel interacting partners 
3.3.1. Tandem Affinity Purification (TAP) 
Tandem Affinity Purification (TAP) utilises a modular tag consisting of protein A and 
calmodulin binding domains to allow the purification of the protein of interest, in this case 
Chl1p, in a two-step process using IgG and calmodulin Sepharose resins respectively. 
Following initial binding of the tagged Chl1p to the IgG resin, the protein is then incubated 
with TEV protease which cleaves the tag at a specific site, removing the protein A domain 
and eluting the protein of interest. This eluate is bound to calmodulin Sepharose and then 
washed and eluted with buffer containing EGTA. Protein samples can then be analysed by 
SDS PAGE followed by mass spectrometry to identify proteins that co-purify with Chl1p. 
The process has been shown to be extremely effective in identifying protein interacting 
partners and components of biological complexes [180, 181]. However, potential problems 
with the TAP method include the possibility that transient protein interactions may not be 
detected. It is also possible that the tag itself may affect expression levels of the protein of 
interest or interfere with protein interactions.  
In the case of CHL1, the TAP tag has been cloned at the C-terminus of the CHL1 gene 
using a PCR-based homologous recombination method [181]. This ensures that Chl1p 
expression is controlled by the endogenous promoter which may increase the chances of 
identifying biologically relevant interacting proteins. A disadvantage of this is that 
endogenous Chl1 expression is fairly low level so the overall yield of the TAP experiment 





3.3.2. Optimisation of Chl1-TAP expression  
The S. pombe CHL1-TAP strain was a gift from E. Noguchi, Drexel University College of 
Medicine. To determine whether Chl1-TAP was indeed expressed in this strain, a western 
blot was performed on total cell extract using a commercial antibody against the protein A 





Figure 3.1. Western blot showing expression of TAP-tagged Chl1p detected by an 
anti-Protein A antibody. The control is total extract from wild-type cells (5 minute 
exposure). Forty µg of lysate was loaded in each well. Unfortunately no loading 
control antibody was available. 
Forty micrograms of total extract from both TAP-CHL1 expressing cells and wild-type 
control cells were analysed by SDS PAGE. Expression of the Chl1-TAP fusion protein 
was confirmed by the western blot analysis, however the five minute exposure time could 
indicate that the levels of protein expression are quite low. There was no commercially 
available antibody against endogenous S. pombe Chl1p that would have allowed 
comparison between expression levels of the TAP-tagged protein and the untagged 
endogenous Chl1. Although the Chl1-TAP protein is expressed under the control of the 
endogenous promoter it is possible that the large TAP module at the C-terminus of the 





Control   TAP-CHL1 
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After confirming expression of the TAP-tagged protein, it was then assessed for solubility 
in the lysis buffer that would be used for carrying out the TAP protocol.  Several sodium 
salts were tested in the buffer to ensure the best possible yield of soluble protein for the 
particular protein of interest. As the aim of the tandem affinity purification is to identify 
potential interacting proteins, the salt concentration was kept at 0.15M for each of the 




Figure 3.2. Western blot showing soluble TAP-tagged Chl1 in buffers with various 
salts (15 minute exposure). Anti-protein A antibody was used for detection. The 
control lane is soluble extract from wild-type cells in NaCl buffer. Protein 
concentration of soluble extracts was determined by BCA assay and equal amounts 





No significant difference in solubility was observed between the different buffers.  Figure 
3.3 compares Chl1 protein levels in both total cell extract and soluble extract. Equal 








Figure 3.3. Western blot comparing levels of soluble TAP-tagged Chl1p, in NaCl lysis 
buffer, with Chl1p in total cell extract. Equal amounts of total protein were loaded in 
each well. Anti-protein A antibody was used for detection. 
 
Comparison of total protein extract with soluble extract indicated that the majority of 
Chl1p was soluble in the TAP lysis buffer. After the expression and solubility of the Chl1 
protein was confirmed the TAP experiment was carried out as previously described. The 
eluted protein was analysed by SDS PAGE followed by silver-staining of the gel. 
Precautions were taken at all stages of the staining process to avoid external contamination 
of the gel by keratins and other exogenous proteins in order to get the best quality data 
possible from subsequent mass spectrometric analysis. 
Control        TAP Control         TAP 
Total cell extract Soluble fraction 
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3.3.3. Tandem Affinity Purification and mass spectrometry analysis 
The TAP experiment was repeated four times in total in an attempt to improve the quality 
of the data and identify interesting interacting partners. Figure 3.4 shows the silver-stained 
gel image taken after the second attempt at the tandem affinity purification of Chl1. A 
control sample was analysed in parallel with the Chl1-TAP cells. The indicated bands that 
were specific to the Chl1-TAP lane were excised and analysed by mass spectrometry, as 
were the corresponding regions in the control lane. However, on this occasion the only 
protein that was identified was Chl1. Further attempts were made to repeat the experiment 
and have the gel analysed at the in-house mass spectrometry facility at the University of St 









Figure 3.4. Silver-stained gel of eluted protein from Chl1-TAP expressing cells or 
control wild-type cells expressing untagged protein. The indicated bands/sections 




Andrews. * indicates excised band and ] indicates an excised section. The 
corresponding regions from the control lane were also analysed.  
One of the issues raised by the gel images from the TAP experiments was that the band 
corresponding to Chl1 was fairly low intensity compared to some of the other non-specific 
bands that were present. This low-yield could be due to a number of reasons, including the 
probable low-level expression of Chl1. However, it could also be caused by issues such as 
poor binding of the Chl1-TAP protein to either the IgG or calmodulin resins or by 
inefficient TEV cleavage which could both result in loss of the protein at various stages of 
the protocol. Initially the only available antibody was directed against the protein A 
component of the tag. Upon cleavage by TEV protease the protein A domain remains 
bound to the IgG Sepharose meaning that, using the protein A antibody, it would not be 
possible to accurately determine cleavage efficiency.  
As a crude method of determining relative Chl1 expression levels compared with other 
DNA replication-associated proteins in S. pombe, I obtained a panel of lysates from Dr 
Stuart MacNeill, University of St Andrews. These lysates were from three yeast strains 
containing TAP-tagged endogenous Mcm2, Mlh2 and Psf1 and had previously been used 
successfully to perform TAP experiments which identified novel binding partners. Figure 
3.5 shows Chl1 expression relative to these proteins. Chl1 expression appears to be 
significantly lower which could account for the difficulty in using the endogenously 













Figure 3.5. Western blot showing the relative expression levels of endogenous TAP-
tagged Chl1, as indicated with the arrow, compared with the endogenously expressed 
TAP-tagged S. pombe proteins Mcm2, Mlh2 and Psf1. Anti-protein A antibody was 
used for detection 
It is possible that with such a small amount of bait protein present and the need for silver-
staining gels in order to visualise the bands, the mass spectrometry instrumentation in-
house was at the limit of its ability to identify peptides and provide meaningful data. 
Therefore it was decided to repeat the experiment again and have the samples analysed at 
the proteomics facility at the University of Dundee since the instruments available there 
are more sensitive. Figure 3.6 shows the Coomassie stained gel from the fourth TAP 
experiment. 
 
Chl1 Mcm2 Mlh1 Psf1 Chl1 Mcm2 Psf1 Mlh1 






Figure 3.6. Coomassie-stained gel of eluted protein after purification from Chl1-TAP 
expressing cells or control wild-type cells expressing untagged protein. Only the 
Chl1-TAP lane was divided into sections and analysed. * indicates Chl1. The 
corresponding regions from the control lane were retained for analysis at a later date.  
 
Significant protein hits from the analysis of this gel are presented in table 4. Proteins that 
were found, upon review of the literature, either to be known non-specific contaminants of 
TAP experiments or to be highly abundant cellular proteins with little functional relevance 
to Chl1 have not been included in the table. For example, elongation factor 1 alpha and 
glyceraldehyde phosphate dehydrogenase which were also identified in a prior analysis, 
are both likely to be non-specific contaminants. 
Proteins were considered to be significant hits if two or more peptides were present, each 
with a sufficiently high peptide score. The Mascot score shown in the table is a probability 
score that is generated based on the number of peptides detected for a particular protein 
combined with the individual scores of these peptides and taking into account overall 
sequence coverage of the protein. 
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Protein ID Mascot 
Score 
Function 
Moc2/Ded1 308 ATP-binding RNA helicase involved in translation 
initiation. Inactivation of ded1 prevents mitotic cell cycle 
progression at G1 and G2/M. 
Rvb2 212     DNA helicase that is a component of several chromatin 
remodeling complexes, including the SWR1 and the 
INO80 complexes.  
Rad24 144     Required for the DNA damage checkpoint. It belongs to 
the 14-3-3 family of proteins. 
Rad25 204     Required for the DNA damage checkpoint and also 
belongs to the 14-3-3 family. 
 
Table 4. A shortlist of potential Chl1 interacting proteins was generated based on the 
mass spectrometry data as well as using relevant functional data available in the 
literature.   
 
3.3.4. Novel interacting partners of Chl1p  
Without analysis of the corresponding control lane it cannot yet be determined whether 
these identified proteins are indeed specific interactors. However RuvBL2, the human 
homologue of Rvb2, was identified independently in a TAP pull-down of human ChlR1 
carried out in the Parish lab by Dr Katherine Feeney. In this instance the control was 
analysed in parallel and RuvBL2 was not found to be present suggesting that it could be a 
specific interacting partner of ChlR1. Its proposed roles in chromatin remodelling and 
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DNA repair also suggest some potential functional relevance. Rvb2 is a DNA helicase that 
is a component of several chromatin remodeling complexes, including the SWR1 and the 
INO80 complexes [182-184]. The SWR1 complex mediates the ATP-dependent exchange 
of histone H2A for the H2A variant HZT1, thought to be a mechanism of transcriptional 
regulation. The INO80 complex remodels chromatin by altering the position of 
nucleosomes and is also thought to be involved in DNA repair. Both of these remodeling 
complexes are now considered to have roles beyond their canonical function in 
transcriptional regulation and have been implicated in other essential cellular processes 
including DNA repair, replication and checkpoint control [185].  
The identification of both Rad24 and Rad25 which are 14-3-3 proteins in S. pombe could 
also be potentially interesting. 14-3-3 proteins are involved in numerous cellular processes 
as important adaptors and modulators of protein function [186-188]. Although neither 
Rad24 or Rad25 are essential in S. pombe, simultaneous deletion of the two genes is lethal. 
Rad24 mutants in particular show high sensitivity to DNA damaging agents and cells 
lacking Rad24 enter mitosis prematurely resulting in a phenotype of abnormally small 
rounded cells. Selvanathan et al published data from a TAP pull-down of Rad24 in S. 
pombe which did not identify Chl1 as an interacting protein, however this could be 
attributed to the potentially transient nature of such an interaction [187]. Also, as the level 
of Chl1 expression is not only generally low, but also largely cell-cycle dependent [189] it 
could be that the interaction is indeed real but that varying experimental conditions have 
prevented confirmation with the reciprocal pull-down.  
Further confirmation by co-immunoprecipitation is still required to validate these putative 
interacting partners of Chl1. However, with a shift in focus towards the human homologue 
ChlR1 as a result of recent data generated in the Parish lab (K. feeney, C. Wasson and 
J.Parish unpublished), coupled with a lack of available biological tools for S. pombe, any 
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attempts to further characterise these interactions will most likely be performed in a 
mammalian cell system. In light of the mass spectrometry data generated by Dr Katherine 
Feeney which identified the Rvb2 homologue RuvBL2 as a potential interacting partner of 
human ChlR1, an attempt was made to co-immunoprecipitate flag-tagged RuvBL2 with 
endogenous ChlR1 in hTERT-RPE1 cells. This was unfortunately unsuccessful and 









3.4. Cloning, expression and purification of S. pombe Chl1  
In order to express Chl1 for biochemical and structural studies, large amounts of purified 
protein must be generated. To circumvent problems caused by low expression levels in S. 
pombe, the CHL1 gene was cloned into an E. coli expression vector. Bacterial promoters 
can drive higher gene expression levels and thus allow for the production of much larger 
amounts of protein. However, to express Chl1 in E. coli it was necessary to clone the gene 
without introns since bacteria lack the necessary RNA splicing machinery to allow the 
protein to be properly expressed. 
This was achieved by extracting total RNA from S.pombe cells using a similar Trizol™ 
extraction method to that described by Chomczynski and Sacchi in 1987 [190]. The 
method was adapted for S. pombe cells which require an additional mechanical lysis step 
to break open their tough cell wall. After RNA extraction, first-strand cDNA synthesis was 
carried out using a commercial kit that utilised oligodT primers to specifically synthesise 
cDNA by priming at the poly-A tail of mRNA. After synthesis of the cDNA, specific 
primers were used to amplify the CHL1 gene for subsequent cloning. 
Chl1 was initially cloned into the pET24b vector which introduced a His-tag at the C-
terminus of the protein. Although all expression and purification has been carried out using 
this construct, work was also undertaken to clone chl1 into several other expression 
vectors including pHisTev which allows an N-terminal, cleavable hexahistidine tag to be 
introduced and pLou3, a vector engineered by Dr Huanting Lui (University of St Andrews) 
which allows expression of the protein as an MBP-His fusion. 
Following successful cloning of the Chl1 gene, different E. coli expression systems were 
evaluated with the eventual goal of enabling the purification of full-length, soluble Chl1 
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protein that could then be used for biochemical studies and potentially for structural 
analysis. 
 
3.4.1 Cloning of Chl1 
Total RNA was extracted from exponentially growing wild type S. pombe cells and first-
strand cDNA synthesis carried out. A control reaction, without the reverse transcriptase 
(RT), was included to check for contamination of the RNA preparation with genomic 
DNA. Using chl1-specific primers containing NdeI and XhoI restriction sites, the forward 
and reverse primer respectively, Chl1 was then amplified from the cDNA (figure 3.7). No 
signal was observed in the no RT control PCR. As a positive control, Dcc1-specific 
primers were used to amplify an 800bp fragment of the S. pombe Dcc1 gene. These 















Figure 3.7. Agarose gel image demonstrating the specific amplification of CHL1 from 
synthesised cDNA. A band corresponding to the expected size of Chl1 (~2500bp) was 
clearly visible while no band was present in the no RT controls indicating that the 
RNA preparation was not contaminated with DNA. Dcc1 primers were used as a 
positive control. 
 
The PCR reaction was purified using a Sigma PCR clean-up kit and the DNA yield was 
quantified.  As the quantity of DNA was quite low several reactions were pooled and then 
subjected to restriction digest using the appropriate enzymes. In parallel, the pET24b 
vector was also digested with the same enzymes. Both reactions were once again purified 
using the commercial clean-up kit and then both the vector and insert were incubated with 
T4 ligase in the appropriate buffer for 3 hours at a ratio of 1:3.  
Several initial attempts at cloning Chl1 failed, possibly due to the low yield of insert DNA. 
This was overcome by pooling several PCR reactions to increase the quantity of insert 
DNA available. Although many colonies were screened, almost all appeared to be due 
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either to re-ligation of the vector or the vector being uncut in the first place. Single digests 
of the vector were performed to ensure that it was being effectively cut by the restriction 
enzymes and this was confirmed upon analysis by gel electrophoresis. It is also possible 
that digestion of the insert itself was inefficient due to the small overhang provided by the 
primers, although it would not be possible to distinguish undigested from digested insert 
on a gel. 
However, after scaling up the initial PCR reaction to obtain more insert DNA, colonies 
were screened by restriction digestion and two positive clones were identified and 
subsequently confirmed by sequencing (figure 3.8). 
 
 
Figure 3.8. Agarose gel image showing the screening of 10 colonies by restriction 
digest of the extracted plasmid DNA. Colonies 5 and 6 both contained an insert which 







3.4.2 Expression of Chl1 
After confirmation by sequencing, the pET24b-Chl1 construct was transformed into both 
BL21 and Rosetta 2 cells to check protein expression in these bacterial systems. 
Transformed cells were then grown in the presence of the appropriate antibiotic to an 
OD600 of around 0.7 prior to induction with 0.5mM IPTG. The pET24b plasmid encodes a 
kanamycin resistance marker while the Rosetta 2 cells also contain the pRARE plasmid 
which encodes tRNAs which are rarely used in E. coli and which help to optimise 
eukaryotic protein expression. Therefore Rosetta 2 cells require the addition of 
chloramphenicol to the growth medium in order to maintain this plasmid. After IPTG 
induction, cells were then grown for another 3 hours at 30oC.  Samples of cells lysed by 
boiling in SDS sample buffer were analysed by SDS PAGE followed by Coomassie 









Figure 3.9. Coomassie-stained gel of cell extract from either BL21 or Rosetta 2 
strains, -/+ IPTG induction. The red arrow indicates a band potentially 
corresponding to expressed Chl1. 
 
Upon induction with IPTG there is a faint band visible in the BL21 sample that 
corresponds to the correct molecular weight for full-length Chl1. There is no 
corresponding band visible for the Rosetta 2 cells. Western blot analysis confirmed that 
full-length Chl1 was expressed in both cell systems (figure 3.10), however it appeared that 
expression was higher in BL21 cells. In contrast, although expression in Rosetta 2 cells 
seems significantly lower than in BL21 there does appear to be less degradation of the 
protein. Also, in BL21 cells there is some apparent leakage. This indicates that expression 
of the protein is not as strictly regulated by the addition of IPTG in BL21 cells while in 
Rosetta 2 cells the expression is more tightly controlled due to the presence of T7 
lysozyme which reduces basal levels of expression of the protein of interest. This lack of 
regulation of protein expression can lead to problems with solubility and also cause protein 
degradation. It is possible that the relatively low expression level of Chl1 in E. coli, 
particularly in Rosetta 2 cells, could be an advantage.  Lower levels of expression may 
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mean that the protein is less likely either to be degraded by the bacteria or to end up in 





Figure 3.10. Western blot of BL21 and Rosetta 2 cell extract, -/+ IPTG. Anti-His 
antibody was used for detection. Left-hand panel is a 5 second exposure. Right hand 
panel shows a long exposure of the same blot. The arrow indicates full-length Chl1. 
 
The next step was to test whether the expressed protein was soluble.  Expression of Chl1 
was induced for 3.5 hours at 30oC in both BL21 and Rosetta 2 cells and once again 
samples were taken both prior to and after IPTG induction. Cells were then harvested and 
pellets were lysed by sonication in lysis buffer (50mM Tris-HCl pH7.6, 500mM NaCl and 
0.1% Triton). Total extract and soluble lysate were both loaded on a gel and analysed by 
western blot (figure 3.11). It appeared that Chl1 was more soluble when expressed in 






Figure 3.11. Western blot of BL21 (top panel) or Rosetta 2 (bottom panel) cell 
extract. Samples of uninduced (UI), induced (Ind), total cell extract (Total) and 
soluble lysate (Lys) were analysed by SDS PAGE and blotted with anti-His antibody. 
Soluble protein was only detected in Rosetta 2 cell extract. 
 
As it could be demonstrated that Chl1 was soluble when expressed in Rosetta 2 cells but 
not in BL21, further optimisation of conditions was carried out using the Rosetta 2 
expression system. By expressing the protein at 37oC instead of 30oC, it was thought that it 
might be possible to increase the expression, and subsequently the yield, of Chl1. 
However, when the western blot analysis was performed it was clear that when expression 
is carried out at 37oC, Chl1 is not soluble and the majority remains in the pellet after lysis 
(figure 3.12). On the contrary, when Chl1 is expressed at a low temperature (20oC) over a 
prolonged period of time, in this case overnight, the majority of the protein remains 
soluble. For the overnight expression a lower concentration of 0.2mM IPTG was used. 
Different exposures of the western blots are shown for each of these pilot expressions, 
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therefore they should not be directly compared to each other. The same amount of total 
protein was loaded compared with soluble lysate so it can be suggested that in the case of 
the overnight expression the majority of the expressed protein is soluble since the 





Figure 3.12. Expression of Chl1 carried out at 20oC overnight (top panel) or 37oC for 
3.5 hours (bottom panel). The bottom blot clearly shows that the majority of the 
protein remains in the pellet. This is a very short exposure – in longer exposures the 
signal from the lane where the pellet has been loaded is too intense to allow 





3.4.3. Purification of Chl1 
Having determined that Chl1 is soluble in Rosetta 2 cells under at least two sets of 
conditions, some small-scale purification experiments were performed using nickel beads 
to try to pull-down His-tagged Chl1. Briefly, this method involves induction of protein 
expression in a 10ml culture of cells. These cells are then harvested, resuspended in lysis 
buffer (50mM Tris-HCl pH7.6, 500mM NaCl and 0.1% Triton plus 10mM imidazole) and 
lysed by sonication. The clarified lysate containing soluble protein is then incubated with 
20µl of nickel beads for 30 minutes at room temperature on a shaking platform. The beads 
are washed twice with lysis buffer containing 30mM imidazole and then finally the His-
tagged protein is eluted in buffer plus 250mM imidazole. Samples were taken at each stage 
for analysis by both SDS PAGE and western blot (figures 3.13 and 3.14). Purified Chl1 
protein is clearly visible on the Coomassie stained gel when the protein is expressed at 
20oC overnight while there is no detectable band on the gel when expression is carried out 
for 3.5 hours at 30oC. Western blot analysis using an anti-His antibody confirms that Chl1 
has indeed been purified under the first set of conditions. There is some protein detectable 
in the eluate of the 30oC expression experiment but in this instance it looks like the 
majority of the protein remains insoluble, with only a small fraction present in the lysate. 
From these data it was concluded that a gentle overnight induction of Chl1 expression 
greatly improved the solubility of the protein and thus these conditions were selected for 







Figure 3.13. The top panel shows the Coomassie gel of samples taken at each step of 
the small scale purification of Chl1 from an overnight, 20oC expression. Bottom panel 













Figure 3.14. The top panel shows the western blot of samples taken at each step of the 
small scale purification of Chl1 from an overnight, 20oC expression. Bottom panel 
shows the same sample set from a 3.5 hour, 30oC expression.  A 5 second exposure is 
shown for both. 
 
It is noteworthy that in both small-scale purifications, upon analysis of the western blots, it 
is apparent that there is very little visible depletion of Chl1-His between the initial lysate 
and the unbound fraction after removal of the beads. It would be expected that the majority 
of the His-tagged protein should be bound to the beads and thus there should be less 
protein detected in the unbound fraction. As this is not the case it should be considered that 
perhaps Chl1-His does not bind efficiently to the beads. It may be the His-tag is poorly 







cloning with an N-terminal tag. Alternatively, the addition of a larger tag such as MPB 
(maltose-binding protein) could also improve binding as the small size of the His-tag 
compared to the relatively large size of Chl1 might be an issue.  
For FPLC purification of Chl1, a 250ml culture of Chl1-His expressing Rosetta 2 cells was 
grown up and induced overnight at 20oC. Cells were harvested by centrifugation and the 
pellet was lysed in the same lysis buffer as previously with the addition of a Roche 
complete protease inhibitor tablet and 0.5mM DTT to prevent possible oxidation of the 
iron-sulpher cluster of Chl1. Clarified lysate containing the soluble protein was then 
affinity purified on a 1ml Fast-Flow nickel column. After loading of the lysate, the column 
was then washed through with several volumes of Buffer A (50mM Tris-HCl pH7.6, 
500mM NaCl, 20mM imidazole). Next the concentration of imidazole was increased to 
60mM for several more column volumes before increasing in a gradient to 250mM 
imidazole over a 10 minute period. The chromatography trace is shown in figure 3.15. 







Figure 3.15. Chromatography trace of Chl1 affinity purification. The UV absorbance 
is shown in blue while the imidazole concentration is indicated by the green line. The 









Figure 3.16. Coomassie gel (top) and western blot (bottom) of fractions from 
purification of Chl1. The Chl1 band is visible on the western blot at around 95 kDa, 
corresponding to the expected size of His-tagged Chl1 protein. 
 
Fractions A6 to B5 were also analysed, however no protein was detected in any of these 
fractions. The broad peak in absorbance apparent on the chromatogram could be due to the 
increasing imidazole concentration rather than protein. Chl1-His is definitely present in 
fraction A1 which corresponded to the increase in imidazole concentration to 60mM. This 
step is normally used to eliminate non-specific proteins that have bound weakly to the 
column, however it seems in this case that Chl1-His also has a low affinity for binding to 
the column. However, there is no Chl1-His detectable in the flow though which suggests 
that it does bind to the column albeit with low-affinity. This could be a problem with the 
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localisation of the His-tag at the C-terminus and could potentially be resolved either by 
using an N-terminal tag, by using a larger affinity tag such as MBP or by simply 
optimising the purification protocol to take into account the low affinity binding. 
Another attempt was made to purify Chl1 using FPLC, this time washing extensively with 
20mM imidazole before introducing a shallow gradient up to 100mM imidazole. This was 
followed by another steeper gradient to 250mM imidazole to ensure complete elution of 
bound proteins. The chromatography trace is shown in figure 3.17. 
Although the trace did not look promising, the zoomed-in view showed a series of very 
shallow peaks. These fractions were collected and analysed on a Coomassie-stained gel 




Figure 3.17. Chromatogram of Chl1 purification (left). The concentration of 
imidazole was increased to 100mM gradually over a 10 minute period before 
eventually increasing to 250mM. The right panel is a zoomed-in view showing 







Figure 3.18. Coomassie-stained gels of fractions from Chl1 purification (top). 
Western blots of the same fractions are shown below (bottom), using anti-His 
antibody. The western blots shown are each a different exposure. The left hand side is 








From the Coomassie gels shown in figure 3.18 there is a band corresponding to full-length 
Chl1 visible in fractions A11-B6. This was confirmed by western blot to be Chl1-His. 
Different exposures of the two blots have been shown in order to illustrate that there is also 
a small amount of Chl1-His present in the other fractions (A6-A8) which suggests that 
some Chl1-His is eluting from the column at lower concentrations of imidazole.  It might 
be possible to repeat the purification using a shallower gradient to improve resolution of 
individual peaks. However, if the low-affinty of Chl1 is causing it to elute gradually from 
the column upon increasing the imidazole concentration, the result might always be a very 
broad, shallow peak with small amounts of Chl1 present in each fraction. As these 
purifications were still fairly small-scale, it was thought that increasing the amount of Chl1 
in the starting material could improve the results with more Chl1 likely to bind to the 
column compared with non-specific contaminants.   
Thus, larger scale experiments using  first 1 litre and then 4-6 litres of bacterial culture 
were carried out to attempt to optimise the purification conditions. Neither scaling up nor 
reducing the gradient resulted in a significant improvement in protein purity despite the 
presence of an obvious peak on the chromatography trace as demonstrated in figure 3.19. 
However, this optimisation process did result in the development of a purification strategy 
which consistently provided acceptable yields of partially purified Chl1-His protein. A 
typical example of a Coomassie stained gel from a nickel affinity purification from 6 litres 
of bacterial culture is shown (figure 3.19). A 5ml Fast-flow nickel column (GE healthcare) 
was used and the imidazole gradient was increased from 10mM to 250mM over 25 column 
volumes. These conditions were used as the first step in all subsequent purification 
attempts and the purest Chl1-containing fractions were then pooled for further downstream 
purification. For example, the fractions highlighted in red in figure 3.19 were considered 
sufficiently pure to be carried forward.  
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It was determined that the pooled and dialysed fractions from the nickel affinity 
chromatography could be concentrated and stored at 4°C for up to 1 week without 
significant protein precipitation or visible degradation of Chl1 as determined by 
Coomassie staining. The dialysis buffer used was 50mM Tris-HCl pH 7.6, 500mM NaCl, 
10% glycerol plus 1mM DTT.  Encouragingly, following concentration of the nickel 
purified fractions the soluble protein had a yellowish appearance which can often be 
observed in iron-binding proteins. This suggested that the iron-sulpher cluster remained 
intact and protected from oxidative damage due to the precautions taken during the 
purification process.  However, after storage at 4°C for 2 weeks, some degradation did 
become apparent by Coomassie staining and the protein solution had lost its yellow tinge 



























Figure 3.19. Top: Chromatogram of Chl1 purification from 6 litres of bacterial 
culture. The concentration of imidazole was increased from 10mM to 250mM 
gradually over 25 column volumes. Bottom: Coomassie stained gel showing alternate 
fractions from B10-C12 where the majority of Chl1 protein eluted. Several co-
purifying bands were still visible even in the cleanest fractions. The highlighted 




fractions were chosen as the most promising fractions for further purification based 
on purity. 
 
It is common for nickel affinity chromatography to be merely the first step in the 
purification process and therefore it was not unexpected that additional steps had to be 
considered to enable the protein to be used for downstream applications. However, further 
purification steps must be carried out quickly and with exceptional care in order to 
maximise the chances of producing adequate quantities of stable, active enzyme of 
sufficient purity for biochemical assays.  
Heparin is a very highly negatively charged polysaccharide molecule which is often used 
in affinity chromatography as an intermediate step in the purification of DNA binding 
proteins due to its charge and structural similarity to nuceic acids. Heparin therefore has 
the capacity to act as both an affinity ligand as well as a cation exchanger. However with 
regards to Chl1, which has a theoretical isoelectric point of 4.8, a relatively acidic buffer 
pH would need to be used to generate a net positive charge on the protein. This was 
considered inadvisable as it could detrimentally affect the function of the protein for 
downstream applications. Nevertheless, as Chl1 is a DNA helicase which evidently binds 
to DNA, the potential still remained to utiise heparin as an additional affinity 
chromatography step in the hope of further purifying the protein.  
The pooled fractions from the nickel column were dialysed to remove the imidazole as 
well as to carry out a buffer exchange to promote binding to the heparin column. The 
binding was performed in a buffer containing 20mM MES pH 6.0, 0.1M NaCl with 1mM 
DTT and elution was achieved by gradually increasing the ionic strength of the buffer 
from 0.1M NaCl up to 1M NaCl. The chromatography trace and accompanying 
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Commassie gels are shown in figure 3.20. It is clear that Chl1 does indeed bind to the 
heparin column as the corresponding band is absent in the flow through fraction. 
Unfortunately, many of the contaminating proteins also appear to bind to the column and it 
was not possible to separate Chl1 from these co-purifying proteins using this method. In 
fact this suggests that it is probable that these contaminating proteins may actually be 
binding specifically to Chl1, not simply to the column. This could be problematic and 
might indicate that using this bacterial system it may not be possible to achieve the level of 
purity required to carry out biochemical studies on Chl1. The major bands highlighted on 
the gel in figure 3.20 were excised and sent for identification by mass spectrometry. 
The mass spectrometry analysis confirmed the band 1 as Chl1, however interestingly band 
2 running around 70kDa was also identified as Chl1. This would normally suggest that the 
protein is cleaved, probably towards the C-terminus due to the fact that this band is not 
picked up on western blots by the anti-his antibody. Rather counter-intuitively however, 
when a closer inspection of the peptide coverage was undertaken, peptides were in fact 
identified at both the N and the extreme C-terminus of the protein in this sample. The only 
explanation for this is cross-sample contamination, either from the gel itself or from carry 
over from the previous mass spectrometry sample run. Bands 3-5 were confirmed to be 



















Figure 3.20. Top: Chromatogram of Chl1 nickel-purified fractions run on a heparin 
affinity column. The concentration of NaCl in the buffer was increased from 100mM 
to 1M gradually over 25 column volumes. Bottom: Coomassie stained gel showing 
fractions from A11-B9 corresponding to the major chromatogram peaks. Again, 
several co-purifying bands were still visible even in the cleanest fractions. The 












Despite the issues with the contaminating proteins, it was felt that the nickel-affinity 
purification scheme was robust enough that it was worth going ahead and attempting to 
purify both the wild type Chl1 and the helicase dead K50R mutant in parallel. The idea 
being that with a helicase-dead Chl1 protein purified using the same method, to act as a 
biological control in any downstream biochemical assays, it might still be possible to 
generate some data even without optimal levels of purity being reached. 
Cloning of the K50R mutant was carried out by site-directed mutagenesis of the original 
Chl1 wild type construct in the usual way, as described in materials and methods, and 
confirmed by sequencing. A Rosetta 2 expression strain was then generated as previously 
described and expression and solubility confirmed by western blot analyisis before 
purification was attempted. 
Figure 3.21 shows the chromatography trace and Coomassie stained gels from the 
purification of the Chl1 K50R helicase-dead protein. The trace shows more of a bump than 
the peak that was usually observed with the wild type protein, however after analysis of 
alternating fractions by Coomassie staining it was clear that the purification had been 
successful. The representative gels shown in figure 3.21 were unfortunately allowed to run 
for slightly too long and therefore the usual low molecular weight contaminating proteins 




















Figure 3.21. Top: Chromatogram of Chl1 K50R helicase-dead mutant purification 
from 6 litres of bacterial culture. The concentration of imidazole was increased from 
10mM to 250mM gradually over 25 column volumes. Bottom: Coomassie stained gel 








Having demonstrated that both the wild type protein and the K50R mutant can be partially 
purified by nickel-affiinity chromatography to the level where it should theoretically be 
possible to separate the smaller contaminating proteins via size exclusion chromatography, 
the purest fractions were pooled and concentrated preps of both proteins were run on a 
Superose 6 gel filtration column. Chromatography traces and Coomassie stained gels are 
shown in figure 3.22. In size exclusion chromatography, high molecular weight molecules 
and complexes are too large to enter the pores of the stationary matrix and thus elute more 
quickly than smaller molecules which will enter the matrix pores and therfore take longer 
to travel through the column. It would be expected that using this method, which 
essentially separates protein mixtures based on size, Chl1 should elute earlier than the low 
molecular weight bacterial ribosomal proteins. While this appears true to some extent 
based on the Coomassie gels shown in figure 3.22, there is still a significant proportion of 
Chl1 which co-elutes with these contaminants. This is even more prominent in the K50R 
mutant. The caveat with this approach, as in the case of the heparin column, is that if the 
contaminating proteins are actually binding directly to your protein of interest, then it 
becomes extremely difficult to separate them using any sort of conventional 
chromatography method. For some proteins there remains the option of attempting 
purification under denaturing conditions which could potentially circumvent this problem. 
For an iron-sulphur cluster containing enzyme like Chl1 however this would not be 
recommended as it would be potentially difficult, if not impossible, to re-fold the protein 































Figure 3.22. Top: Chromatogram of Chl1 and Chl1 K50R helicase-dead mutant gel 
filtration using a Superose 6 column. Bottom: Coomassie stained gels showing 
fractions A12-C6 from each purification were used to determine whether Chl1 could 
be resolved from the contaminating bacterial proteins via size exclusion 
chromatography.  
 
At this point a number of options were considered. From the gels in figure 3.22, it looked 
like it may have been possible to isolate and pool a few of the purest fractions, even 
although it would likely yield only a small amount of protein. From 6 litres of bacterial 
culture only approximately 4mg of partially purified protein was obtained following nickel 
affinity chromatography as calculated by bradford assay of the pooled and concentrated 
samples. Visual inspection of the Coomassie stained gels however suggests that at best the 
sample is 10-20% pure, indicating a much lower yield of approximately 400-800µg of total 
ChlR1 protein. For the downstream biochemical applications such as DNA helicase assays, 
only very tiny amounts of active enzyme are required, thus it might still have been possible 
to perform some of these experiments with the inclusion of the helicase dead mutant as the 
appropriate control. However, after seeking advice from experts in these types of assay, it 
was decided that the purity was still unlikely to be sufficient for the generation of 
meaningful data. Moreover, the publication of a comprehensive biochemical 
characterisation of the human homologue ChlR1, in combination with some exciting 
functional data generated in the Parish group in human cell systems, resulted in further 
attempts to purify the yeast Chl1 protein being put on hold as the focus of the project 




3.5. Discussion  
3.5.1. The use of Tandem Affinity Purification of Chl1 to identify novel interacting 
partners 
At the time this work was undertaken, much of data concerning the function of Chl1 had 
been generated using yeast as a model organism. While parallel work in the Parish lab 
focused on dissecting the biological role of human ChlR1, it was thought that using a yeast 
system to identify novel interacting proteins would lend itself further down the line to 
potential genetic studies in S. pombe that would provide novel insight into the cellular 
function of this conserved protein.   
However, there were several caveats to the approach initially adopted which limited the 
success of this aspect of the project. Firstly, S. pombe as a model organism for carrying out 
large scale proteomic experiments are not ideal due to their tough outer cell wall that 
makes cell lysis extremely difficult on a large scale. In fact, mechanical lysis is required in 
order to effectively break open the cells. This was accomplished by first pelleting the yeast 
grown in culture, resuspending in lysis buffer before snap freezing droplets of the 
suspension in liquid nitrogen. These frozen pellets then had to be transferred to a pre-
chilled mechanical grinding machine to be ground to a very fine powder. When this 
thawed it could then be spun down just like normal cell lysate and the supernatant would 
contain the soluble proteins. Because it is necessary to keep the lysate cold and because the 
grinding generates heat, the grinder itself is cooled in liquid nitrogen prior to use. On 
several occasions malfunctions of this equipment resulted in loss of sample due to thawing 
of barely or partially lysed cellular material. And because each experiment required the 
growth of 12 litres of yeast culture per sample, this proved both costly and time-consuming 
each time this occurred. 
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Another issue with the experiment was the relatively low expression of endogenous Chl1 
as shown in figure 3.5. The protocol was developed based on proteins with a slightly 
higher level of endogenous expression in yeast, thus despite good solubility there was very 
little Chl1 visible on the gel post-purification. When the abundance of the bait protein 
itself is so low it is very difficult to then detect interacting partners which are expected to 
be present at even lower levels of abundance.  
Scaling up the experiment to increase the yield was not an option as 24 litres of total 
cultures per experiment was already at the limit of what was practically feasible. A 
possible solution could have been to clone the TAP-tagged Chl1 gene into a S. pombe 
expression vector with a promoter driving overexpression of the gene. In fact, this was 
attempted but without success. It proved difficult to successfully PCR out the TAP-tagged 
Chl1 gene from the S. pombe strain gifted by Prof E. Noguchi so therefore several attempts 
were made to achieve success with the original method. 
Low yield of the bait protein could also be caused by poor binding of the Chl1-TAP 
protein to the resins or inefficient TEV cleavage. Samples were taken after each step of the 
purification process and stored for analysis however as previously stated, only an anti-
protein A antibody was initially available which allowed testing of the first binding step 
only. The majority of TAP-Chl1 bound to the IgG resin with very little detectable in the 
lysate following incubation. To test for efficient TEV cleavage an anti-CBP antibody was 
purchased, however several attempts to use it for western blot analysis resulted in very 
dirty blots with multiple bands that could not be interpreted. The TEV protease used in the 
protocol was commercially purchased from Invitrogen rather than in-house purified so it 
seems unlikely that this would be a significant factor in explaining the low yield of Chl1, 
although it remains a possibility. 
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Finally, although several attempts were made to analyse protein gels using the in-house 
mass spectrometry facility, only the bait protein was ever positively identified. External 
analysis at the University of Dundee did however yield some positive hits, following 
careful exclusion of known contaminants or highly abundant cellular proteins with no 
functional relevance. The most promising of these was Rvb2, the human homologue of 
which, RuvBL2, was also identified in a parallel TAP pulldown of ChlR1. Verification of 
this interaction by co-immunoprecipitation was not successful however. It has to be said 
that the data generated from the human TAP experiment has been far more interesting. 
Replication proteins such as PCNA and Mcm7 were identified as well as the catalytic 
subunit of the DNA repair kinase DNA-PK supporting the hypothesis that ChlR1 has a 
role in these cellular processes.   
With the focus of this project now shifting towards the human ChlR1 protein, there 
remains scope for further utilisation of the tandem affinity approach or perhaps SILAC 
(Stable Isotope Labelling of Cells in Culture) quantitative proteomics using the established 
human cell system. It would be interesting, for example, to see whether under conditions 
of replication stress novel interacting proteins could be identified.  
 
3.5.2. Purification of Chl1 for biochemical studies 
Until the Brosh lab published their detailed biochemical analysis of the human ChlR1 
protein in 2012 [179], there was very little data available regarding the functional 
biochemical properties of the protein.  Hirota and Lahti provided evidence that ChlR1 was 
indeed a DNA-dependent helicase which could unwind both DNA:DNA and DNA:RNA 
duplexes [174] while Farina et al followed this up in 2008 with a biochemical study that 
conclusively demonstrated the ATPase and helicase activities of the protein [21]. Hirota 
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and Lahti also showed that the enzymatic activity of ChlR1 could be abolished by 
mutating a crucial lysine residue in the Walker A box which is responsible for the binding 
and hydrolysis of ATP, thus generating the K50R helicase-dead mutant which is now 
frequently used as an essential control for assaying ChlR1 activity or biological function 
[174].  
The initial aim of this project was to purify the yeast Chl1 in order to carry out a detailed 
biochemical study using various available DNA substrates to further elucidate the function 
of ChlR1 in DNA metabolism. Previous biochemical studies using the human ChlR1 had 
yielded only very tiny quantities of protein using both baculovirus and human expression 
systems. A secondary aim of the project was therefore to potentially generate larger 
quantities of the yeast protein that could be used for structural studies. It was hoped that 
some of the difficulties associated with previous attempts to purify human ChlR1 would be 
circumvented by focusing on yeast Chl1. 
Bacteria were chosen as an initial expression system due to their propensity to produce 
higher protein yields than in eukaryotic systems. However, after cloning Chl1 into the 
pET24b expression vector and transforming into both BL21 and Rosetta 2 cells it was 
clear from initial optimisation experiments that there would need to be a trade-off between 
yield and solubility (figures 3.10-3.14). While expression appeared higher in the BL21 
system, the protein showed increased degradation and lower solubility. Rosetta 2 cells 
were chosen as the preferred expression system despite the lower expression. It should be 
noted that the very fact that a western blot was required to detect expression of the Chl1 
protein after IPTG induction rather than the visualisation of a strong Coomassie stained 
band is indicative of a low yield by bacterial expression standards. 
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Nevertheless, despite the relatively low level of expression the first step purification of 
Chl1 by nickel affinity purification was successful. Although it did not yield pure protein, 
when the Chl1 containing fractions were pooled and concentrated, the protein remained 
relatively stable in solution, once 10% glycerol was added to the storage buffer, which 
allowed for further purification strategies to be attempted. However, the most effective 
purification schemes are those which yield protein of the required purity with the 
minimum amount of manipulation. Each additional step in the process introduces more 
handling time, during which the protein can become degraded, oxidised or precipitate out 
of solution which means starting again from scratch. Unfortunately, after establishing a 
consistent and robust technique for the nickel affinity purification of Chl1 it was apparent 
that it could not be significantly improved upon in terms of resolving the contaminating 
bands any further using this method alone.  
 Both heparin affinity and size exclusion chromatography techniques were utilised as 
secondary purification steps with neither yielding protein of the necessary purity for the 
intended downstream applications. With regards to the size exclusion, increasing the size 
of the gel filtration column also increases the resolution of proteins and this was 
considered an option. However, when proteins of such drastically different masses appear 
in the same fractions after size exclusion chromatography it does strongly suggest that 
these proteins exist in complex with each other. Furthermore, previous attempts to use a 
larger gel filtration column to increase resolution resulted in fractions so dilute that Chl1 
could not be detected on the gel and could only be visualised by western blot. This was 
however from a smaller culture size. Ion-exchange chromatography using a Mono-Q 
column was also attempted on some pooled fractions post-size exclusion. These had been 
stored at 4°C for a few days but were used in order to have a quick assessment of whether 
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it might be useful as an alternative step in the process. The Mono-Q column also failed to 
resolve the co-purifying proteins.  
In addition to the pET24b C-terminal His-tagged Chl1, other Chl1 expression constructs 
were generated which have only been partially characterised thus far.  Chl1 was cloned 
into a pHisTev vector which introduces an N-terminal, cleavable His tag and also into 
pLou3 which expresses Chl1 as a cleavable MBP-His fusion protein. Both of these 
constructs are expressed, although solubility and stability have not been fully determined. 
The advantage of a cleavable tag is that the His tag can be cleaved from affinity purified 
Chl1 fractions which can then be passed back through the nickel column. This would in 
theory re-bind the contaminating proteins, leaving purified Chl1 in the flow through. As 
with the other methods already described however, this is not helpful if the contaminating 
proteins are binding directly to Chl1. 
It does seem from all the purification strategies attempted thus far, that at least a 
proportion of the contaminating bacterial proteins are associating with Chl1. The only way 
to circumvent this problem would be to change the expression system. Given that previous 
biochemical studies have used alternative eukaryotic systems to purify ChlR1, it is 
possible that even in the case of the yeast homologue, bacterial expression and purification 
to a satisfactory standard is not feasible. With the recent publication by Brosh and 
colleagues, which elegantly characterises not only the wild-type ChlR1 protein but also 
describes the biochemical properties and substrate specificity of a patient-derived mutated 
form of the protein [179], the decision was made to set aside this branch of the project in 























4.0 Introduction and Aims of Chapter 4 
Cellular processes including DNA replication, DNA damage repair and cell cycle 
checkpoint control all play important and fundamental roles in the ability of cells to 
survive and replicate.  Control and regulation of these vital processes requires the 
coordinated action of an array of cellular proteins, many of which will have functions in 
more than one of these essential pathways.   
ChlR1 is known to be involved in the process of establishing sister chromatid cohesion and 
has also been implicated in DNA replication [21, 65, 129, 131] although it’s exact role and 
mechanism of action is still not fully understood. Furthermore, there is evidence from 
studies in yeast that indicates a possible role for yeast homologue Chl1 in DNA repair 
pathways [165] and, in fact, the identification of ChlR1 mutations in patients with a unique 
cellular phenotype combining features of both Fanconi anaemia and the cohesinopathy 
Roberts syndrome has also suggested for ChlR1 in the DNA damage response [139]. The 
recognition of Warsaw breakage syndrome as a distinct disease seen specifically in 
patients with ChlR1 mutations seems to lend credence to the assertion that the protein may 
have some involvement in the mammalian response to DNA damage and could perhaps 
function in coordinating the processes of DNA repair and chromatid cohesion in response 
to DNA damage. This taken together with the interaction of ChlR1 with various 
components of the replication machinery, including PCNA, the Ctf18-RFC complex and 
FEN1 [21], is suggestive that the ChlR1 helicase could be important in situations where 
cells encounter replication stress resulting in fork stalling, ultimately leading to DNA 
strand breaks. ChlR1-deficient cells typically progress normally through the cell cycle (K. 
Feeney, unpublished data) so it could be hypothesised that the function of the protein 
becomes more significant when cells encounter damage or stress that results in the stalling 
of replication and the need for the DNA damage response pathways to be activated. 
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The aim of this chapter was to further characterise the effects of ChlR1 depletion on the 
cellular response to DNA damage, in particular to agents that cause replication stress, in 
order to better understand the function of ChlR1 in the processes of DNA replication 
and/or in DNA repair pathways. 
 
4.1 siRNA mediated depletion of ChlR1 has little effect on cell survival in response to 
various DNA damaging agents 
As mentioned above, several publications characterising ChlR1 mutations in WBS patient 
cell lines have suggested a role for ChlR1 in the DNA damage response [191]. Patient 
derived cell lines were shown to have sensitivity to a variety of DNA damaging agents 
including the DNA crosslinking agent mitomycin-C (MMC) and topoisomerase inhibitor 
camptothecin (CPT) as well as a slight sensitivity to ionising radiation (IR) [139]. 
Additionally, Noguchi and colleagues have recently shown that ChlR1 has a role in 
recovery from replication stress and that ChlR1 deficient HeLa cells appear to be sensitive 
to the effects of interstrand crosslinking agent cisplatin [178].  
In order to further understand the role of ChlR1 in the cellular response to DNA damage, 
ChlR1 was first depleted in hTERT-RPE1 cells using a specific siRNA targeting the 3’ 
UTR of the ChlR1 transcript. Cells were transfected with either ChlR1 specific siRNA or a 
commercially available non-targetting siRNA as a control. The western blot in figure 4.1 
confirms the successful knockdown of ChlR1 at the protein level. β-actin serves as a 
loading control.  
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Using the standard nucleofection protocol for the siRNA knockdown of ChlR1 described 
in the methods section, a >90% reduction in ChlR1 protein level was consistently 









Figure 4.1. Western blot of hTERT-RPE1 cell lysate showing siRNA knock down of 
endogenous ChlR1. Cells were transfected with either ChlR1 specific siRNA or a 
non-targetting control oligo. 20ug of total protein was loaded in each lane as 
determined by Bradford assay. Lysates were probed with the indicated antibodies.  
 
To determine the sensitivity of ChlR1 depleted cells to various DNA damaging agents, two 
different methods were used to assay cell survival. The first method employed was the 
cck-8 cell viability assay (Dojindo Molecular Technologies) which measures the reduction 
of a water soluble tetrazolium salt to an orange coloured formazen compound, a reaction 
which is mediated by cellular dehydrogenase enzymes. This colour change can then be 
measured and used to determine cell viability or survival. 
ChlR1 
β-actin 
siRNA: control ChlR1 
118 
 
Graphs plotting cell survival for ChlR1 depleted cells versus control cells following 
treatment with several DNA damaging agents are shown in figure 4.2. Although Van der 
Lilij et al showed that the WBS patient cells were sensitive to camptothecin, in our 
knockdown system there was little difference in cell survival between the control and the 
ChlR1 knockdown except at the lowest dose (figure 4.2A). The overall trend does suggest 
that the ChlR1 depleted cells are more sensitive; however the large error bars reflect the 
high level of variability within this particular experiment. It is also possible that the doses 
of CPT used in this experiment were too high and may have had an effect on the accuracy 
of the readings at the higher doses. Interestingly, a recent study has shown that lower doses 
of CPT, while still inducing replication fork stalling, can lead to lesions which resolve by 
fork regression without the need for activation of the double strand break repair pathway. 
As it appears that ChlR1 depleted cells may be more sensitive to CPT than control cells at 
the lower doses, a role for ChlR1 in replication fork stability or in the resolution of 
replication coupled DNA damage could be supported.  
ChlR1-depleted cells showed no significant sensitivity to either ionising radiation or to the 
replication inhibitor hydroxyurea (HU) compared with control siRNA treated cells using 
this assay (figure 4.2B and C). In order to consolidate these results, the more traditional 
colony formation assay was also employed. In this case, HeLa cells were substituted for 




















































































Figure 4.2. Graphs showing cell survival of ChlR1 depleted HTERT-RPE1 cells 
versus control siRNA treated cells. Cells were treated with increasing doses of the 
indicated DNA damaging agent and assayed using using the cck-8 cell viability assay 
as described in the methods section. Cells were treated with (A) camptothecin, 3 hour 
drug treatment followed by 2 washes (B) ionising radiation and (C) hydroxyurea, 24 
hour drug treatment followed by 2 washes. Following the drug treatments, cells were 
incubated for 72 hours before the assay was performed. Each graph represents a 
single representative experiment performed in triplicate with error bars representing 














Figure 4.3 shows graphs of cell survival as determined by the colony forming ability of 
either ChlR1 depleted or control cells treated with the indicated DNA damaging agents. 
The data from the colony formation experiments largely corroborated the previous data 
using the cck-8 assay. A treatment with mitomycin-C was included in these experiments in 
order to determine whether siRNA-mediated reduced expression of ChlR1 results in the 
same sensitivity to DNA crosslinking agents that had been previously reported in the 
patient-derived cells. The data generated from the colony survival assays strongly 
suggested that in fact, ChlR1-depleted HeLa cells were not sensitive to mitomycin-C 
(figure 4.3A). Additionally, no significant sensitivity to camptothecin was observed and 
only a very subtle sensitivity to higher doses of hydroxyurea (figures 4.3B and C) was 




















































































Figure 4.3. Graphs showing cell survival of ChlR1 depleted HeLa cells versus control 
siRNA treated cells. Cells were treated with increasing doses of the indicated DNA 
damaging agent and assayed for their ability to subsequently form colonies. Colonies 
were stained and counted 10 days post-treatment. Cells were treated with (A) 
mitomycin-C for 3 hours (B) camptothecin for 3 hours and (C) hydroxyurea for 24 
hours. Each graph represents a single representative experiment performed in 
triplicate with error bars representing +/- SEM. Each experiment was independently 















Taken collectively, the results described in figures 4.2 and 4.3, suggest that at best ChlR1-
depleted cells show only a very slight sensitivity to any of the DNA damaging agents used 
in these cell survival assays. Unfortunately, this does little to shed further light on the 
potential role of ChlR1 in the DNA damage response. However, although ChlR1 depleted 
cells do not appear particularly sensitive to any of the specific cytotoxic agents that have 
thus far been tested, this does not necessarily preclude a role for ChlR1 in the response to 
DNA damage or replication stress. For example cells lacking ChlR1 may utilise alternative 
pathways under conditions of stress that result in no visible reduction in viability. 
Additionally, it should be noted that the majority of previous cell survival data has been 
generated using primary patient-derived cells which may behave differently to our knock-
down system.  
 
4.2 ChlR1 depleted cells are less efficient at repairing damaged DNA after exposure 
to ionising radiation 
To further analyse the potential role of ChlR1 in the DNA damage response, the alkaline 
comet assay, or single cell gel electrophoresis as it is sometimes known, was used to 
determine whether ChlR1 cells could effectively repair IR-induced DNA damage. From 
the data above, ChlR1 depleted cells showed no sensitivity to IR which correlates with 
published data showing patient-derived cells also showed only a slight sensitivity to this 
type of DNA damage. However, the comet assay directly quantifies the amount of damage 
present in a single cell, offering a much clearer insight into the kinetics of the DNA repair 
process when compared with cell viability assays alone. The hypothesis being that ChlR1 
deficient cells could still have a DNA repair defect that does not necessarily lead to a 
reduction in viability.  
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The comet assay or single cell gel electrophoresis assay is used to detect fragmented DNA 
in individual cells by subjecting the cells to electrophoresis to draw the fragmented, 
damaged DNA out of the nuclei resulting in a distinctive ‘comet’ tail when stained and 
visualized. The larger the percentage of DNA in the comet tail the more fragmented DNA 
has migrated from the nucleus and the greater the amount of damage. If cells are allowed 
to recover in growth medium after damage has been induced it is possible to measure the 
extent of the recovery and to determine the efficiency of repair in control versus ChlR1-
depleted cells.  
Previous data generated in the Parish lab had suggested that ChlR1-depleted HeLa cells 
were less efficient in their ability to repair IR-induced DNA damage (C.Wasson, 
unpublished data). To confirm this HeLa cells were nucleofected with either non-targeting 
or ChlR1 specific siRNA and harvested 72 hours post-transfection. Briefly, cells were 
immobilised on a microscope slide in a thin layer of low melting temperature agarose prior 
to irradiation. Cells were then allowed to recover in growth medium for the indicated times 
post-damage before being subjected to single cell gel electrophoresis as described. Figure 
4.4A shows representative images of cells that are either undamaged or cells subjected to 
5gy of γ irradiation. The characteristic ‘comet’ tail is visible in the damaged cells and is 
composed of fragmented, damaged DNA which migrates from the nucleus during 
electrophoresis and can be quantified using specialist software. Figure 4.4B is a screen 
shot of a cell which has been scored by the software. For simplicity, the measurement of 

















Figure 4.4. Representative epifluorescent images of undamaged and irradiated cells 
after single cell gel electrophoresis. The DNA has been stained with propidium iodide 
for visualisation (A). (B) is an example of a cell which has been scored by the Comet 
IV software with the green peak corresponding to head intensity while the red peak 
represents tail intensity. 
  





HeLa cells that are depleted for ChlR1 show an impaired capacity to repair the damage 
induced by IR compared with cells transfected with the control siRNA (figure 4.5). 
Figures 4.5A and 4.5B represent two independent experiments each showing the same 
trend. The average head intensity of 100 cells is plotted for each sample. In agreement with 
data previously obtained in the Parish Lab (Wasson, Parish unpublished), the data indicate 
that the ChlR1 deficient cells are less efficient at repairing the DNA damage. However, 
after 3 hours recovery the ChlR1 depleted cells do seem to have reached the same level of 
repair as the control cells suggesting that there is a delay in repair rather than an inability 






























Figure 4.5. Alkaline comet assay performed on HeLa cells damaged with 5gy γ-
radiation. Data is plotted as percentage of DNA remaining in the ‘head’ or nucleus 
after electrophoresis. 100 nuclei were scored per time point. Error bars represent 
















































This repair defect, while not as prominent, was recapitulated to some extent in hTERT-
RPE1 cells (Figure 4.6A and 4.6B). The statistical significance varied between 
experiments and therefore in the hTERT-RPE1 cells the data supporting a repair defect in 
ChlR1 depleted cells was less convincing. Two representative experiments are shown in 
figure 4.6A and 4.6B. The discrepancy in the results between the two cell types could be 
attributed to hTERT-RPE1 cells being representative of a more ‘normal’ cell type that may 
be able to repair the damage more efficiently than HeLa cells in the absence of ChlR1. To 
achieve the same level of damage in the hTERT-RPE1 cells 10gy of IR was required 
which suggests a general increased tolerance to IR compared with HeLa cells. HeLa cells 
are a well-established cancer-derived cell line and as such it is possible that these cells 
harbor additional mutations in other proteins involved in the DNA damage response which 





























Figure 4.6. Alkaline comet assay performed on hTERT-RPE1 cells damaged with 
10gy γ-radiation. Data is plotted as percentage of DNA remaining in the ‘head’ or 
nucleus after electrophoresis. 100 nuclei were scored per time point. Error bars 
represent 95% confidence intervals. A and B represent two independent experiments 


















































It was hypothesised that in order to see a more dramatic effect of ChlR1-depletion in 
hTERT-RPE1 cells it might be necessary to look at earlier time points since the results in 
figure 4.6A show that the most significant difference is observed at the 1 hour time point. 
If ChlR1 functions early on in the damage response any difference might then be more 
evident (figure 4.7). In this instance no statistically significant difference between control 
and ChlR1-depleted cells was observed although the data did follow the general trend of a 




Figure 4.7. Alkaline comet assay performed on hTERT-RPE1 cells damaged with 
10gy γ-radiation. Data is plotted as percentage of DNA remaining in the ‘head’ or 
nucleus after electrophoresis. 100 nuclei were scored per time point. Error bars 
represent 95% confidence intervals. Cells were analysed at shorter intervals post-



























Evidence has suggested that ChlR1 may have a role in DNA replication and work in the 
Parish lab has shown that ChlR1 deficient cells are less able to restart stalled replication 
forks when cells are treated with hydroxyurea (K. Feeney, unpublished). It was therefore 
proposed that ChlR1 function may be specific to damage encountered during DNA 
replication, for example, it might be involved in the resolution of stalled forks and/or 
prevention of the collapse of these forks into double strand breaks. To determine whether 
cells in S-phase were more susceptible to the effect of ChlR1 depletion, hTERT-RPE1 
cells were synchronized using the double thymidine block method. The cells were then 
released into S-phase prior to inducing damage and performing the comet assay (Figure 
4.8). Results indicated no significant difference between the control and ChlR1-deficient 











Figure 4.8. Alkaline comet assay performed on hTERT-RPE1 cells synchronised in S-
phase and damaged with 10gy γ-radiation. Data is plotted as percentage of DNA 
remaining in the ‘head’ or nucleus after electrophoresis. 100 nuclei were scored per 
time point. Error bars represent 95% confidence intervals. The graph shown is 
representative of two independent experiments. 
 
4.3 G2 checkpoint remains intact in cells treated with ChlR1 siRNA 
Following the observation of a DNA repair defect in response to IR, assessment of the IR-
induced G2 checkpoint function in ChlR1 depleted cells was carried out. Under normal 
circumstances, cells exposed to ionising radiation will arrest at G2 to allow for the damage 
to be repaired which prevents cells entering mitosis with unrepaired DNA damage, 
subsequently contributing to genomic instability. It was thought that if ChlR1-depleted 
cells fail to activate this checkpoint and progress through mitosis without efficient repair of 


























deficient cells. To assess G2 checkpoint activation, hTERT-RPE1 cells were damaged with 
3 Gy of γ-IR and then harvested at the indicated time points post-irradiation. Cells were 
fixed and stained with an Alexa488 conjugated antibody against phosphorylated histone 3, 
a marker of mitotic cells, before being subjected to analysis by flow cytometry and the 
percentage mitotic cells determined (Table 3). As expected, following exposure to ionising 
radiation the control cells exhibited an arrest at G2 as indicated by the drop in the number 
of cells progressing to mitosis. There was no significant difference observed between 
control cells and cells treated with ChlR1 siRNA in terms of mitotic entry across two 
independent experiments, which suggests that the IR-induced G2 checkpoint remains 
intact in ChlR1 depleted cells. 
 
 % mitotic cells 
Experiment 1 Experiment 2 
Control siRNA ChlR1 siRNA Control siRNA ChlR1 siRNA 
Untreated 1.97 1.85 1.43 1.05 
4h post-IR 0.023 0.002 0.003 0.006 
8h post-IR 0.5 0.73 0.46 0.43 
10h post-IR 0.62 0.6 0.43 0.42 
 
 Table 3. The percentage of mitotic cells in control siRNA treated hTERT-RPE1 cells 
versus ChlR1 depleted cells as determined by flow cytometric analysis. Phospho-H3 
positive cells were gated and expressed as a percentage of the total cell population. 
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Approximately 30000 events were counted per condition. The data is representative 
of three independent experiments. 
 
4.4 ChlR1 depleted cells show an increased level of DNA damage in response to 
treatment with the replication inhibitor hydroxyurea 
Data generated in the Parish lab by K. Feeney has shown using DNA fibre analysis that 
while ChlR1-depleted hTERT-RPE1 cells progress normally through the cell cycle with no 
S-phase delay, these cells have a significantly reduced replication fork speed when 
compared to controls. These cells also show an impaired ability to restart replication after 
induction of fork stalling by treatment with hydroxyurea (K. Feeney, unpublished). While 
data from the comet assays in figures 4.5-4.8 indicates a mild repair defect in response to 
ionizing radiation, it is possible that the primary role of ChlR1 is in the repair of 
replication-coupled DNA damage or in the promotion of replication fork stability under 
conditions of replication stress. To investigate this, the comet assay was performed on 
ChlR1-depleted cells which had been treated for 2 hours with 2mM hydroxyurea to inhibit 
DNA replication. The results shown in figure 4.9 suggest that in the ChlR1 depleted cells 
there is a significant increase in the amount of DNA damage accumulated after exposure to 
















Figure 4.9. Alkaline comet assay performed on hTERT-RPE1 cells treated with 2mM 
hydroxyurea. Data is plotted as percentage of DNA remaining in the ‘head’ or 
nucleus after electrophoresis. 100 nuclei were scored per time point. Statistical 
significance was determined using a students’ T test and the relevant p values 
indicated on the graph. This experiment was independently repeated twice. 
 
It is worth noting that the alkaline comet assay quantifies all types of DNA damage in a 
cell including single strand breaks and alkali labile sites in addition to double strand 
breaks. This is an important consideration when interpreting the results in figure 4.9 as it 
cannot be concluded from this data whether the absence of ChlR1 results in more 
collapsed replication forks or an increase in stalled forks which result in the accumulation 




























In an attempt to determine whether ChlR1 depletion results in an increase in replication 
fork collapse leading to DNA double strand breaks following treatment with hydroxyurea, 
hTERT-RPE1 cells were treated with 2mM HU for 2 hours and then assessed for 53bp1 
foci formation, a key marker of double strand break repair. Cells treated with either control 
or ChlR1 specific siRNA were grown on coverslips, treated with 2mM hydroxyurea for 2 
hours and then allowed to recover for either 1, 4 or 8 hours before fixing with 4% 
paraformaldehyde and staining with the appropriate antibodies for the immunofluorescent 
(IF) detection of 53bp1. Cells with >10 foci were scored and expressed as a % of the total 
cells counted (figure 4.10A). 150-200 cells were counted for each time point. A 
representative graph is shown in figure 4.10B. This experiment was repeated three times 
and while the overall trend remained the same, due to significant variation in the actual 




























































Figure 4.10. Representative IF images showing cells stained with anti-53bp1 primary 
antibody, detected using an Alexa 488 conjugated secondary antibody and imaged by 
epifluorescent microscopy. Examples of an undamaged cell and a cell with >10 
damage induced foci are shown in (A). Cells with >10 foci were scored and expressed 
as a % of total cells counted (B). 150-200 cells were counted per time point. Cells 
were either untreated, treated with HU for 2h (HU) or treated, washed and allowed 
to recover for the indicated times: 1hR, 4hR and 8hR. The histogram shown is 
representative of three independent experiments. 
While the numbers of 53bp1 foci immediately following the 2h HU treatment increase 
slightly for both the control and the ChlR1 depleted cells, at the 1h post-HU time point 
there is a considerable increase in foci formation in the controls. While the ChlR1 depleted 
cells also show elevated foci formation at the 1h time point, the increase is less dramatic. 
In contrast, after 4h the numbers of foci in the control cells appear to have reduced 
substantially from the peak observed at 1h, while the ChlR1 depleted cells show a definite 
increase. By 8h post-HU, there still appears to be an elevated number of foci present in the 
ChlR1 deficient cells compared to in the controls. This data could indicate a potential 
delay in the ability of ChlR1 cells to repair double strand breaks; a result which seems to 
be supported by the previous comet assay data analyzing the capacity of ChlR1 cells to 
repair IR-induced DNA damage (figure 4.5).   
It is still unclear from this data however whether or not ChlR1 has a role in replication fork 
stability. While the increased level of physical damage apparent after HU treatment 
suggests more stalled or collapsed forks (figure 4.9), the 53bp1 foci formation assay seems 
to indicate that there is also a potential delay in the damage response. There does not seem 
to be any great overall increase in 53bp1 foci numbers in ChlR1 deficient cells, rather the 
kinetics of foci formation post-HU treatment would appear to indicate a delay in the DNA 
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damage response pathway. This is perhaps unsurprising as it is well established that even 
in the absence of any exogenous stress or damage the most obvious phenotype of ChlR1-
deficient cells is their abnormal sister chromatid cohesion. This is likely to have a 
detrimental impact on homologous recombination; a major pathway for repair of double 
strand breaks in late S-phase and G2.  
 
4.5 ChlR1 depleted cells are sensitive to hydroxyurea-induced replication fork 
stalling  
Mono-ubiquitination of PCNA by the Rad18 ubiquitin ligase occurs in response to DNA 
damage or stalled replication. This mono-ubiquitination activates the translesion synthesis 
pathway (TLS) responsible for bypassing lesions caused by damaged DNA via recruitment 
of specialised low-fidelity DNA polymerases [30, 86, 192-195]. While it is widely 
acknowledged that PCNA becomes ubiquitinated in response to hydroxyurea treatment, 
the absence of any physical lesion to bypass this has meant that the role of PCNA mono-
ubiquitation during this type of replication stress is less well understood. It is possible that 
the stalled replication machinery itself acts as an obstacle and the ubiquitination of PCNA 
acts to recruit proteins responsible either for its subsequent removal to allow repair of the 
lesion or for the promotion of fork restart. 
While it is still unclear whether ChlR1 depletion leads to decreased replication fork 
stability, western blot analysis of chromatin-associated PCNA indicates a distinct increase 
in the levels of mono-ubiquitinated protein after treatment with HU which is amplified in 
the ChlR1 depleted cells (figure 11). Additionally, while the levels of total PCNA remain 
relatively constant, there is a reduction in the amount of chromatin bound PCNA following 
HU treatment which is again more apparent in the ChlR1 depleted cells versus the 
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controls. Both the increased ubiquitination and reduction of the chromatin bound fraction 
of PCNA is to be expected following stalled replication and the fact that both of these 
phenotypes are exacerbated in the ChlR1 knockdown suggest that these cells are more 
sensitive to hydroxyurea induced replication stress. Sustained PCNA ubiquitination after 
release from HU treatment is also evident in ChlR1-depleted cells compared to controls 
again suggesting a deficiency in the ability of these cells to repair the damage caused by 


























Figure 4.11. Western blot indicating an increase in mono-ubiquitinated PCNA in 
hTERT-RPE1 cells that have been transfected with ChlR1-specific siRNA compared 
with cells transfected with control siRNA. Cells were treated with 2mM HU for 1 or 2 
hours or then washed and released for the times indicated. The top two panels show 
total protein while the bottom two panels show just the chromatin associated 
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In addition to ubiquitination of PCNA another marker of stalled replication is an 
accumulation of RPA-coated single stranded DNA. This can be visualised by 
immunofluorescence as discrete nuclear foci which become apparent after exposure to 
DNA damaging agents or agents that cause replication stress. Control or ChlR1-depleted 
cells were grown on coverslips and treated for 2 hours with 2mM HU before fixing and 
staining with an antibody specific to RPA34 subunit of the RPA complex. Cells were 
scored as foci-positive if they contained more than 10 discrete RPA foci present in the 
nucleus. Figure 4.12A shows representative images of an untreated cell and an RPA 
positive cell following hydroxyurea treatment. The percentage of RPA positive cells was 
quantified in the control and the ChlR1-depleted samples before and after hydroxyurea 
treatment and the results are shown in figure 4.12B. The data indicates that there are an 
increased number of RPA positive cells in the ChlR1-depleted cells. Furthermore, sub-
cellular fractionation was performed on cells subjected to the same hydroxyurea treatment 
and the chromatin associated fraction was isolated and probed with an anti-RPA34 
antibody as an alternative method of quantifying the chromatin bound fraction of cellular 
RPA. The western blot is shown in figure 4.12C. It is evident that there is more 
chromatin-associated RPA in the ChlR1 depleted cell compared to the controls which 
further corroborates the hypothesis that ChlR1 deficient cells are more sensitive to 
replication fork stalling in the presence of hydroxyurea. From the western blot data it also 
looks like after 1 hour release from hydroxyurea, ChlR1 depleted cell have recovered from 
the replication stalling to a level comparable to control cells. This also concurs with the 
immunofluorescence foci data and suggests that while the cells seem more sensitive to fork 
stalling they may still be able to eventually restart the stalled fork or to resolve the damage 
induced by fork stalling. If this were the case it would be assumed that the intra S-phase 
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Figure 4.12. (A) Representative immunofluorescent image of a nucleus stained with 
anti-RPA32 antibody, followed by an Alexa 488 coupled secondary antibody for 
detection. Top image shows an untreated foci-negative cell with diffuse nuclear 
staining while the bottom image shows a foci-positive cell following 2mM HU 
treatment for 2 hours (B) Quantification of foci positive cells in either untreated, 
hydroxyurea treated or hydroxyurea treated cells that were allowed to recover for 1 
hour. 200 cells were counted per condition and the graph shown is representative of 
two independent experiments (C) Western blot showing the chromatin associated 
fraction of RPA in hTERT-RPE1 cells treated with hydroxyurea for the indicated 















4.6 Checkpoint activation and cell cycle progression is normal in ChlR1 depleted cells 
that have been exposed to replication stress 
Previous work in the Parish lab has shown that in the absence of exogenous stress ChlR1-
depleted cells progress normally through the cell cycle despite an observed reduction in 
replication fork speed. However, it has also been observed that ChlR1-depleted cells are 
less efficient at restarting stalled replication forks (K. Feeney, unpublished) as well as 
showing an increase in hydroxyurea-induced DNA damage and an increase in PCNA 
ubiquitination (figures 4.9 and 4.11). It was therefore of interest to determine whether 
ChlR1 deficient cells were capable of activating the intra-S phase DNA damage 
checkpoint as efficiently as control cells, thus allowing the cell to effectively repair 
replication-coupled DNA damage. When replication fork stalling occurs, the single strand 
DNA binding protein RPA accumulates ahead of the stalled fork and results in activation 
of the ATR checkpoint pathway. ATR in turn phosphorylates Chk1, the major effector 
kinase of this pathway. In normal cells, this will trigger cell cycle arrest until the damage 
can be resolved. Figure 4.13 shows western blots of hTERT-RPE1 whole cell lysates 
which have been treated with 2mM HU and allowed to recover for the indicated times. 
Checkpoint activation was assessed by probing with a phospho-specific antibody for Chk1 
at residue serine 345. Activation of the ATM pathway, which is primarily involved in the 
response to DNA double strand breaks, was also investigated using phosphorylated Chk2 
as a read-out. The data suggests that not only does checkpoint activation appear normal 
upon treatment with HU, it also seems that recovery from the induced replication stress 
occurs just as efficiently in the ChlR1-depleted cells. This is somewhat at odds with both 
the increased amount of DNA damage observed in the hydroxyurea comet assay as well as 
















Figure 4.13. Representative western blot showing HU induced checkpoint activation 
in hTERT-RPE1 cells that have been transfected with ChlR1-specific siRNA 
compared with cells transfected with control siRNA. Cells were treated with 2mM 
HU for 1 or 2 hours, then washed and released for the times indicated. Whole cell 
lysates were probed for both total and phosphorylated forms of the checkpoint 
proteins Chk1 and Chk2 with β-actin as a loading control. The western blot shown is 
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To confirm that cell cycle progression and checkpoint activation was normal in ChlR1 
depleted cells after induction of replication stress, flow cytometry analysis of DNA content 
was carried out on cells which had been treated with increasing doses of either 
hydroxyurea or camptothecin for 24 hours. Both of these agents cause replication stress via 
different mechanisms. Hydroxyurea acts as an inhibitor of the enzyme ribonucleotide 
reductase which is involved in dNTP synthesis, thereby depleting the cellular pool of 
dNTPs available for replication to proceed while camptothecin is a topoisomerase I 
inhibitor which results is the formation of DNA-topoisomerase covalent complexes that act 
as a physical block to the replication machinery. Cells were simultaneously treated with 
nocodazole which prevents spindle formation and thus arrests cells in prometaphase. This 
allowed analysis of one single cell cycle. The experiment was attempted without the 
addition of nocodazole but this proved very difficult to analyse, particularly at the lower 
drug doses, as cells continued to cycle making the interpretation of the data problematic. 
Figure 4.14A shows control and ChlR1 siRNA treated hTERT-RPE1 cells either 
asynchronously growing or treated with 250ng/ml nocodazole for 24 hours. The graphs of 
DNA content, as determined by propidium iodide staining, versus cell number indicate that 
in cells treated with nocodazole only, the same proportion of cells are arrested at G2/M in 
the control and ChlR1 depleted samples. There is also no difference in relative cell cycle 
distribution in the asynchronous cells which supports previous data generated in the lab 
indicating ChlR1 depleted cells show normal cell cycle progression. Following treatment 
with increasing doses of hydroxyurea for 24 hours (50uM-1mM) both the control and 
ChlR1 depleted cells show an accumulation of cells in S-phase and eventually in G1 at the 
higher doses which would be expected as cells arrest following inhibition of replication 
(figure 4.14B). There appears to be little difference between the control RPE1 cells and 
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ChlR1 depleted cells in this respect which supports the previous western blot data showing 
that ChlR1 deficient cells have normal checkpoint activation in response to hydroxyurea-
induced replication stress (figure 4.13). To check whether this also applied to damage 
induced by camptothecin, which causes a physical lesion that blocks replication and 
therefore requires resolution and/or repair, the same experiment was carried out using 
increasing doses of this drug (10nM-500nM). Again, no difference was observed in 
relative cell cycle distribution between control and ChlR1 depleted cells (figure 4.14C). 
Taken together this would suggest that the intra S-phase replication checkpoint is intact in 
ChlR1 deficient cells and that additionally these cells do not appear to arrest more readily 
















































Figure 4.14. Flow cytometry analysis of hTERT-RPE1 cells transfected with either 
ChlR1 or control siRNA. Propidium iodide profiles showing DNA content of (A) 
asynchronous hTERT-RPE1 cells or cells treated for 24h with 250ng/ml nocodazole 
to arrest cells in mitosis and allow analysis of one single cell cycle. Cells were treated 
with increasing doses of either HU (B) or CPT (C) for 24 hours in the presence of 
nocodazole to allow analysis of cell cycle progression in the presence of replication 
stress. Graphs as are plotted as DNA content, determined by propidium iodide 
staining and detected in the PE-Texas red channel (X axis) versus cell count (Y axis). 
A total of 30000 events were captured per sample with the healthy singlet population 





This conclusion is supported by western blot analysis. Cells were treated for 3h with 
increasing doses of either hydroxyurea or camptothecin and total lysates were then probed 
for various checkpoint proteins (figure 4.15). There is no increase in Chk1 
phosphorylation at serine 345 in response to increasing doses of camptothecin. While from 
the western blots shown in this figure it appears as though there may be a very subtle 
increase in the levels of Chk1 phosphorylation in response to hydroxyurea, repeats of this 
experiment showed no difference. Lysates were also probed for Timeless, a known 
interacting protein of ChlR1 that is known to have an important role in replication fork 
stability and in checkpoint activation [65]. Levels of Timeless were consistently lower in 
ChlR1-depleted cells even in untreated samples. In this experiment, total Chk1 also 
seemed to be reduced in the ChlR1 knockdown although it is possible this was due to 
inaccurate quantification of the samples by Bradford assay prior to running the gels as 
actin was also slightly reduced in the hydroxyurea experiment. However, with regards to 
the camptothecin treated cells, quantification and loading seemed satisfactory and total 
Chk1 still appeared reduced. Repeats of these western blots confirmed that total Chk1 
appeared to be consistently lower in ChlR1-depleted cells (figure 4.16), a phenomenon 
that had been also observed previously by K. Feeney in earlier experiments. Currently, an 
off-target effect of the ChlR1-specific siRNA cannot be conclusively ruled out however it 
should be noted that this effect is not always consistently apparent in the ChlR1 knock 
down as evidenced by previous western blots shown in figure 4.13. At present, there is no 
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Figure 4.15. Representative western blots showing HU (top panel) and CPT (bottom 
panel) induced checkpoint activation in hTERT-RPE1 cells that have been 
transfected with ChlR1-specific siRNA compared with cells transfected with control 
siRNA. Cells were treated with increasing doses of each drug for 3 hours prior to 
harvesting and lysis. Whole cell lysates were probed for both total and 
phosphorylated forms of Chk1 and Timeless as well as for ChlR1. Two exposures are 
shown for p-Chk1. β-actin was used as a loading control. The western blot shown is 
representative of two independent experiments. 
 
Evidence  in the literature suggested that ChlR1 deficient cells, both from patients and in a 
knock-down model [139, 178] are particularly sensitive to DNA crosslinking agents. 
However no evidence to that effect was observed in the cell survival data generated in the 
Parish lab. Nevertheless, mitomycin-C treated cells were included in the panel of 
checkpoint western blots shown in figure 4.16. These repeats confirmed the observations 
discussed above with regards to total Chk1 but also show that Chk1 S345 phosphorylation 
remains unaffected. Again, no significant differences in Chk1 phosphorylation were 
observed following MMC treatment in ChlR1-depleted cells versus controls although 
Timeless is once again reduced. This appears to be a general effect of ChlR1 knock-down 
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Figure 4.16. Representative western blots showing HU, CPT and MMC induced 
checkpoint activation in hTERT-RPE1 cells that have been transfected with ChlR1-
specific siRNA compared with cells transfected with control siRNA. Cells were 
treated with increasing doses of each drug for 3 hours prior to harvesting and lysis. 
Whole cell lysates were probed for both total and phosphorylated forms of Chk1 and 
Timeless. β-actin was used as a loading control. The western blot shown is 
representative of three independent experiments. 
 
4.7 ChlR1 depletion does not affect the recruitment of cohesin subunits to chromatin 
Previous evidence published by various groups strongly indicates a role for ChlR1 in the 
establishment of sister chromatid cohesion [21, 131, 175]. Coupled with the evidence 
pointing to a role for ChlR1 in the cellular tolerance of replication stress, it was 
hypothesised that ChlR1 may function at the interface between DNA replication and 
establishment of chromatid cohesion. In an attempt to test this, sub-cellular fractionation 
was carried out to isolate chromatin-associated fractions from ChlR1 depleted cells before 
and after treatment with 2mM hydroxyurea for 2 hours. The chromatin-associated fractions 
were then probed with antibodies specific to the cohesin subunits Rad21 and SMC1 to 
determine whether their recruitment to chromatin was affected by the absence of ChlR1. 
Figure 4.17 shows a panel of control western blots to confirm that the sub-cellular 
fractionation kit (Pierce) used for these experiments was reliable. A kit was chosen over 
the previous fractionation method for these experiments to ensure consistency of results. 
ChlR1 was included in this control experiment to determine which fractions ChlR1 
primarily localised to. Interestingly there appeared to be an abundance of ChlR1 present in 
the cytoplasmic and membrane fractions with only a small amount seemingly associated 
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with chromatin under normal conditions. Unfortunately, confirmation of endogenous 
ChlR1 localisation by immunofluorescence has not been possible as there are currently no 











Figure 4.17. Panel of control western blots to confirm that the Pierce sub-cellular 
fractionation protocol can reliably differentiate between fractions. C=cytoplasm, 
M=membrane bound, NS=nuclear soluble, Ch=chromatin-associated and 
P=pellet/cytoskeletal components. Standard marker proteins, known to be present in 
specific sub-cellular fractions as indicated by parentheses, were blotted for to 
determine how effective the fractionation process was at separating fractions. ChlR1 
was also included to ascertain which fractions the protein predominantly localised to.  
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From the H3 western blot shown in figure 4.17, the majority of the marker protein does 
localise to the chromatin fraction with only small amounts present in the nuclear soluble 
and the pellet. This was deemed satisfactory for proceeding with the analysis of the 
chromatin fraction to evaluate association of the cohesin subunits Rad21 and SMC1. 
Figure 4.18 shows the chromatin-associated fraction, isolated using the Pierce 
fractionation kit, before and after treatment with 2mM HU for 2 hours. There is no 
difference in the chromatin association of either cohesin subunit in the absence of ChlR1, 
either under normal conditions or following hydroxyurea treatment. This suggests that 
ChlR1 is not involved in the loading of cohesin subunits onto DNA, rather its function is 
probably required in the downstream process of establishing cohesion between chromatids. 
This is consistent with previously published data[117, 121, 134]. Interestingly, there 
appears to be an increase in chromatin-associated ChlR1 in response to hydroxyurea 
treatment. This was reproducible across three independent experiments. This result could 
indicate that ChlR1 is important in the maintenance of replication fork stability in response 
to replicative stress which concurs with previous data (figures 4.9-4.12) that shows cells 


















Figure 4.18. hTERT-RPE1 cells were transfected with either control or ChlR1 siRNA 
before being treated with 2mM HU for 2 hours and subjected to sub-cellular 
fractionation using the Pierce kit. Representative western blot panel shows the 
chromatin-associated fractions which were probed with anti Rad21 and anti-SMC1 
antibodies, two major components of the cohesin complex as well as with anti-ChlR1 
antibody. Western blot is representative of two independent experiments. 
 
The effect of ChlR1 depletion on the chromatin association of a wider panel of proteins 
known to be involved in DNA replication and replication fork stability was also analysed 
using this subcellular fractionation method. Figure 4.19 shows the proportion of various 
replication proteins which localise to the chromatin fraction before and after hydroxyurea 
treatment. As shown in figure 4.18, the proportion of cellular ChlR1 that is associated 
with chromatin increases after exposure to hydroxyurea. In ChlR1 depleted cells there is 
an increase in the amount of ubiquitinated PCNA and chromatin associated RPA compared 
-      +     -     + 







with control cells which corroborates the data in figures 4.11 and 4.12. The fraction of 
chromatin bound Timeless is significantly reduced in the ChlR1 depleted cells, however 
from previous experiments it was apparent that total Timeless is also reduced in the 
absence of ChlR1. Whether ChlR1 depletion affects the expression of Timeless or whether 
it has an effect on protein stability remains to be investigated. Topbp1, which is a known 
activator of ATR signalling in response to replication stress, is also increased in the 
chromatin associated fraction as is Rad9 which binds to RPA and becomes heavily 
phosphorylated following stalled replication. From the western blots it seems that both its 
association with chromatin and an increase in phosphorylation occur in response to ChlR1-
depletion and that this effect is exacerbated by treatment with hydroxyurea. Fen1 was 
included in the panel as it has been previously published that Fen1 interacts with ChlR1 
and that this interaction stimulates Fen1 endonuclease activity. However, the Fen1 western 
blots were not conclusive even on repetition and any effect is extremely subtle. H3 acts as 




















Figure 4.19. hTERT-RPE1 cells were transfected with either control or ChlR1 siRNA 
before being treated with 2mM HU for 2 hours and subjected to sub-cellular 
fractionation using the Pierce kit. Representative western blot panel shows the 
chromatin-associated fractions which were probed with antibodies against various 
proteins involved in DNA replication or in the cellular response to replication stress. 
These blots are representative of three independent experiments. 
 
A co-immunoprecipitation was performed to determine whether ChlR1 interacted with 
RPA either in unperturbed cells or under conditions of replication stress. The results are 
shown in figure 4.20. While no association is apparent in undamaged cells or cells 
exposed to HU for 2h, following a longer HU treatment there is some evidence of an 
interaction between the two proteins. This might be because the treatment has enriched for 
stalled replication forks or it might be the case that ChlR1 is involved in the repair of forks 
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ChlR1 has previously been shown to have roles in the process of cohesion establishment, 
in DNA replication and potentially in maintenance of replication fork stability [131, 178]. 
The proposed involvement of ChlR1 in such closely-coupled processes is intriguing and 
lends itself to speculation regarding the specifics of ChlR1 function in DNA metabolism. 
While there is evidence that suggests ChlR1 depletion leads to sensitivity to replication 
stress and that the absence of ChlR1 leads to major defects in sister chromatid cohesion, 
how ChlR1 functions to link these two cellular processes remains unclear and is 
undoubtedly worthy of further investigation. The implications of the data described above 



































Figure 4.20.  Co-immunoprecipitation showing an interaction between ChlR1 and 
RPA following an 18h treatment with 2mM HU. IgG was used as a control antibody 
for IP. Inputs are shown in the top panel and IPs on the bottom. This experiment was 
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The involvement of Chl1p, the yeast homologue of ChlR1, in the process of sister 
chromatid cohesion establishment has been well-characterised over the years. The 
observation of major cohesion defects in mammalian cells deficient for ChlR1 in addition 
to the interaction of ChlR1 with cohesin subunits strongly suggests a similar role for this 
protein in human cells [131, 139]. Studies have also shown that ChlR1 interacts with 
components of the replisome as well as the Timeless/Tipin fork protection complex 
suggesting that ChlR1 may be involved at the interface between DNA replication and 
cohesion establishment [21, 65, 68]. Furthermore, recruitment of cohesin has been shown 
to be important in DNA repair processes, particularly in homologous recombination repair, 
and with the recent discovery that ChlR1 mutations are responsible for the phenotypes 
observed in patients with the genetic disorder Warsaw Breakage Syndrome 
(WBS/WABS), the potential role for ChlR1 in the DNA damage response also provides 
scope for exploration. 
Does ChlR1 have a function in DNA damage repair?  
Despite evidence published by other groups using patient-derived cells to investigate the 
sensitivity of ChlR1 mutant cells to various DNA damaging agents [139, 177], no 
significant increase in sensitivity to any of the cytotoxic agents tested was observed in our 
siRNA-mediated ChlR1 depleted cells. However, while the siRNA treatment does 
generally result in a very effective reduction in protein levels, it is possible that in primary 
cells any effect of ChlR1 depletion is much more apparent than in cell lines. Moreover, in 
WABS patients, typically any protein that is present is not fully functional which may well 
result in a more detrimental effect in cells than just depletion of the protein alone.  
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However, while no effect of ChlR1 depletion was observed in cell survival assays, direct 
quantification of DNA damage using the comet assay yielded more interesting data. Here, 
it appeared that in HeLa cells at least, there was a delay in the ability of ChlR1 depleted 
cells to repair damage caused by ionising radiation. Nevertheless, after 3 hours post-IR the 
cells had in fact managed to repair the damage to the same level as the control cells which 
may explain the lack of obvious phenotype in cell survival assays (figures 4.2-4.5). 
The alkaline comet assay quantifies both double and single strand breaks and nicks as well 
as damage caused by alkali labile sites in the DNA. It is therefore a measure of global 
DNA damage in contrast to the adapted neutral comet assay which specifically quantifies 
DNA double strand breaks. As ionising radiation causes a range of molecular lesions in 
DNA, it is possible that the relatively modest effect of ChlR1 depletion could be due to the 
lack of specificity of the assay employed. If ChlR1 is involved in the repair or processing 
of a particular type of DNA lesion, for example, in the processing of a stalled replication 
fork or the repair of a double strand break then this may partially explain the subtle nature 
of the observed defect.  
Sister chromatid cohesion established during S-phase has been shown to be crucial for the 
efficient repair of double strand breaks in S-phase and G2 by facilitating homologous 
recombination [148, 151, 163]. Repair by HR typically requires the sister chromatid to be 
maintained in close proximity for use as a template and thus promoting error-free repair of 
the DNA lesion. However, it has been suggested that in addition to the canonical role of 
cohesin in sister chromatid cohesion, the complex may also be recruited directly to the 
sites of DNA double strand breaks and thus have a role in the DNA repair process that is 
independent from its function in chromatid cohesion [153, 158]. Therefore, one hypothesis 
is that the absence of ChlR1 results in the inability of cells to efficiently recruit cohesin to 
these sites leading to the observed repair defect. Alternatively, the repair delay could 
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simply be the downstream consequence of the impaired sister chromatid cohesion in 
ChlR1 depleted cells which indirectly affects the cells capacity to successfully utilise 
homologous recombination as a repair mechanism. No increased effect of ChlR1 depletion 
on the repair kinetics was observed in cells synchronised by double thymidine block to 
early S-phase, however as HR predominantly occurs only in late-S and G2, repeating the 
experiment during this phase of the cell cycle may be more informative.  
Interestingly, it has been proposed that the process of homologous recombination is an 
important cellular mechanism of replication fork stabilisation and reactivation, distinct 
from its more familiar function in the repair of double strand breaks (reviewed in [17]). 
Mutations in several HR proteins including BRCA2 and Rad51 have been shown to result 
in reduced fork velocity in mammalian cells, a phenotype also observed in ChlR1-depleted 
cells (Parish lab, unpublished). Results from the comet assay performed on cells treated 
with the replication inhibitor hydroxyurea indicate an accumulation of DNA damage in 
ChlR1-depleted cells. This sensitivity to replication stress could thus be linked to the 
impaired ability of ChlR1-depleted cells to efficiently utilise HR mechanisms to stabilise 
or repair damaged replication forks.   
The role of ChlR1 in response to replication stress 
In parallel to the work presented in this thesis, recent data in the Parish lab has shown that 
unperturbed ChlR1 depleted cells have a mild replication defect characterised by their 
reduced replication fork speed as measured by the DNA fibre assay.  In addition to this, 
these cells have also been shown to be less efficient at restarting stalled replication forks 
following treatment with hydroxyurea.  It was therefore hypothesised that the repair defect 
observed in the ChlR1 depleted cells using the comet assays could be replication-
dependent. ChlR1 may potentially function to stabilise inactivated forks or to promote fork 
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restart. This would be consistent with the published interaction between ChlR1 and the 
Timeless/Tipin replication fork protection complex.  
While the accumulation of damage in hydroxyurea treated cells is apparent using the 
alkaline comet assay, the nature of the assay does not allow us to distinguish between 
damage due to forks which have stalled but which can be reactivated and forks that have 
destabilised and collapsed leading to double strand breaks. If ChlR1 is involved in 
replication fork stabilisation it might be expected that in ChlR1 depleted cells there would 
be an increase in double strand break formation as a consequence of replication fork 
collapse. 53bp1 foci are detectable by immunofluorescence at sites of double strand breaks 
and were used as a measure of DSB formation in cells treated with hydroxyurea to induce 
replication stress.  
There was some concern that a 2mM dose of hydroxyurea for 2 hours would not 
necessarily induce fork collapse as it is known that forks treated with either low doses or 
short durations of replication inhibitors can simply stall transiently and then restart after 
removal of the block [37]. However, from the 53bp1 foci assay, a modest increase in foci 
formation is observed after 2 hours of treatment, while after removal of the drug the 
number of foci continued to increase. This suggests that a proportion of the stalled 
replication forks were unable to restart and instead collapsed into DSBs, to which 53bp1 
was subsequently recruited. Western blot analysis also showed that Chk2 phosphorylation 
occurs following a 2 hour treatment of 2mM HU which further confirms that the ATM 
DSB response pathway is activated at this dose. 
The observed increase in foci formation was consistently attenuated in the ChlR1 depleted 
cells after a 1 hour release from hydroxyurea treatment, however at later time points 
following removal of the drug ChlR1 depleted cells appeared to have accumulated an 
168 
 
increased number of foci compared with the control cells. This could potentially indicate a 
delay in the response to double strand breaks generated by collapsed replication forks in 
ChlR1 deficient cells. This supports the hypothesis that ChlR1 functions to promote repair 
of destabilised replication forks, either due to its role in the establishment of cohesion 
which facilitates repair via HR mechanisms, by recruiting cohesin to the sites of DNA 
damage or even perhaps by a more direct role in the repair process. Alternatively this 
increase in 53bp1 foci formation 4-8 hours post-HU may be indicative that in the ChlR1 
depleted cells, forks that have been stalled during treatment with HU have been stalled 
indefinitely and are unable to restart compared with the majority of forks in the control 
cells which stalled transiently and recovered after the inhibitor was removed. It has been 
well established that forks which remain stalled for prolonged periods do not restart and 
usually collapse into DSBs. In these instances global replication is generally rescued by 
new origin firing [60, 62]. It would be extremely interesting to utilise the DNA fibre 
technique to ascertain whether this is indeed the case for ChlR1 depleted cells and this 
would certainly further support the theory that ChlR1 is important for replication fork 
stability and/or restart rather than repair per se. 
53bp1 performs various functions at double strand break sites including the recruitment of 
other DNA repair factors and signalling proteins, checkpoint activation as well as the 
regulation of DNA repair pathway choice [78, 196, 197]. Recruitment of 53bp1 to DSBs 
inhibits end resection by cellular nucleases [78]. This action thus promotes the non-
homologous end joining (NHEJ) repair pathway rather than repair by HR, due to the 
requirement of the latter for end resection to occur. This then allows the association of 
Rad51 to the exposed single stranded DNA, which is one of the key mediators of HR 
repair. Removal of 53bp1 to allow nucleases to gain access to DNA ends is thought to be 
mediated by BRCA1 in a cell cycle dependent manner [79]. Thus, NHEJ is the preferred 
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DSB repair pathway in G1 but preference then shifts to repair by HR in S phase and G2 in 
the presence of a replicated sister chromatid for use as a template. The level of 53bp1 foci 
in ChlR1-depleted cells remains elevated up to 4-8 hours post-hydroxurea treatment which 
could indicate that 53bp1 is not efficiently removed from DSB sites to allow HR to occur. 
Inappropriate repair of replication induced breaks by error-prone NHEJ could lead to 
downstream mutations and rearrangements which could be deleterious to cells. ChlR1 has 
been shown to be essential in mammalian embryonic development and an inability to 
tolerate replication associated DNA damage leading to genomic instability could explain 
the embryonic lethality observed in the mouse model [175]. 
As well as an apparent increase in DNA damage following replication stress as evidenced 
by the comet assay, an increase in PCNA ubiquitination is also observed. This, coupled 
with the comet assay on HU treated cells, supports the idea that ChlR1-depleted cells are 
more sensitive to replication stress. PCNA mono-ubiquitination by the Rad18 ubiquitin 
ligase occurs in response to DNA damage or stalled replication. This mono-ubiquitination 
is traditionally thought to activate the translesion synthesis (TLS) pathway. This pathway 
is responsible for bypassing lesions caused by damaged DNA via recruitment of 
specialised low-fidelity DNA polymerases which are more tolerant of aberrant templates, 
hence allowing replication to bypass the damage [29]. Mono-ubiquitination of PCNA in 
response to hydroxyurea however presents something of a conundrum as no DNA lesion is 
generated that would benefit from the recruitment of alternative polymerases. In this 
instance it is probable that ubiquitination of PCNA acts as a signal or scaffold for the 
recruitment of other repair factors or proteins required to stabilise the replication complex 
at the stalled fork. Interestingly, ChlR1 has been shown to interact with PCNA as well as 
with components of the Timeless/tipin complex which has been shown to be important in 
maintaining replication fork stability, further suggesting that ChlR1 also functions in this 
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process [21, 65]. Additionally, when replication stalls the replicative helicase continues to 
unwind the DNA duplex ahead of the stalled fork leading to long tracts of single-stranded 
DNA that become coated with RPA. Increased association of RPA with chromatin is also 
observed in ChlR1-depleted cells treated with HU, which similarly suggests an increase in 
stalled replication in these cells compared with controls.  
Despite indications that absence of ChlR1 results in an accumulation of replication 
coupled damage, whether this can be attributed to an increase in fork stalling, a decrease in 
fork stability or a defect in the repair processes associated with replication stalling, 
analysis of checkpoint activation and recovery in response to replication stress in these 
cells appears to be normal. Both western blot analyses of checkpoint proteins as well as 
flow cytometry analysis of cell cycle progression in response to HU and CPT is 
comparable with control siRNA treated cells. Since the ChlR1-depleted cells appear to 
activate the intra S-phase replication checkpoint normally after damage and also arrest 
appropriately in response to replication inhibitors, cells are likely prevented from 
continuing through the cell cycle with unrepaired damage or incomplete replication as a 
result of the increase in stalled or collapsed forks. This could suggest that ChlR1 depleted 
cells employ some compensatory mechanisms to rescue replication or to repair the damage 
caused by fork collapse. The former could be facilitated by an increase in new origin firing 
while the utilisation of the NHEJ repair pathway in preference to HR in S-phase to repair 
collapsed forks could circumvent problems caused by the diminished cohesion in ChlR1 
deficient cells and the impact this has on the ability to carry out HR mediated repair. Both 
of these hypotheses could be tested experimentally.  
Experiments evaluating the chromatin association of various proteins in both unperturbed 
ChlR1-depleted cells as well as in cells treated with 2mM HU for 2 hours also yielded 
some interesting data. Encouragingly, ChlR1 appeared to consistently accumulate in the 
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chromatin fraction in response to the HU treatment. This supports much of the previously 
discussed data indicating a role for the protein in replication fork stability or maintenance. 
Unfortunately direct localisation of endogenous ChlR1 by immunofluorescence-based 
techniques was not possible due to lack of appropriate antibodies. The in-house rabbit anti-
ChlR1 antibody was tested for IF using control and ChlR1-specific siRNAs to deplete 
ChlR1 in hTERT-RPE1 cells. Although the knock-down of the protein was approximately 
90% efficient by western blot, there was no reduction in the level or specificity of staining 
as visualised by IF (data not shown). 
Chromatin-association of the cohesin subunits SMC1 and Rad21 did not appear to be 
reduced in ChlR1 depleted cells, which remains consistent with the current body of 
evidence implicating ChlR1 in the process of replication-coupled cohesion establishment 
as opposed to cohesin loading which has been shown to be a separate and temporally 
distinct process in mammalian cells [117, 134]. It was thought that exposure to 
hydroxyurea could potentially lead to an increase in chromatin associated cohesin in 
normal cells due to the phenomenon known as damage-induced cohesion which has been 
extensively characterised in yeast models but which lacks convincing evidence in higher 
eukaryotes [153, 198, 199]. The theory was that in ChlR1-depleted cells this association 
may be reduced if ChlR1 has a role in the specific recruitment of cohesin to double strand 
break sites. Treatment with HU had no effect on the levels of cohesin on the chromatin 
however. This could be a number of explanations for this. As mentioned previously, there 
is little evidence in mammalian systems to suggest that cohesin is actually recruited to sites 
of DNA damage. It is also possible that the level of damage induced by the HU treatment 
is not significant enough to observe any effect, particularly because cohesin is so abundant 
on the chromatin under normal conditions. Any subtle effect is therefore likely to be 
masked when using a basic fractionation method. 
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Timeless, one of the components of the Timeless/Tipin replication fork protection 
complex, showed reduced chromatin association in ChlR1 depleted cells. However, levels 
of Timeless protein in whole cell lysate were also reduced in ChlR1 depleted cells so it is 
possible that ChlR1 is involved in stabilising Timeless, perhaps via its recruitment to 
chromatin in response to endogenous as well as exogenous replication stress. In control 
cells the level of Timeless associated with the chromatin did not appear to increase in 
response to the HU treatment, however in whole cell lysates it was clear that expression of 
Timeless increased in response to both HU and CPT in control cells and to a significantly 
reduced extent in ChlR1 depleted cells. These observations are intriguing and support the 
notion that ChlR1 may somehow be required for the stability of the Timeless/Tipin 
complex. Interestingly, a previous study has shown that reduction of Timeless also leads to 
a reciprocal reduction in the association of ChlR1 with chromatin [65].  
Depletion of Timeless and/or Tipin has been shown to lead to both G2 and intra S-phase 
checkpoint defects [200]. However, as far as can be determined from the experiments in 
this thesis, despite the reduction in Timeless protein levels evident in the ChlR1-depleted 
cells, there is no discernable impact on checkpoint function. It is probable that the 
relatively modest reduction in Timeless protein observed when ChlR1 is knocked down is 
not enough to significantly impact on checkpoint function. Unlike the Timeless binding 
partner Tipin, which associates directly with the replicative helicase and depletion of 
which results in destabilisation of Timeless and leads to major checkpoint defects, it is 
possible that the interaction between ChlR1 and Timeless is important for stabilisation of 
the complex under more specific circumstances, such as at regions of DNA with 
significant secondary structure or highly transcribed regions i.e. conditions which cause 
endogenous replication stress. In co-immunopreciptiation experiments, Timeless and Tipin 
interact both in the presence and absence of HU suggesting their interaction is not 
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mediated or enhanced by replication stress conditions. It would be interesting to 
investigate whether the reported interaction between Timeless and ChlR1 is amplified after 
treatment with agents which induce DNA damage and/or replication stress. 
When investigating the increased monoubiquitination of PCNA in ChlR1-depleted cells, it 
was observed that during treatment with HU, a significant proportion of PCNA appeared 
to dissociate from the chromatin in both control and ChlR1 deficient cells (Figure 4.11). 
The fraction that did remain bound appeared to be the fraction modified by ubiquitin. This 
dissociation is probably indicative of the down-regulation of replication in response to the 
inhibitor, which is more apparent in the ChlR1 depleted cells.  While the fractionation 
experiments performed using the commercial Pierce kit showed no visible reduction in 
chromatin association of PCNA (figure 4.19), it should be noted that in any sub-cellular 
fractionation protocol stringency can vary such that what is described as the chromatin-
associated fraction in one experiment may well be a slightly different pool of cellular 
protein than in another experiment using an alternative protocol.  
Conversely, Rad9, a component of the trimeric protein clamp known as the 9-1-1 complex 
(Rad9-Rad1-Hus1) which exhibits significant structural homology to PCNA, appears to 
increase its association with chromatin in response to HU. This is consistent with 
published reports which show 9-1-1 is a sensor of DNA damage which is recruited to 
stalled replication forks and subsequently loaded onto DNA by the Rad17-RFC complex 
[201]. 9-1-1 is then thought to facilitate the phosphorylation-dependent recruitment of 
Topbp1 which is known to up-regulate the activity of ATR in response to replication 
stress. ChlR1-depleted cells show a greater accumulation of both Rad9 and Topbp1 on the 
chromatin both in the absence and presence of HU which is consistent with our other 
findings suggesting ChlR1-depleted cells are more vulnerable to the effects of replication 
stress, whether endogenous or exogenous. 
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Finally, while these observations have certainly shed further light on the complex role of 
ChlR1 in DNA replication and the response to replication stress, in depth study of the 
function of this protein is still essential to understand the complex nature of its 
involvement in the various aspects of DNA metabolism in which it has so far been 
implicated. Thus far the actual biochemical mechanisms by which ChlR1 carries out its 
function in the processes of cohesion establishment and maintenance of replication fork 
stability have remained elusive and only recently have researchers succeeded in a thorough 
in vitro biochemical analysis of the helicase and its substrates [179]. How this data can be 
interpreted in the context of the current biological evidence informing ChlR1 function will 
be discussed in later chapters. Additionally, by investigating the impact of ChlR1 
mutations associated with the genetic disorder Warsaw Breakage Syndrome an attempt 
will be made to further elucidate the role of ChlR1 in the genome stability maintenance in 














 Characterisation of patient-derived ChlR1 mutations 












5.1. ChlR1 mutations and Warsaw Breakage Syndrome (WABS) 
For many years, much of the understanding of the function of ChlR1 came from genetic 
and biochemical studies of the yeast homologue Chl1. Few studies were carried out in 
mammalian cells directly looking at the role of ChlR1, although data from Jo Parish and 
others largely concluded that the mammalian ChlR1, like it’s yeast counterpart, played a 
crucial role in cohesion establishment. The exact mechanism and biological function of the 
protein, however, remained unclear. 
In 2010, Van der Lelij and colleagues identified a patient with a novel human genetic 
disorder directly attributed to mutations in the ChlR1 gene [139]. The patient presented 
with severe growth defects, abnormal skin pigmentation and microcephaly. This disease, 
which they named Warsaw Breakage Syndrome (WABS) after the location of the affected 
individual, displayed features of both known cohesinopathies such as Roberts Syndrome as 
well as Fanconi Anaemia. Cytogenetic analysis indicated severe sister chromatid cohesion 
defects as well as sensitivity to MMC-induced chromosomal breakage. The patient was 
found to have biallelic mutations in the ChlR1 gene with the paternal mutation resulting in 
an in-frame deletion of a highly conserved lysine residue (ΔK897) at the C-terminus of the 
protein, and a maternal splice site mutation which results in the deletion of the last 10 base 
pairs of exon 22. The maternal mutation is thought to lead to nonsense-mediated decay of 
this product. Very little protein was detectable by western blot from these patient cells 
suggesting that the ΔK897 mutant protein product is also likely to be unstable. Later 
biochemical studies on the ΔK897 protein confirmed that it was indeed less stable than the 
wild-type in thermostability assays as well as consistently producing a significantly lower 
yield in recombinant expression systems. 
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Subsequently, three more patients were identified with a similar phenotype to the original 
WABS patient, all within the same Lebanese family [177]. All were found to have a 
homozygous point mutation in the ChlR1 gene (R263Q). Biochemical analysis of the 
purified protein showed that this resulted in a protein with perturbed DNA binding and 
DNA-dependent ATP hydrolysis, upon which the helicase activity is dependent. Separate 
biochemical studies carried out by Brosh et al using the ΔK897 mutant have shown that 
this protein has a similarly impaired helicase function suggesting that these clinically 
relevant mutations share this feature and also serves to emphasise the probable in vivo 
importance of the helicase function of ChlR1, the exact biological function of which is still 
unclear [179]. 
Recently, yet another patient has been identified with a WABS-like phenotype (G.Stewart, 
University of Birmingham). Although originally diagnosed with the chromosomal 
instability disorder Nijmegen breakage syndrome, this patient was later found to harbour a 
point mutation in the coding sequence of one allele of the ChlR1 gene (c.169G>C 
p.Gly57Arg) while the other allele contains a second point mutation affecting the last base 
of intron 26 (c.2692-1G>A). At the protein level, the major effect of this mutation appears 
to be increased retention of intron 26 resulting in an in-frame insertion of an additional 25 
amino acids. How this affects protein function or stability has not been characterised. 
Western blots for ChlR1 in these patient cells however revealed barely detectable levels of 
a protein which showed no decreased mobility by SDS PAGE. Therefore, it was initially 
assumed that the splice mutation leads to an unstable protein product and the small amount 
of detectable protein present is due to transcription from the G57R mutant allele. However, 
further western blots on patient-derived fibroblasts using our in-house anti-ChlR1 antibody 
do result in multiple higher molecular weight bands and the possibility that a small amount 
of the larger protein is also expressed cannot be definitively excluded.  
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While in vitro biochemical analysis has so far been carried out on two of the known 
patient-derived mutant ChlR1 proteins, little functional cell biology has been undertaken 
with these mutants to determine the actual biological role of ChlR1 in cellular processes. 
Additionally, the G57R mutation has yet to be fully characterised. With this in mind, by 
making use of two patient-derived mutant proteins, as well as an artificially generated 
helicase dead construct (K50R), work was undertaken to try to further our understanding 
of the functional relevance of ChlR1 and the mechanism by which ChlR1 mutations result 
in genomic instability phenotypes. 
 
5.2. Characterisation of patient-derived ChlR1 mutations 
5.2.1. Generation of stable cell lines in G57R patient background 
In order to study the biological significance of these patient-derived ChlR1 mutations, a 
strategy was developed whereby stable cell lines were generated using the G57R mutant 
patient fibroblasts as a genetic background. Using a retroviral-based system, G.Stewart and 
K. Feeney (University of Birmingham) established a panel of five fibroblast cell lines each 
re-expressing either HA-tagged vector only, wild-type ChlR1 or either of three ChlR1 
mutants: K50R, G57R and ΔK897. 
Stable expression of these constructs was determined by western blot analysis using our in-











Figure 5.1. Western blot analysis showing the relative expression of the various 
ChlR1 constructs in the G57R patient background. There is a faint visible band in 
the vector only lane, indicating a small amount of endogenously expressed G57R 
ChlR1 in this background. However, the identity of the higher molecular weight 
bands is not known and it is possible that one of these, perhaps the faint band 
running at 130 kDa, is the larger protein product expressed from the c.2692-1G>A 
allele. Protein concentration was determined by Bradford assay and 20ug of total 
protein loaded in each lane. 
 
From the western blot it seems there remains a small amount of endogenously expressed 
G57R ChlR1 protein present in the vector only cell line as expected. While the re-
introduced wild-type and K50R mutant proteins both express well, the G57R and ΔK897 
protein levels are significantly reduced by comparison. It is possible that, like the ΔK897 
mutation, the G57R point mutation also affects protein stability.  
 Localisation of endogenous ChlR1 had previously been attempted in both RPE1 and HeLa 
cell lines, however the lack of availability of an antibody which works well for 
immunofluorescence led to limited success of previous localisation studies. The panel of 
ChlR1 






fibroblast cell lines presented an opportunity to study the localisation of the wild-type and 
ChlR1 mutant proteins by utilising their HA epitope tag. Immunofluorescence images 










































Figure 5.2. Immunofluorescence images showing the localisation of the HA-ChlR1 
proteins. Coverslips were stained with a commercially available HA 9110 antibody 
(Abcam) followed by detection with Alexa 488 conjugated secondary antibody 
(Invitrogen). Hoescht 33342 was used as a nuclear counterstain. All images were 
taken at the same exposure using a Zeiss inverted epifluorescent microscope fitted 
with a 60x oil immersion objective. Images shown are representative of two 
independent experiments. 
 
Wild-type and the K50R mutant ChlR1 proteins are predominantly localised to the 
nucleus, with particularly strong nuclear staining apparent in the K50R mutant. There also 
appears to be some enrichment in the nucleolus which correlates with the original 
observations of Lahti and colleagues. This may be cell type dependent as nucleolar 
enrichment was not observed in a subsequent publication by Parish et al. This might also 
be explained by differences in the slide preparation and staining procedures. Although it is 
clear from the western blot that the G57R and ΔK897 proteins are less well expressed, it 
still appears that the localisation of these proteins is more diffuse with increased 
cytoplasmic staining compared with wild-type or K50R. 
 
5.2.2. Cohesion defects in fibroblast cell lines are rescued by wild-type ChlR1 
Metaphase spread analysis of the vector only line and the three ChlR1 mutant fibroblast 
cell lines indicated the presence of severe cohesion defects, either ‘rail-road’ type 
chromosomes or premature chromatid separation (PCS), consistent with the WABS 
phenotype (figure 5.3a). The cell line stably expressing wild-type ChlR1 however showed 
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significant rescue of the cohesion defect (figure 5.3b). Interestingly, upon analysing the 
percentage of metaphases displaying the more severe PCS phenotype across the different 
cell lines, it appeared that both the K50R mutation and the ΔK897 may have a slightly 
higher incidence of PCS (figure 5.3c). It must be noted that the number of metaphases 
counted for each cell line was relatively low due to the very slow proliferation of these 
cells and it was difficult to accumulate enough metaphase cells to perform the experiment. 
Indeed, for many subsequent experiments the point must be made that statistical 









































































































Figure 5.3. Quantification of metaphase spreads on the five fibroblast cell lines. 
Metaphases showing 1 or more ‘railroad’ chromosome were scored as having a 
cohesion defect, as were metaphases displaying premature chromatid separation 
(PCS). Examples of these cohesion defects are shown in (a). The total percentage of 
metaphases in each cell line with cohesion defects is shown in (b) while (c) indicates 
the percentage of metaphases with PCS only. N=30-50 for each cell line. This 
experiment was only performed once due to the difficulty in culturing the fibroblast 
cell lines. 
 
5.2.3. Sustained checkpoint activation in ChlR1 mutant cell lines 
To further understand the functional significance of the ChlR1 mutations and to relate the 
patient cell phenotypes to what had been observed in the knock-down system described in 
results chapter 2, each of the fibroblast cell lines were treated with 2mM HU for 2 hours to 
perturb DNA replication. This leads to rapid activation of the Chk1 pathway as well as 
phosphorylation of H2AX (γ-H2AX) at stalled forks. Figure 5.4 shows a panel of western 



















Figure 5.4. Western blot panel showing Chk1 and H2AX phosphorylation in response 
to HU across the panel of fibroblast cell lines. β-Actin is included as a loading control. 
Western blots are representative of three independent experiments. 
 
All five cell lines show normal activation of Chk1 in response to HU, however the K50R 
and the ΔK897 mutants appear to show sustained activation of the pathway following 
removal of the drug. They also both show sustained γ-H2AX in response to the HU 
treatment. Interestingly, these are the same mutants that show an increased incidence of 
PCS upon analysis of metaphase spreads. Biochemical analysis carried out on purified 
samples of these proteins confirmed that they both lack the ability to hydrolyse ATP and 








available as yet for the G57R mutant so it is potentially feasible that this protein retains its 
helicase function thus allowing for normal checkpoint recovery. 
 
5.2.4. Helicase dead K50R mutant still interacts with the cohesin complex 
The fact that two of the known ChlR1 patient mutations linked to WABS result in proteins 
with impaired helicase activity strongly suggests that the helicase function of the protein is 
crucial and when absent has serious biological consequences. It is still unclear exactly 
what role this helicase function plays in either cohesion establishment or during DNA 
replication or damage repair. For example, do the helicase dead mutant proteins still 
interact with the cohesin complex? Co-immunoprecipitation experiments using the 
fibroblast cell lines were carried out using an anti-HA antibody to immunoprecipitate (IP) 
the ChlR1 proteins. IPs were then probed with anti-ChlR1 or anti-Rad21 antibodies to 






















Figure 5.5. Co-immunoprecipitation (Co-IP) experiment using anti-HA antibody 
(Abcam) to immunoprecipitate the HA-tagged ChlR1 proteins. Inputs (2.5%) are 
shown in the top panel, IPs are shown in bottom panel. Different exposures were used 
for the inputs and IPs. This experiment was only performed once due to difficulties in 















The co-IPs show that the K50R mutant still interacts with the Rad21 component of the 
cohesin complex. The wild-type protein also co-IPs Rad21 as expected. It is less clear 
whether this is true for either of the patient mutations on the panel. Even though there is no 
clear band visible in the co-IP for either the G57R or the ΔK897, this may simply be due to 
the relatively low expression of these proteins and the fact that the co-IP conditions may 
not be optimal.  For example, the interaction between ChlR1 and the cohesin complex me 
be specific to S-phase when sister chromatid cohesion is established. The fibroblast cell 
lines on the other hand grow very slowly and are likely to be predominantly in G1 at any 
given time. 
These data suggest that, at least in the case of the K50R mutation, absence of helicase 
activity does not impact on its ability to interact with the cohesin complex. The fact that 
cohesion defects are still prominent in the K50R mutant even though interaction with 
Rad21 is not disrupted suggests that inability to interact with the cohesin complex is not 
the most likely mechanism behind the ChlR1 mutant phenotype. Rather, this suggests that 
it is probably the intrinsic helicase activity of ChlR1 that is crucial for its biological 
function in DNA metabolic processes. This will be explored in detail in the discussion 
section of this chapter. 
 
5.2.5. G2 checkpoint defect in ChlR1 mutant cells 
Having found evidence of severe cohesion defects in all the mutant cell lines, rescued only 
by re-expressing wild-type protein, the G2 checkpoint was targeted for investigation to 
determine whether these cells were perhaps entering into mitosis when they shouldn’t due 
to a defective checkpoint. Cells were treated with 3gy of gamma-IR and allowed to recover 
for 2 hours and 8 hours before being fixed and analysed by flow cytometry for the 
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presence of mitotic cells. After 2 hours post-IR it would be expected that the majority of 
cells should have arrested in G2 if the checkpoint is intact. This is evidently the case in the 
wild-type, however it appears that the vector-only and the three mutant lines do indeed 
have a partially defective G2 checkpoint with more cells continuing to enter mitosis 
despite IR treatment (figure 5.6). This defect is more prominent in the vector-only cell 
line, which as discussed above, only express a very small amount of mutant protein. This 
differs from our knock-down system described in chapter 4, in which no checkpoint defect 
is apparent, in that the residual protein remaining after siRNA treatment is obviously wild-
type. The reduction at the 8 hour time point may be caused by a G1 arrest that prevents 
cells from cycling back into mitosis. Or taking into account the timing, could be more 
likely attributed to activation of an intra-S phase checkpoint that prevents mutant cell lines 
from completing S phase and entering mitosis after 8 hours while the wild-type cells 







Figure 5.6. IR-induced G2 checkpoint arrest is deficient in the mutant fibroblast cell 
lines. Flow cytometric analysis of mitotic entry using phospho-H3 staining to detect 
mitotic cells. Each cell line was normalised to its own untreated sample which was set 
to 100%. The number of mitotic cells post-IR was then expressed as a proportion of 
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Characterisation of these patient mutations has been hindered by the technical difficulties 
encountered through working with this particular cell system. As such, much of the above 
data is very preliminary and requires further confirmation. However, it is clear that the 
cohesion defect phenotype and G2 checkpoint defect exhibited by the patient cells can be 
rescued by re-expressing wild-type ChlR1 protein, further confirming the functional 
importance of ChlR1 in these WABS patients. Over-expression of either the G57R, or the 
two helicase-dead mutants K50R and ΔK897, does not appear to have the same effect. 
Furthermore, while the G57R mutant has yet to be biochemically characterised, there 
appeared to be a striking difference between this mutation and the confirmed helicase dead 
mutants upon analysis of Chk1 activation in response to HU. The G57R cells (in case of 
both the vector-only and the G57R over-expressing cell line) showed the same rapid de-
phosphorylation of Chk1 as wild-type upon removal of the drug. It will be interesting to 
discover whether this difference in some way corresponds to some retention of helicase 
activity in this mutant. This mutant also showed a lower incidence of PCS, perhaps 
indicating some milder abrogation of function compared with those which have previously 









As discussed above, one of the main difficulties in studying the in situ effects of these 
ChlR1 mutations was successfully culturing and maintaining the patient-derived fibroblast 
cell lines which were the system chosen for these experiments. Their slow proliferation 
and tendency to rapidly senesce after only a few passages posed a challenge for 
experiments where significant cell numbers were required, for example the analysis of 
metaphase spreads. Because of this, statistical significance was unfortunately not obtained 
in the majority of the experiments discussed here. However, despite this caveat, the 
observations made do support previously published findings regarding the association of 
ChlR1 mutations with the cellular WABS phenotype as well as hinting at the possibility of 
phenotypic differences, at least at the cellular level, depending upon the nature of the 
mutation.  
While there were certainly some difficulties with the stable cell lines, the availability of the 
HA epitope tag on the re-expressed proteins did provide an opportunity to analyse the 
localisation of these ChlR1 mutant proteins, albeit in an overexpression system. Although 
the proteins all expressed at different levels, a comparison between the wild-type and 
K50R mutant showed no obvious difference in localisation, both displaying strong nuclear 
staining. On the other hand, despite the G57R and ΔK897 proteins obviously reduced 
levels of expression, both did appear to show more diffuse cytoplasmic staining. 
Interestingly, the in vitro biochemical study carried out by Brosh and colleagues indicated 
that the ΔK897 protein was unable to bind DNA, unlike the artificially generated K50R 
mutant which still bound DNA despite lacking the ability to hydrolyse ATP. The observed 
differences in subcellular localisation could be taken to correlate with the Brosh data as it 
is conceivable that the inability of the ΔK897 to bind DNA in the cell might thus lead to 
increased nuclear exclusion and/or decreased protein stability. As there is currently no 
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biochemical data available for the G57R protein, it is possible that this protein may also 
have perturbed DNA binding. This, however, along with the potential helicase function of 
the G57R mutant, remains to be determined. 
Metaphase spread analysis of the fibroblast panel confirmed that re-expressing the wild-
type protein rescued the cohesion defects present in the mutant cell lines. This supports the 
evidence in the literature linking ChlR1 mutations with the WABS phenotype. However, 
overexpression of the mutant proteins did not rescue the defect. While the helicase activity 
status is unknown in the case of the G57R mutant, both the K50R and the ΔK897 have 
been shown in biochemical studies to be helicase-dead. In addition, the ΔK897 protein has 
also been shown to be unstable [179], data which is supported by its comparatively low 
expression in western blot analyses (fig 5.1). The K50R mutant protein on the other hand, 
expresses as well as wild-type and has been shown to be equally stable in in vitro 
experiments [174, 179]. Therefore it can be concluded that the helicase activity of ChlR1 
is essential to its biological function and abrogation of this activity likely leads to the 
cohesion defects observed in WABS patients. Furthermore, although attempts to determine 
whether the panel of ChlR1 mutants could still interact with the cohesin complex were 
hindered by the low expression levels of the ΔK897 and G57R proteins, it was clear that 
the K50R mutant still interacted with the Rad21 subunit. This suggests that the cohesion 
defects observed in WABS patient cells are unlikely to be a direct consequence of 
abolishing the interaction between ChlR1 and cohesin and more likely due to loss of 
helicase function. 
While attempting to explore whether the WABS cohesion defect was the result of an 
underlying problem with DNA replication or the ability of cells to tolerate replication 
stress, it became apparent that while all of the cell lines responded to HU treatment by 
activating Chk1 as expected, only the wild-type, the vector only and the G57R mutant 
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appeared to show the corresponding de-phosphorylation and continuation of replication 
following removal of the drug. This is consistent with data obtained using siRNA to knock 
down endogenous ChlR1 in the RPE1 cell system where no difference in Chk1 activation 
and recovery was observed between ChlR1 and control siRNA-treated cells.  The two 
confirmed helicase-dead mutants on the other hand showed sustained Chk1 activation, 
presumably indicating continued stalling of replication and S-phase arrest. This could 
potentially be explained by considering that the presence of an overexpressed inactive 
mutant is more detrimental that having little or no active protein present at all (as would be 
the case in the knock-down system or in the vector only cell line). Particularly in the case 
of the K50R mutant which can still bind DNA and might therefore present a physical 
obstacle to the use of alternative pathways for replication recovery. Moreover, while the 
ΔK897 has been shown not to bind DNA in vitro there is still the possibility that it retains 
the ability to interact with other ChlR1 binding partners and in doing so prevent efficient 
resolution of replication-coupled damage. 
The intriguing observation that the G57R mutant protein behaves similarly to wild-type 
protein in this assay raises the possibility that this particular mutant may well retain some 
or all of its helicase activity. This would suggest that the WABS phenotype observed in 
this patient is due to either the reduction in total ChlR1 protein levels or a partial reduction 
in helicase activity rather than complete abrogation of function. It is perplexing however 
that despite this apparently normal response to HU treatment and recovery, overexpression 
of the G57R mutant does not actually rescue the cohesion defect. Whether this is because 
the protein is in fact helicase-dead or only partially functional, or whether this is indicative 
of an additional helicase-independent function of ChlR1 requires further investigation. 
Interestingly, analysis of the G2 checkpoint in the fibroblast panel indicated that all the 
mutants had a slightly defective checkpoint in response to IR with the vector only cell line 
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exhibiting a more severe defect than the others. This lends some credence to the notion 
that there may well be an alternative helicase-independent checkpoint function for ChlR1 
that has yet to be thoroughly explored. 
As discussed in the introduction to this chapter, there does remain some ambiguity with 
regards to the potential product of the second mutant allele (c.2692-1G>A) in the G57R 
patient fibroblasts and its effect on protein expression and function. While highly 
speculative, it is possible that the addition of an extra twenty-five amino acids at the 
extreme C-terminus of the protein results in an unstable product that is rapidly degraded. 
While there is no tangible evidence of this, the somewhat surprisingly severe biochemical 
consequences of a single amino acid deletion at the C-terminus represented by the ΔK897 
mutation would suggest that the protein is highly sensitive to disruption at this location.  
In choosing to perform the experiments described above in this patient background, 
interpretation of the results becomes somewhat challenging. The biochemical properties of 
the G57R mutant protein have not been characterised and it is still not entirely clear if a 
protein product is produced from the second mutant allele. If both protein products are in 
fact present in the patient cells, albeit at low levels, drawing any concrete conclusions with 
regards to the G57R mutation and its function is untenable.  In an attempt to circumvent 
this issue, stably-transfected RPE1 cell lines were generated using the same mutant 
constructs used to transfect the fibroblasts. It would therefore be possible in future to use 
these cells to repeat some of the experiments discussed above and further characterise the 
mutants without the uncertainty of the patient background. Using RPE1 cells instead of 
primary fibroblasts would also avoid many of the technical difficulties experienced when 
culturing the fibroblast lines. However, the caveat to this as an alternative system is that 
the endogenous wild-type ChlR1 would have to be knocked down with siRNA which is 
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not ideal from a practical perspective as well as inevitably resulting in a small amount of 
wild-type protein remaining in cells and thus potentially complicating matters further. 
Finally, while the novel G57R mutant has not yet been biochemically characterised, at 
least two clinically relevant ChlR1 mutations are known to abrogate the helicase activity of 
the protein. It is therefore tempting to speculate that this enzymatic function of ChlR1 is 
crucial for the in vivo functions of the protein, some of which have been investigated in 
previous chapters of this thesis. Furthermore, the data from these biochemical studies has 
provided invaluable information on ChlR1 substrate specificity that allows important 
insight into how ChlR1 potentially functions in DNA metabolism and genome 
maintenance. The concluding chapter of this thesis will attempt to discuss the functional 
biological data presented thus far in the context of these recent biochemical studies with 


























ChlR1 is a member of a family of proteins known as the DEAD/H box helicases which 
also includes other helicases known to have important roles in genome stability 
maintenance such as RTEL, XPD and FANCJ (reviewed in [202]). Structurally, these 
proteins all contain a conserved iron-sulphur (Fe-S) cluster motif that appears to be crucial 
for protein function.  Indeed, one of the fundamental concerns when attempting to purify S. 
pombe Chl1 was preserving the structural integrity of this Fe-S motif by preventing 
oxidation. Although purification to the standard of homogeneity required for biochemical 
or structural analysis was never achieved, the observation that the protein preparations 
were coloured with a yellow-green tinge strongly suggested the presence of an iron-
binding protein with an intact binding cluster. Several classes of proteins with diverse 
cellular functions are known to contain this Fe-S motif and as a result both structural and 
functional roles have been proposed for this domain. Structural and biochemical studies of 
other Fe-S helicases however, coupled with site-directed mutagenesis to disrupt the 
domain integrity, have provided insight into how the Fe-S cluster in this instance 
potentially functions to allow the recognition of the boundary between single and double 
stranded DNA and promote the strand displacement critical to duplex unwinding [203, 
204]. Additionally, clinically relevant mutations that disrupt the integrity of the Fe-S 
cluster have been identified in both XPD and FANCJ, leading to the genetic disorders 
trichothiodystrophy (TTD) and Fanconi Anaemia respectively [204]. At least one recently 
described patient derived mutation in ChlR1, which leads to the WABS phenotype, also 
disrupts the Fe-S cluster and severely abrogates the helicase function [177]. 
In the cases of both XPD and FANCJ, different mutations have the potential to lead to 
different disease phenotypes. In fact mutations in XPD are linked to three distinct genetic 
disorders: Xeroderma Pigmentosum, Cockayne’s Syndrome and TTD. FANCJ mutations 
on the other hand have been linked to both Fanconi Anaemia and an increase in breast 
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cancer susceptibility. Currently it is not known whether the same may be true of mutations 
in ChlR1 however the recent data generated in the Parish lab suggests that the novel G57R 
mutation may represent a variant with a biochemical phenotype distinct from the patient 
mutations which have so far been characterised. The patient from whom this mutation was 
derived was originally diagnosed with Nijmegen Breakage Syndrome (NBS) which has a 
very similar clinical presentation to WABS although no mutation in NBS1 was 
subsequently detected [205]. This patient, unlike the other WABS patients who have been 
identified thus far, displayed hypersensitivity to X-rays which normally confirms a 
diagnosis of NBS in conjunction with the other clinical features. It is therefore possible 
that, similar to other related helicases, mutations in ChlR1 can lead to a spectrum of 
clinical phenotypes depending upon the nature and function of the particular mutation. 
Remarkably, a variant of FANCJ identified in women with early-onset breast cancer 
actually showed an increase in ATPase and helicase activities compared with wild-type 
protein in in vitro assays [206]. How this apparent gain of function mutation contributes to 
cancer development or progression is not yet understood but interestingly, recent 
experiments in the Parish lab have suggested that in terms of replication fork speed the 
G57R re-expressing mutant appears to be slightly faster than wild-type and the cells 
themselves also seem to proliferate at a faster rate (K. Feeney, unpublished). Whether this 
is a truly gain of function mutation has yet to be determined and only through purification 
and biochemical analysis will better understanding of the nature of this mutation be 
achieved. 
Biochemical characterisation of the substrate preference of purified recombinant ChlR1 
protein showed that the helicase preferentially unwound forked duplex structures and that 
it favours a 3’ overhang of 5-10 nucleotides for optimal activity. In the same study the 
ΔK897 patient-derived mutant protein was also purified and characterised but showed no 
201 
 
catalytic activity on any of the substrates tested [179]. This is in contrast to a second study 
that attempted to characterise another clinically relevant mutant of ChlR1, R263Q, which 
at high concentrations showed some residual helicase activity on forked duplex structures 
[177]. The WABS patients with the homozygous R263Q mutation did not display the same 
skin pigmentation abnormality observed in the original WABS patient and also had a more 
severe intellectual disability, further underlining the potentially heterogeneous nature of 
ChlR1-associated disease phenotypes. Interestingly, the R263Q mutation results in the 
substitution of glutamine for a highly conserved arginine residue in the Fe-S domain. The 
Fe-S motif has been shown to be essential for the helicase activity of FANCJ and XPD and 
in fact the equivalent mutation in XPD results in loss of helicase activity, defective 
nucleotide excision repair as well as a reduction in the protein levels of the transcription 
factor TFIIH of which XPD is a crucial component [204]. It is possible that disruption of 
the structural integrity of the Fe-S domain not only abrogates the helicase activity of 
ChlR1 but also disrupts other important protein-protein interactions that further impacts 
upon function. This is particularly important to consider as some of our data could be 
taken to indicate a helicase-independent checkpoint function for ChlR1, although this 
requires further verification. With this in mind, more in depth biochemical and functional 
characterisation of the novel G57R mutation could be crucial in further defining the 








K50R Point mutation in Walker A box. Binds DNA but cannot 
hydrolyse ATP. Helicase dead. 
G57R Point mutation near the helicase domain. Biochemically 
uncharacterised. 
ΔK897 Deletion of a lysine residue at the extreme C terminus. Does not 
bind DNA in vitro 
R263Q Point mutation of a conserved arginine residue in Fe-S domain. 
Some residual helicase activity at high concentrations in vitro 
 
Table 5. Table explaining the biochemical properties of the ChlR1 mutant proteins 
 
The in vitro biochemical characterisation of wild-type ChlR1 also suggested that ChlR1 
was able to unwind some varieties of G4 quadruplex DNA structures. These are DNA 
secondary structures thought to arise in G-rich tracts of DNA sequence which may thus 
impede crucial cellular processes such as replication, transcription and repair if not 
successfully resolved by the cellular machinery [207]. However, treatment of ChlR1-
depleted U2OS cells with the G4 stabilising ligand telomestatin did not result in any 
increase in markers of DNA damage compared with control cells [208]. Depletion of the 
related helicase FANCJ on the other hand showed a marked increase in γH2AX foci 
following treatment with the drug. It is therefore not conclusive whether the in vitro G4 
unwinding ability of ChlR1 has real physiological relevance in vivo. Nevertheless, in C. 
elegans, a double mutant of CHL-1 and DOG-1 (the putative FANCJ homologue in 
worms) showed an increase in the number of deletions upstream of polyguanine tracts 
compared with those observed in the DOG-1 mutant alone, although no deletions were 
apparent in the CHL-1 single mutant. The authors suggest that this points to a potential 
role for CHL-1 in resolving G4 structures that lead to genomic instability either in the 
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absence of DOG-1 or in specific circumstances such as during DNA replication [209]. It 
must be noted however that additional mutations in cohesin subunits as well as in HR 
proteins also lead to an exacerbation of the DOG-1 mutant phenotype which could also 
suggest that it is the more general homologous recombination repair pathway that is 
utilised to compensate for or prevent potentially deleterious genomic deletions that occur 
in the absence of DOG-1. This does not negate a role for CHL-1 in the specific resolution 
of G4 quadruplex structures but perhaps the downstream cohesion defect and its impact on 
HR repair presents an equally viable alternative explanation for the above observations. It 
would nonetheless be interesting to test the effects of telomestatin treatment on a ChlR1 
FANCJ double knockdown to determine whether a similar additive effect on DNA damage 
can be observed in human cells.  
In the same study by Brosh and colleagues, ChlR1-depleted cells treated with an inter-
strand crosslinking agent did show an increase in DNA damage which would seem to be 
consistent with the observation that cells derived from WABS patients are sensitive to 
MMC. Although in our hands ChlR1-depleted cells showed no increased sensitivity to 
MMC, it should be noted that both the cell type and biological endpoint used were 
different. Use of the comet assay to analyse the response of ChlR1-depleted cells to cross-
linking agents such as MMC or cisplatin may well yield different results compared with 
the cell survival assays that we initially employed. Our comet assay data which shows that 
ChlR1-depleted cells are more sensitive to hydroxyurea mediated replication stress, as well 
as the published data indicating WABS patient cells are also sensitive to camptothecin 
which causes stabilisation of the topoisomerase-DNA intermediate rather than a DNA 
crosslink, supports the hypothesis that the observed cellular sensitivity to MMC is 




Comet assay data published recently by the Noguchi lab appears to confirm that following 
treatment with cisplatin, ChlR1-depleted cells show elevated levels of DNA damage [178]. 
They follow this up with evidence that suggests ChlR1-depleted cells which have been 
arrested by hydroxyurea are less able to resume replication when released into fresh 
growth medium containing cisplatin compared with control-treated cells. Presumably, this 
indicates that ChlR1 is required for processing cisplatin-induced DNA crosslinks during 
DNA replication but does not necessarily confirm that ChlR1 is required for replication 
restart. Another caveat to this experiment is that prolonged treatment with hydroxyurea has 
been shown to lead to fork collapse whereby rescue is only possible through new origin 
firing. It is therefore difficult to definitively conclude that restart of stalled forks is actually 
being measured in this instance rather than simply re-initiation of replication from new 
origins. Perhaps a better approach to answer that particular question would be to simply 
transiently arrest cells with hydroxyurea and then assay for replication restart in the 
absence of further drug treatment. Although using an alternative assay to Noguchi and 
colleagues, DNA fibre data from the Parish lab has attempted to shed further light on the 
potential role of ChlR1 in the restart of stalled replication forks. Our data suggest that 
depletion of ChlR1 does lead to an impaired ability to resume replication following 
hydroxyurea treatment, supporting a role for ChlR1 either in replication fork restart or in 
stabilisation of the stalled fork. 
Finally, another potentially exciting observation was reported by the Brosh and colleagues 
in their biochemical analysis of ChlR1 activity [179]. In addition to the traditional ability 
of a helicase to unwind DNA duplex structures, ChlR1 was also able to successfully 
disrupt the interaction between a tetrameric streptavidin complex bound to a biotinylated 
single stranded oligonucleotide. Other functionally related helicases were unable to 
successfully disrupt the complex as effectively under similar conditions suggesting that 
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this novel ability to remodel protein-DNA structures may be mechanistically important for 
the in vivo function of ChlR1. Indeed, in another recent publication, the Brosh lab reported 
that in the case of several helicases, including FANCJ and RECQ1, their ability to 
facilitate the displacement of proteins from DNA is stimulated by interaction with the 
single-strand binding protein RPA [210]. There is some evidence to suggest that under 
certain circumstances ChlR1 also interacts with RPA and it is therefore possible that this 
association somehow promotes the ChlR1-mediated removal of proteins from DNA to 
promote the successful completion of cellular processes such as replication recovery and 
damage repair. Although helicases are well-characterised in terms of their ability to 
unwind DNA, currently there is relatively little understanding of the mechanisms by which 
they might also utilise their intrinsic ATPase motor activity to disrupt DNA-protein 
interactions and how this may be biologically relevant. This presents yet another avenue 
for potential further study in terms of ChlR1 function, particularly given the well-
characterised roles of the protein in sister chromatid cohesion and DNA replication, 
processes where it can easily be imagined that this remodelling function of ChlR1 could be 
biologically important.  
It has been shown in this work and by others that ChlR1 has a role in the cellular response 
to replication stress. Clinically relevant ChlR1 mutations have also been identified in 
patients with a severe genetic disorder characterised by a cellular sensitivity to agents 
which cause replication stress. Furthermore, a recent study has indicated that ChlR1 is not 
only highly expressed in both primary and metastatic melanomas but that ChlR1 
knockdown in these cells results in reduced proliferation, cohesion defects and apoptosis 
[211]. Thus ChlR1 may be an important candidate gene for targeted treatment in the case 
of this extremely aggressive type of cancer. Further biological characterisation of ChlR1 
and patient-derived variants will therefore be central to furthering our understanding of the 
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precise molecular mechanisms underlying ChlR1 function and allow exploitation of its 
potential as a cancer target. 
 
Future work 
Biochemical characterisation of the novel ChlR1 WABS-associated mutation, G57R, will 
be crucial to furthering our understanding and interpretation of the differences in 
checkpoint function observed in the complemented fibroblast cell lines. Determining 
whether this protein retains its helicase activity despite the clear manifestation of a clinical 
WABS phenotype in these patients could shed new light on the potential mechanism by 
which ChlR1 mutations lead to this disease. In addition, comprehensive analysis of 
replication fork dynamics in these complemented patient cells using the DNA fibre 
technique could also be important for investigating the in vivo consequences of ChlR1 
mutations on replication fork progression and stability. It could also allow analysis of how 
these mutations impact on the replication checkpoint. However, the limitations of the 
stable fibroblast cell lines have been discussed in detail within this thesis and development 
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